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 Chapter 1 
Introduction 
 
1.1 Different conformational states are populated during life-span of proteins 
Proteins are among the most important molecules in living organisms as they carry 
out a variety of different and fundamental functions. The function of a given protein is 
directly related to the unique features of its functional state, which determines partners, 
ligands or substrates. Nevertheless, during their life-span proteins can adopt many dif-
ferent conformational states (Chiti and Dobson 2006). 
With reference to figure 1.1, proteins are synthesized on ribosomes from the ge-
netic information encoded in the cellular DNA. In some cases the protein is biologi-
cally active directly after translation, even though it populates an unfolded state 
(Dunker et al. 2001). In many other cases proteins need to achieve a folded structure to 
be functional. Folding in vivo is in some cases co-translational, implying that it is ini-
tiated before protein synthesis is completed, when the nascent chain is still attached to 
the ribosome (Dobson 2003). Other proteins, however, undergo folding after release 
from the ribosome, whereas others fold in specific compartments, such as mitochon-
dria or the endoplasmic reticulum (ER), after trafficking and translocation through 
membranes (Dobson 2003). In the majority of cases, folding in cytoplasm, ER and my-
tochondria is chaperon assisted (Bukau et al. 2006). The native state of the protein is at-
tained through formation of partially folded conformations. Native proteins can then 
interact with partners to form functional oligomers or polymers. Regulation of these 
processes is crucial for cells as errors in folding can give rise to potentially dangerous 
folds (Jahn and Radford 2005; Chiti and Dobson 2006). In physiological conditions 
misfolded peptides are either refolded or degraded but, if this protein quality control is 
impaired, they can expose sticky regions and form toxic oligomers. These species can 
give rise to β-strand rich protofibrils and fibrils (see section 1.3). In the next sections 
the processes of folding and misfolding, that represents topics of the present thesis, are 
discussed in detail. The problems that will be discussed in the next chapters will also be 
introduced. 
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Figure 1.1: Different conformational states can be populated by a polypeptide chain. A nas-
cent protein folds to reach a native and biologically active state. During this process partially 
folded conformations are transiently populated. Native states can form oligomers or poly-
mers. At the end of its life-span a protein is degraded. The equilibrium between these species 
is crucial as folded, partially folded and unfolded states can aggregate. These aggregates can be 
either off-pathway (top of the figure) or on-pathway (bottom of the figure) and initially 
maintain the structural features of the precursor conformational states. They can later reor-
ganise to form β-sheet containing aggregates and then amyloid. Reprinted from (Chiti and 
Dobson 2006). 
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1.2 Protein folding 
1.2.1 Definition of the protein folding problem 
Protein folding is the physical process by which a polypeptide chain changes its con-
formation to reach a biologically active three-dimensional structure. After decades of 
studies, protein folding has been recently named by Science among the 100 biggest un-
solved problems in science (Editorial 2005). Traditionally, the protein folding prob-
lem is made by three distinct problems (Dill et al. 2007): 
1. The thermodynamic question of how a native structure results from the inter-
atomic forces acting on amino acid sequence (the folding code). This problem first 
arose when Christian B. Anfinsen showed that the three-dimensional structure of 
a protein is encoded by its amino acid sequence (Anfinsen et al. 1961; Anfinsen 
1973). Although much work must be done to address this issue, it is now clear 
that the folding code is distributed both locally and not locally in sequence, that its 
dominant component is the hydrophobic interaction and that secondary structure 
is more a consequence than a cause of folding (Dill 1999). Moreover, novel pro-
teins are now being designed as variants of existing proteins (Dwyer et al. 2004; 
Kaplan and DeGrado 2004). 
2. The computational problem of how to predict three-dimensional structures 
solely on the basis of the primary sequence of polypeptides. To address this is-
sue, two different approaches have been proposed to date: (1) the development of 
algorithms that use amino acid sequences as an input and produce, by homology 
modelling, structures as an output. A major milestone in this field is CASP 
(Critical Assessment of Techniques for Structure Prediction), a community-
wide blind test to predict unknown structures (Moult 2006). Currently, struc-
tures of small globular proteins (i.e. about 90 residue long peptides) can be pre-
dicted within RMSD of 2-6 Å (Bradley et al. 2005; Zhang and Arakaki 2005). (2) 
The development of physics-only methods aimed to understand the final struc-
ture without database-derived knowledge. Although these methods are limited 
by huge computational requirements, using a distributed computing system 
(Folding@Home) Pande et al. folded villin to a distance RMSD of 1.7 Å 
(Zagrovic et al. 2002). 
3. The kinetic question of how, and with which mechanism, can a protein fold so 
quickly. In 1968 Cyrus Levinthal first pointed out that, if a given protein is to attain 
its correctly folded configuration by sequentially sampling all the possible confor-
mations, it would require a time longer than the age of the universe to arrive at its 
correct native conformation (Levinthal 1969). Solving Levinthal’s paradox implies 
that folding proceeds in a step-wise manner and that several intermediates with in-
creasing native-like structure are populated along the folding coordinate. In the past 
two decades major advances have been done in folding experiments and possible 
mechanisms of protein folding have been proposed (sections 1.2.2 and 1.2.3). 
1.2.2 The early studies and the characterisation of intermediates 
As a consequence of the Levinthal’s paradox, the idea emerged that the characterization 
of partially folded states transiently populated during folding would give important  
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Figure 1.2: (A) Partially folded states (I) can play different roles in folding. They can be (1) on-
pathway intermediates, (2) off-pathway partially folded states, (3) local minima transiently 
populated in one of many parallel pathways that lead to the formation of the native state (F). 
U refers to the unfolded state. (B) An example of energy landscape for folding of hen egg 
lysozyme (reprinted from (Dinner et al. 2000)). In this graph free energy is reported versus the 
number of native contacts in α (Qα) and β (Qβ) domains. Two parallel pathways are shown. A 
fast pathway (yellow line) directly leads to the formation of the transition state and thus to 
attaining the native state. A slow pathway (red line) leads to the formation of a conformation 
that is in a local minimum, corresponding to a partially folded state in which only α domain is 
structured. 
 
insight into folding mechanism. At the end of 80s, the use of hydrogen exchange pulse 
labelling coupled to NMR (Roder et al. 1988) and of protein engineering methods 
(Matouschek and Fersht 1991) allowed structural characterization of partially folded 
states. More recently, the development of new instrumentation, such as ultra-rapid 
mixing devices (Shastry et al. 1998) and temperature jump relaxation techniques 
(Mayor et al. 2003) allowed the measurements of events within dead-time of normal 
stopped flow experiments. Finally, the destabilization of native state has allowed to in-
crease the equilibrium population of partially folded states (Religa et al. 2005). This has 
allowed solution NMR methods to be applied to solve the structure of folding interme-
diates of small proteins (Religa et al. 2005). Generally, it has been shown that in the in-
termediate states the overall topology resembles the native structure and that some re-
gions are highly structured while other regions are more denatured-like (Matouschek 
et al. 1989b; Salvatella et al. 2005). 
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Figure 1.3: Models for protein folding (reprinted from (Nolting and Andert 2000)). Framework 
model, hydrophobic collapse model and nucleation-condensation model are shown. These 
model are described in the text. 
 
The characterisation of partially folded states raised the question as to whether 
these states are productive species en-route to the native state (true intermediates, see 
model (1) in figure 1.2A) or kinetic traps that slow down the process (off-pathway par-
tially folded conformations, see model (2) in figure 1.2A) (Bai 1999; Gianni et al. 
2007b). If many proteins were shown to form on-pathway partially folded states (Bai 
1999; Capaldi et al. 2001; Travaglini-Allocatelli et al. 2003; Jemth et al. 2004), recent 
observation that non-native interactions may be observed for productive on-pathway 
intermediates suggests that partial protein misfolding may be an obligatory step pre-
ceding native state consolidation (Capaldi et al. 2002; Religa et al. 2005). Moreover, in 
many cases evidence emerged that parallel pathways can lead to the formation of native 
states (Matagne and Dobson 1998) (see model (3) in figure 1.2A). This led to the de-
scription of energy landscapes for protein folding (figure 1.2B) (Dinner et al. 2000; 
Dobson 2003; Vendruscolo and Dobson 2005). This “new view” uses the idea of an en-
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ergy surface to describe the conformational ensemble accessible during folding. Un-
folded molecules, structurally different, follow different pathways and populate differ-
ent conformational states characterised by weak interactions (Matagne and Dobson 
1998). Faster paths and local minima exist in the landscape, but Brownian motions al-
low each molecule to escape kinetic traps and continue the search for the native state. If 
the trajectories can be numerous, the transition state is unique and all pathways lead to 
the formation of native state as native interactions are the most stable (Dinner et al. 
2000). Thus, energy landscapes are not in contrast with the concept of folding pathway; 
they are instead able to join different pathways that can be detected with different ex-
perimental approaches. 
1.2.3 Φ value analysis and folding mechanisms: is there a unifying mechanism? 
Several methods have been developed in the two past decades to study folding (Zarrine-
Afsar and Davidson 2004; Dill et al. 2007). Single molecule measurements can now be 
performed and FRET methods can watch directly the formation of particular contacts 
(Schuler et al. 2002; Magg et al. 2006). A major milestone in the analysis of protein 
folding mechanisms was the introduction, at the end of the 80s, of protein engineering 
methods to perform Φ value analysis (Matouschek et al. 1989b). In this method a single 
point mutation is introduced to remove a specific contact from the native state of a 
given protein. The change in conformational stability upon mutation for the native 
state and for the investigated state is calculated. The ratio between these two quantities 
is a number (Φ value) that varies from0 to 1. A Φ value equal to 0 suggests that the con-
tact removed by mutagenesis is not formed in the investigated state. A Φ value equal to 
1 implies a native-like interaction in the investigated state for the removed group. In 
this way the characterisation of conformational states populated along the folding co-
ordinate is possible. Although the structural information contained in this energetic 
parameter has been long discussed, protein engineering methods have been applied to 
analyse protein folding transition states at atomic level, to find amino acids that control 
folding speed (Matouschek et al. 1989b) and to investigate partially folded states 
(Matouschek et al. 1989a; Matouschek et al. 1992). In this thesis Φ value analysis shall 
be used to investigate a partially folded state transiently populated during folding of 
the acylphosphatase from Sulfolobus solfataricus (see table 2.3). 
Historically, the use of Φ value analysis, coupled to other techniques (Nolting and 
Andert 2000; Daggett and Fersht 2003), allowed three mechanisms to be proposed for 
protein folding (Nolting and Andert 2000): 
• hydrophobic collapse: In this model (figure 1.3) the initial event of the reaction is 
thought to be a relatively uniform collapse of the protein molecule, mainly driven 
by the hydrophobic effect (Baldwin 1989; Dill 1990). Stable secondary structure 
starts to grow only in the collapsed state, which narrows in a confined volume the 
conformational search to the native state. Although this model was initially sup-
ported by the observation that the hydrophobic driving force provided by the ex-
pulsion of water from the burial of non-polar surfaces is substantial, the hydro-
phobic collapse presents a problem because an excess of non-native interactions 
will hinder reorganisation of both the polypeptide chain and side chains (Daggett 
and Fersht 2003). 
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• framework model: According to this model (figure 1.3) folding starts with the 
formation of elements of secondary structure independently of tertiary structure, 
or at least before tertiary structure is locked in place. These elements then assemble 
into the tightly packed native tertiary structure either by diffusion and collision 
(Karplus and Weaver 1994) or by propagation of structure in a stepwise manner 
(Wetlaufer 1973). The validity of this model has been mainly shown for small heli-
cal proteins (Mayor et al. 2000; Myers and Oas 2001). 
• nucleation-condensation: In the early 90s the previous model was challenged by 
two observations: (1) some proteins fold in a two-state process without accumula-
tion of secondary-structure intermediates (Jackson and Fersht 1991); (2) the use of 
Φ value analysis (Matouschek et al. 1989b) showed that in the folding transition 
state secondary and tertiary structure form in parallel (Otzen et al. 1994). This led 
some authors to propose a model (figure 1.3) in which early formation of a folding 
nucleus catalyses further folding (Fersht 1995; 1997). The nucleus primarily con-
sists of a few adjacent residues that have some correct secondary and tertiary struc-
ture interactions but is stable only in the presence of further approximately correct 
interactions. The presence of the folding nucleus allows the transition state to bear 
a native-like topology (Lindorff-Larsen et al. 2005b) and the number of contacts 
that must be sampled dramatically decreases. Many small α and α/β proteins were 
shown to fold similarly (Clarke et al. 1997; Chiti et al. 1999b). 
The three models mentioned above are in apparent contrast. Nevertheless, evidence 
is now emerging that framework and nucleation-condensation represent extreme 
manifestations of an underlying common mechanism. It was shown that when the heli-
cal propensity is increased, folding turns from nucleation condensation behaviour to 
diffusion-collision behaviour, in which helical elements are fully preformed (Gianni et 
al. 2003; White et al. 2005). In agreement with this observation, it was proposed that 
significant secondary structure is present in the denatured state if such structure is suf-
ficiently stable. Thus, the rate-limiting step involves docking of these elements 
(Daggett and Fersht 2003). If instead the secondary structure is not stable in the un-
folded state, a nucleation event is required to favour collapse of the structure (Daggett 
and Fersht 2003). Finally, a PDZ domain was recently shown to recapitulate nucleation 
condensation and diffusion-collision models in three steps: (1) the early formation of a 
weak nucleus formed by few residues with fractional Φ values that determine the na-
tive-like topology of a large portion of the structure, (2) a global collapse of the entire 
polypeptide chain, and (3) the consolidation of the remaining partially structured re-
gions to achieve the native state conformation (Gianni et al. 2007a). 
1.2.4 The role of topology in determining folding; the importance of studying structur-
ally related proteins 
If the fold is important in determining folding mechanism and speed, one can conclude 
a major role for topology in protein folding. Perhaps the most dramatic evidence for 
such a conclusion is the observation of a remarkable correlation between the experi-
mental folding rates of a wide range of small proteins and the complexity of their folds, 
measured by the contact order (Plaxco et al. 1998). The latter is the average separation 
in the sequence between residues that are in contact with each other in the native struc-
ture. A correlation was also found between contact order and the position of the transi-
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tion state along the folding coordinate (Plaxco et al. 1998). Many studies are now in-
vestigating the folding mechanism of different proteins sharing the same fold. The 
folding of several cytochrome c proteins involves the formation of a partially struc-
tured intermediate and some essential structural features of the intermediate and tran-
sition states are highly conserved across this protein family (Travaglini-Allocatelli et 
al. 2004). Five different PDZ domains have been shown to fold via an on-pathway in-
termediate and two transition states whose position is conserved along the folding co-
ordinate (Chi et al. 2007). A comparison between Φ values of structurally related pro-
teins with divergent sequence composition suggested that protein families with con-
served transition states are confined to a single folding trajectory whereas protein 
families with variable transition states have access to multiple pathways (Zarrine-
Afsar et al. 2005). As an addition to this simple rule, it has been proposed that a two 
strand-helix (i.e. two β-strands docking against a single α-helix) motif is the minimal 
folding nucleus, called foldon, and that pathway multiplicity is linked to the multiplic-
ity of foldons within the protein structure (Lindberg and Oliveberg 2007). 
 
Figure 1.4: Features of amyloid fibrils. (A) Fibrils have a long and unbranched shape. White 
lines indicate a hypothetic enlargement of a fibril to show protofilaments. (B) Fibrils show a 
cross-β structure. This scheme represents the typical appearance of fibrils when analysed with 
X-ray fibre diffraction (reprinted from (Serpell 2000)). (C) Amyloid material shows green 
Congo red birefringence under cross-polarised light. In this picture CR staining of amyloid 
deposits of β2-microglobulin is shown (reprinted from (Ivanova et al. 2003)). 
 
In this thesis a characterisation of a partially folded state and transition state populated 
during folding of the acylphosphatase from Sulfolobus solfatricus shall be carried out (see 
section 2.2.2). The results have implications in the study of biological function in the ab-
sence of a structured fold and will be discussed in section 2.2.3. Moreover, the obtained Φ 
values shall be compared in chapter 5 with the results previously obtained on another 
member of the same superfamily, human muscle acylphosphatase (Chiti et al. 1999b). 
1.3 Protein misfolding 
As mentioned above protein quality control is a crucial point of cell metabolism be-
cause incompletely folded proteins must inevitably expose to the solvent at least some 
regions of structure that are buried in the native state and that are prone to inappropri-
ate interaction with other molecules within the crowded intracellular or extracellular 
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environments (Dobson 2003). Protein misfolding is the conversion of a protein into a 
structure that differs from its native state (Chiti and Dobson 2006). This process is re-
lated to a set of human diseases (protein misfolding diseases), usually classified in three 
distinct groups: 
1. Diseases in which an impairment in the folding efficiency of a given protein re-
sults in a reduced amount of native folded protein. An example is cystic fibrosis, 
where a mutated variant of a chloride channel (CFTR) populates a misfolded con-
formation that is degraded instead of being translocated to the cell membrane 
(Thomas et al. 1995). The absence of the properly functioning protein accounts for 
the symptoms of the disease (Thomas et al. 1995). 
2. Diseases in which misfolding of a given protein results in improper trafficking. In 
the case of early-onset enphysema, that we cite here as an example, mutations of 
the gene encoding α1-antitripsyn determine the production of a protein that 
forms polymers. These will be retained in the liver (where α1-antitripsyn is pro-
duced) and will not reach the lungs, where α1-antitripsyn is necessary for a con-
stitutive inhibition of elastase. The absence of such an inhibitory effect gives rise 
to the disease (Chiti and Dobson 2006). 
3. The largest group of protein misfolding diseases is the group of pathological 
states associated with the conversion of a given peptide or protein from its soluble 
native state into highly organised fibrillar aggregates (Dobson 2003; Jahn and 
Radford 2005; Chiti and Dobson 2006). These aggregates are usually referred to 
as amyloid fibrils when they form in vivo outside the cell and intracellular inclu-
sions when they form inside the cell. More than 40 human diseases are associated 
to this process (for a complete list see (Chiti and Dobson 2006)). Importantly, 
many of them have high social impact, such as Alzheimer’s disease, Parkinson’s 
disease and type II diabetes mellitus. In the following sections structure of fibrils 
and mechanisms of aggregation are discussed. 
1.3.1 Definition and structure of amyloid fibrils 
Proteins able to form amyloid aggregates do not share any sequence identity and struc-
tural homology. Despite that, some important structural features are common in amy-
loid fibrils formed by different peptides. Amyloid-like fibrils are defined on the basis 
of peculiar physico-chemical properties when investigated with different techniques 
(figure 1.4). In particular amyloid fibrils have a long and unbranched shape when ob-
served with atomic force microscopy (AFM) or transmission electron microscopy 
(TEM) (figure 1.4A). Fibrils usually consist of a number (typically from 2 to 6) of pro-
tofilaments, each about 2-5 nm in diameter (Serpell et al. 2000) (see figure 1.5A). The 
protofilaments twist together and form rope-like fibrils that are typically 7-13 nm 
wide (Sunde and Blake 1997; Serpell et al. 2000). When analysed by X-ray fiber diffrac-
tion (figure 1.4B), the various protein molecules are arranged so that the polypeptide 
chains form β-strands that run perpendicular to the long axis of the fibril (cross-β 
structure) (Sunde and Blake 1997). Finally, the fibrils have the ability to bind specific 
dyes such as Thioflavin T (ThT) (Krebs et al. 2005) and Congo red (CR, figure 1.4C)  
(Nilsson 2004), although the specificity of binding of CR to amyloid fibrils and the re-
sulting green birefringence under cross-polarised light has recently been questioned 
(Khurana et al. 2001; Bousset et al. 2004b). 
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Figure 1.5: Structure of amyloid fibrils and protofilaments. (A) Structure of Aβ fibrils; reprinted 
from (Petkova et al. 2006). (B) Structure of human amylin fibrils; reprinted from (Kajava et al. 
2005). (C) Structure of Sup35p protofilaments; reprinted from (Krishnan and Lindquist 2005). 
 
High resolution structures of amyloid fibrils have been solved in recent years by 
use of solid state NMR (SSNMR), site-directed spin labelling coupled to electron par-
amagnetic resonance (SDSL-EPR) and by X-ray diffraction analysis carried out on 
nano- or microcrystals of small peptides having characteristics of amyloid fibrils 
(Tycko 2004; Luhrs et al. 2005; Chiti and Dobson 2006; Petkova et al. 2006). In the case 
of Aβ, the peptide whose aggregation is related to Alzheimer’s disease, SSNMR studies 
led some authors to propose that each molecule forms two strands in the core of fibrils, 
spanning residues 12-24 and 30-40. These strands are not part of the same β-sheet but 
participate to the formation of two different parallel in register β-sheets that run paral-
lel to the fibril axis (Antzutkin et al. 2000; Petkova et al. 2002). A single protofilament 
has been proposed to be composed by four β-sheets (i.e. two Aβ molecules) separated 
by distances of 10 Å (figure 1.5A). This structure has been confirmed by SDSL-EPR 
studies that found residues 13-21 and 30-39 highly structured in the fibrils (Torok et 
al. 2002). A peptide derived from the yeast prion Sup35p (GNNQQNY) and the peptide 
KFFEAAAKFFE have been converted in three-dimensional crystals with features typi-
cal of amyloid fibrils. The structures of these crystals have been solved by X-ray crys-
tallography (Makin et al. 2005; Nelson et al. 2005). In the case of the Sup35p fragment, 
the crystal consists of pairs of parallel β-sheets in which each individual peptide mole-
cule contributes a single β-strand. The stacked β-strands are parallel and in register in 
both sheets. The two sheets interact with each other through the side chains of Asn2, 
Gln4, and Asn6 (Nelson et al. 2005). Following these pioneering studies the X-ray 
structure of other assembled peptides have been solved (Sawaya et al. 2007). 
In some cases different approaches have been applied to solve amyloid fibril struc-
tures. A model for fibrils formed by human amylin, whose aggregation is related to 
type II diabetes mellitus, has been recently proposed on the basis of different experi-
mental evidences, such as protofilament diameter, the cross-β structure and the ex-
perimental evidence of a parallel and in register arrangement of the β-strands formed 
by adjacent molecules (Kajava et al. 2005) (figure 1.5B). In the obtained model three 
different β-strands, formed by residues 12-17, 22-27 and 31-37, participate to the for-
mation of three β-sheets that run parallel to the fibril axis. In the case of the NM region 
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of the yeast prion Sup35p, 37 single point mutations to cysteine were produced. These 
variants were labelled with fluorescent probes (Krishnan and Lindquist 2005). The 
wavelength maximum and the emission intensity of probes bound to different posi-
tions were then used to get information about burial of residues and possible interac-
tion in fibrils. On the basis of these experiments a model was drawn in which NM 
molecules interact via head-to-head (residues 25-38) and tail-to-tail (residues 107-
157) interactions (Krishnan and Lindquist 2005). The N-terminal (residues 1-20) and 
the distal end (residues 158-250) are instead structurally heterogeneous and solvent 
exposed (Krishnan and Lindquist 2005) (figure 1.5C). This approach has been used in 
chapter 3 to get insight into the protofibril structure of the acylphosphatase from Sul-
folobus solfataricus. 
1.3.2 Mechanisms of amyloid aggregation 
If formation of amyloid fibrils is related to the onset of several human diseases, the 
ability to form amyloid-like aggregates in vitro was shown to be an inherent property 
of the protein back-bone. Several proteins that are not involved in disease were shown 
to form amyloid-like aggregates using particular cosolvents, temperature and salts 
(Guijarro et al. 1998; Chiti et al. 1999c). Nevertheless, the fact remains that different 
proteins show different tendencies and pathways leading to the formation of amyloid-
like fibrils and that these differences can be explained on the basis of their sequence, 
that is on the basis of the physico-chemical properties of the side chains of their amino 
acids. 
It is now clear that amyloid aggregation is a multi-step process in which different 
states are transiently populated. The formation of amyloid fibrils has many character-
istics of a “nucleation-growth” mechanism (Chiti and Dobson 2006). Conversion of 
proteins into their fibrillar form follows two phases: (1) a lag phase, in which aggrega-
tion nuclei are formed and (2) a growth phase, in which further monomers or oli-
gomers bind to the nuclei (Serio et al. 2000; Pedersen et al. 2004). This mechanism is 
confirmed by the observation that the addition of aggregation nuclei (seeds) to the 
sample shortens or abolishes the lag phase (Serio et al. 2000). 
In the overall process of amyloid fibril formation various aggregates are thought 
to form before mature amyloid fibrils accumulate. In the case of Aβ1-40 and Aβ1-42 
oligomeric species made by 2-4 and 5-6 molecules have been observed, respectively 
(Bitan et al. 2001; Bitan et al. 2003). In the case of Sup35p oligomers form rapidly and 
these species only afterwards convert into species with extensive β-sheet structure able 
to nucleate aggregation (Serio et al. 2000). 
Other important species populated prior to the appearance of fibrils are protofi-
brils. These are isolated or clustered spherical beads 2-5 nm in diameter with β-sheet 
structure (Chiti and Dobson 2006). These species usually can bind both ThT and CR 
(Walsh et al. 1999). Species of this type have been observed for α-synuclein (Conway et 
al. 2000), amylin (Kayed et al. 2004), transthyretin (Quintas et al. 2001) and the acyl-
phosphatase from Sulfolobus solfataricus, one of the proteins object of this thesis 
(Plakoutsi et al. 2004) (see chapter 3). 
The study of oligomers has seen an increasing importance as these species have 
been shown to be the most toxic for cells (Bucciantini et al. 2002). This is probably due 
to the fact that these inherently misfolded species expose an array of groups that are 
Francesco Bemporad 12 
normally buried in globular proteins or dispersed in highly unfolded peptides. This is 
likely to trigger aberrant events resulting from inappropriate interactions with cellular 
components, such as membranes, small metabolites, proteins, or other macromole-
cules. These interactions cause impairment of oxidative stress, ion balance and other 
factors that lead to cell death (Chiti and Dobson 2006). 
It was also shown that, even if the final structure is conserved, different conforma-
tional states can be the starting point for amyloid-like aggregation (Bemporad et al. 
2006) (see also figure 1.1). (1) A number of systems, including Aβ and α- synuclein, are 
largely unfolded prior to aggregation (Bemporad et al. 2006; Chiti and Dobson 2006). 
Short peptides have been shown to be able to form amyloid-like material (Lopez de la 
Paz and Serrano 2004). In this case, since the whole protein sequence is fully exposed to 
the solvent, aggregation is governed by simple physico-chemical factors, such as hy-
drophobicity, secondary structure propensities and net charge (Chiti et al. 2003) (for a 
complete description of the determinants of aggregation from unfolded states see sec-
tion 4.1.1). (2) In most cases globular proteins need to unfold, at least partially, to ag-
gregate into amyloid-like fibrils. It is clear for example that conditions that promote 
their partial unfolding, such as temperature, low pH, presence of organic cosolvents, 
increase their propensity to aggregate (Guijarro et al. 1998) (Chiti et al. 2000; Gosal et 
al. 2005). The aggregation of HypF-N can be initiated by a population of less than 1% 
of a partially folded conformation in equilibrium with the native one (Marcon et al. 
2005). (3) Although the “conformational change hypothesis” can account for the aggre-
gation properties of many proteins, increasing evidence is now accumulating that na-
tive proteins retain a significant, albeit small, tendency to aggregate ((Bemporad et al. 
2006) and chapter 3). Formation of amyloid-like fibrils of insulin at low pH is pre-
ceded by an oligomerization step in which a native-like α-helical content is retained, 
while β-sheet rich aggregates form only later on (Bouchard et al. 2000). The acylphos-
phatase from Sulfolobus solfataricus aggregates from an ensemble of native-like con-
formations into early aggregates that retain enzymatic activity, while unfolding is two 
orders of magnitude slower than aggregation (Plakoutsi et al. 2004; Plakoutsi et al. 
2005). 
In conclusion, the initial step of aggregation is the conversion of single molecules 
populating an aggregation prone state -folded, partially folded or unfolded- into an 
oligomer in which each monomer resembles the initial state. These oligomers convert 
afterwards into β-sheet rich species that lead to formation of amyloid fibrils. 
1.4 Aim of this thesis 
1.4.1 The acylphosphatase-like family 
In this thesis we focus our attention on proteins belonging to the acylphosphatase-like 
structural family, the acylphosphatase from Sulfolobus solfataricus (Sso AcP) and the 
acylphosphatase from human muscle (mt AcP).Acylphosphatase (AcP) is a small 
(about 100 residue long) α + β protein belonging to the ferredoxin-like fold (that is a α 
+ β sandwich with antiparallel β-sheet). The structure of the protein is highly con-
served throughout the family. All the AcPs so far characterised show the same βαββαβ 
topology that originates a β-sheet docking against the two helices (figure 1.6A to 1.6H) 
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(Pastore et al. 1992; Thunnissen et al. 1997; Zuccotti et al. 2004; Miyazono et al. 2005; 
Pagano et al. 2006). Sso AcP also bears an unstructured, N-terminal 11 residue long 
segment that plays a major role in the aggregation mechanism of the protein 
((Plakoutsi et al. 2006) and chapter 3). AcP is an enzyme (enzyme commission 3.6.1.7) 
able to hydrolyse acylphosphates, with formation of a phosphate ion and a carboxylate 
group (Stefani et al. 1997) (figure 1.6I). The mechanism of catalysis has been studied in 
detail in mt AcP (Taddei et al. 1994; Taddei et al. 1996; Taddei et al. 1997). The catalytic 
residues consist on an Arg and an Asn residues highly conserved within the family. 
The catalytic cycle can be summarised as follows. (1) The Arg binds to the phosphate. 
(2) The Asn residue stabilises the pentacovalent intermediate that forms following nu-
cleophilic attack of a water molecule. (3) The products are released. 
 
Figure 1.6: The structure of AcPs is highly conserved. AcPs are shown from Pyrococcus horiko-
shii (A, PDB entry 1W2I), Thermus thermophilus (B, PDB entry 1ULR), Drosophila mela-
nogaster (C, PDB entry 1URR), Homo sapiens (muscolar type, D, PDB entry 1APS), Homo 
sapiens (common type, E, PDB entry 2ACY), Escherichia coli (F, PDB entry 2GV1), Sulfolobus 
solfataricus (H, PDB entry 1Y9O). HypF-N from Escherichia coli is also shown (G, PDB entry 
1GXT), (I) Reaction catalysed by AcP on benzoyl-phosphate, a substrate largely used for AcP 
enzymatic activity measurements (Stefani et al. 1997). 
 
The function of the protein is yet not well understood. The initial observation that 
the enzyme is active on 1,3-bisphosphoglycerate suggested for AcP a possible regula-
tive role on glycolysis (Ramponi 1975). Nevertheless, different functions have been 
proposed for this protein. The evidence that the enzyme is able to hydrolyse the α-
aspartyl-phosphate, which forms during action of membrane pumps, led some authors 
to propose a role in regulation of membrane transport (Nediani et al. 1996). More re-
cently it was shown the ability of AcP to induce apoptosis in HeLa cells (Giannoni et al. 
2000). Since the protein structure is similar to the RNA binding domain of ribonucleo-
proteins (Swindells et al. 1993), it was proposed that the interaction of this protein with 
nucleic acids has a physiological role. It was shown also a nuclear migration of mt AcP 
and its interaction with other DNAses in response to various apoptotic stimuli either 
in K562 or in Jurkat cells (Chiarugi et al. 1997). Finally, since the AcP levels increase 
in several cell lines during differentiation and AcP is able to hydrolyse both γ and β 
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phosphate groups of ATP, it was proposed a role for AcP in regulation of differentia-
tion through control of [ATP]/[ADP] levels (Paoli et al. 2000). 
1.4.2 Folding and aggregation in the acylphosphatase-like family 
In the last decade AcP has been largely used as a model for folding and amyloid-like 
aggregation studies. The folding process shows high variability in the acylphospha-
tase-like family. Equilibrium and kinetic fluorescence studies suggest that the folding 
of mt AcP is a two state process characterised by a rate constant (0.23 s-1) very low if 
compared with both other members of the family and with other proteins (van Nuland 
et al. 1998; Maxwell et al. 2005). The transition state for folding of mt AcP was also 
characterised (Chiti et al. 1999b; Vendruscolo et al. 2001). The most structured region 
corresponds to the central part of the β-sheet (β-strand 1 and 3). The second α-helix as 
well plays an important role as it appears fully structured in the transition state (Taddei 
et al. 2000). The other human AcP isoform, common type AcP (ct AcP) folds in a two-
state process with a folding rate constant equal to 2.3 s-1. Although ct AcP bears a lower 
conformational stability than mt AcP, this value is ten-fold higher than folding rate for 
mt AcP, suggesting no correlation between folding rate and conformational stability 
within the AcP family (Taddei et al. 1999). Interestingly, HypF-N from E. coli folds 
with a rate constant equal to 70 s-1, two orders of magnitude higher than the folding rate 
constant measured for mt AcP (Calloni et al. 2003). Folding proceeds via formation of 
a partially structured state that forms on the sub-millisecond time-scale (Calloni et al. 
2003). The folding of Sso AcP has been characterised in some detail. The protein folds 
through formation of a partially folded state to reach the native structure with a folding 
rate constant equal to 5.4 s-1 (see section 2.1 details). These studies, carried out on struc-
turally related but evolutionary distant proteins, allowed some important parameters 
for folding to be identified. Indeed, correlations within the acylphosphatase-like family 
indicate hydrophobicity, relative contact order and α-helical propensity as important 
determinants for folding rates (Chiti et al. 1999b; Taddei et al. 2000; Calloni et al. 2003; 
Bemporad et al. 2004). Moreover, these studies clearly suggested that proline isomer-
ism is not evolutionary conserved as proline residues that slow down folding are not 
conserved in the family (Bemporad et al. 2004). In chapter 2 we shall present a charac-
terisation of the partially folded state, transiently populated during folding, and of the 
major transition state for folding of Sso AcP. The obtained results have important con-
sequences in the study of biological function carried out in the absence of folded struc-
tures and will be discussed in section 2.3 and in section 5.2.  
The amyloid aggregation processes of different AcPs have been studied as well. In-
terestingly, different conformational states can trigger the amyloid-like aggregation 
process. In the case of mt AcP and HypF-N, it was shown that a partial unfolding is re-
quired to initiate the process (Chiti et al. 1999c; Marcon et al. 2005). By contrast, an 
acylphosphatase from Drosophila melanogaster and Sso AcP have been shown to ag-
gregate from a native-like state (Plakoutsi et al. 2004; Soldi et al. 2006a). The latter 
mechanism is particularly important as it suggests that native states have significant 
tendency to aggregate and that evolution has worked to keep under control this process 
((Richardson and Richardson 2002) and paragraphs 1.3.2 and 3.1.1). The aggregation 
mechanism of Sso AcP has been studied (Plakoutsi et al. 2004; Plakoutsi et al. 2005; 
Plakoutsi et al. 2006). Although it was shown that an edge β-strand and the N-terminal 
unstructured segment play an important role in the process, the mechanism of aggrega-
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tion of this system is still unclear (Plakoutsi et al. 2006). In chapter 3 we get some im-
portant clues into this process and we try to propose a possible model that summarises 
all the experimental evidence so far observed including those described here and in our 
previous work (see section 3.4). The model will be discussed with respect to the aggre-
gation of other systems that aggregate starting from a native state. 
The study of the aggregation of mt AcP has allowed several parameters that favour 
aggregation to be proposed. An algorithm has been proposed to predict change in ag-
gregation rate upon mutation that takes into consideration hydrophobicity, secondary 
structure propensities and net charge as parameters (Chiti et al. 2003). Nevertheless, 
several other parameters have been proposed as determinants for amyloid aggregation 
(for details see section 4.1 and (DuBay et al. 2004; Pawar et al. 2005)). Among these pa-
rameters, the presence of aromatic residues has been proposed as an important deter-
minant for aggregation rate constants (section 4.1). Nevertheless, several authors have 
shown that aromatic residues play an important role only because of their hydropho-
bicity and secondary structure propensity (section 4.1). In chapter 4 the possible role 
for aromaticity in amyloid aggregation is studied using mt AcP as a model. The results 
are discussed in view of their possible implications in the development of new algo-
rithms. 
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 Chapter 2  
Enzymatic activity in non-native Sso AcP 
2.1 Introduction 
Proteins are among the most abundant macromolecules in living systems and carry out 
a vast number of functions including the catalysis of virtually every chemical trans-
formation occurring in cell biology and the transduction of signals inside and between 
cells. While it is well known that the flexibility of the native states of folded proteins is 
crucial in the processes determining their function, increasing evidence is accumulat-
ing about the existence of proteins or protein domains that adopt unstructured but 
functional states under physiological conditions (Dunker et al. 2001; Fink 2005). The 
mechanisms, however, by which certain proteins are capable of being active and yet 
natively unfolded is not completely understood (Fink 2005). 
In this chapter we shall focus our attention on the acylphosphatase from the ar-
chaeon Sulfolobus solfataricus (Sso AcP, figure 2.1) and show that this protein retains 
an ability to function as an enzyme when adopting a non-native state in which the cata-
lytic site is largely unstructured and flexible. Sso AcP is a 101-residue protein belong-
ing to the acylphosphatase-like structural family. The structure of the native state of 
Sso AcP was recently determined by nuclear magnetic resonance (NMR) spectroscopy 
and X-ray crystallography (Corazza et al. 2006). This protein shares the same βαββαβ 
topology, typical of the ferredoxin-like fold, with the other acylphosphatases so far 
characterised  (Pastore et al. 1992; Thunnissen et al. 1997; Zuccotti et al. 2004; Miya-
zono et al. 2005; Pagano et al. 2006). By contrast to related proteins, however, Sso AcP 
contains an unstructured, 12-residue N-terminal tail (Corazza et al. 2006). Sso AcP is 
able to hydrolyse benzoyl-phosphate (BP; figure 1.6I), with kCAT and KM values of 
198 ± 20 s−1 and 0.36 ± 0.04 mM, respectively, at pH 5.3 and 25 °C, and to be competi-
tively inhibited by inorganic phosphate (Corazza et al. 2006). The kCAT value of the en-
zyme is low at 25 °C, but increases with temperature and reaches at 81 °C -the living 
temperature for the Archaeon Sulfolobus solfataricus- a value close to those previously 
reported for the mesophilic enzymes at 25 °C (Corazza et al. 2006). The native state of 
Sso AcP is thermodynamically very stable with a free energy change of unfolding 
(ΔGU-FH2O) of 47 ± 1 KJ mol−1 at 37 °C (Corazza et al. 2006). The midpoint of thermal 
unfolding of the protein (Tm) is 100.8 ± 4.1 °C and at 81 °C the ΔGU-FH2O is as high as 
20.6 ± 0.3 KJ mol-1, similar to that of human muscle acylphosphatase (mt AcP) at 28 °C 
(Corazza et al. 2006). 
The folding mechanism of Sso AcP was previously described at pH 5.5 and 37 °C 
(Bemporad et al. 2004). After removal of the denaturant, the unfolded state of this pro-
tein collapses on the microsecond time scale into an ensemble of partially folded con-
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formations. This ensemble, which has a free energy of unfolding (ΔGU-IH2O) of 12.5 ± 2 
KJ mol-1, is capable of binding the fluorescent dye 8-anilino-1-naphthalenesulfonic 
acid suggesting the presence of hydrophobic clusters exposed to the solvent, and pre-
sents a far-UV mean residue ellipticity comparable to that of the fully native state, indi-
cating that a native-like secondary structure is already formed in this state (Bemporad 
et al. 2004). The partially folded ensemble converts into the fully folded state with a 
rate constant of 5.4 ± 1.0 s-1; a small fraction of molecules (ca. 10%) folds slower with a 
rate constant of ca. 0.2 s-1 as their folding process is rate-determined by the cis to trans 
conversion of the Leu49-Pro50 peptide bond (Bemporad et al. 2004). The presence of a 
relatively stable, partially folded state accumulating during folding of Sso AcP offers a 
very favourable opportunity to study the function of a protein in a conformational state 
different from the native and folded one. 
Figure 2.1: Spectroscopic probes of Sso AcP. Trp4, Tyr17, Tyr21, Tyr45, Tyr61, Tyr86, Tyr91 
and Tyr101 are depicted in orange. The figure has been drawn with VMD 1.8.3 for win 32 
(Humphrey et al. 1996). 
 
In this work the functional properties of the partially folded state of Sso AcP accu-
mulating during folding are investigated using a procedure that allows the recovery of 
enzymatic activity during folding to be determined in real time. The protein engineer-
ing method is then used to obtain information on the degree of structure formation, at 
the level of the mutated residues, in both the partially folded and transition states of the 
protein (Matouschek et al. 1989b). We shall show that the partially folded state of Sso 
AcP accumulating during folding shows enzymatic activity comparable to that of the 
native state. The experimentally obtained Φ values are used as restraints in molecular 
dynamics simulations to obtain a model of the structures of the partially folded and 
transition state ensembles (Vendruscolo et al. 2001; Gsponer et al. 2006). These proce-
dures illustrate how this state is made up by an ensemble of conformations displaying a 
native-like topology, but in which those regions of the sequence forming the active site 
in the folded protein exhibit high structural heterogeneity. In spite of the high flexibil-
ity existing at the level of the active site, which is also indicated by ΦIH2O values close to 
0 for mutations of residues in the catalytic loop, the native-like topology and the close 
proximity between the main substrate binding residue (Arg30) and the main catalytic 
residue (Asn48) ensures that this conformational state retains enzymatic activity. 
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Figure 2.2: (A) Folding trace of Sso AcP recorded using intrinsic fluorescence as a probe in 
0.275 M GdnHCl, 50 mM acetate buffer pH 5.5, 37 °C. The inset shows the first second of re-
cording. (B) Observed folding/unfolding rate constant ln k versus denaturant concentration; 
readapted from (Bemporad et al. 2004). The continuous line represents the expected plot for 
a two-state model. (C) Observed folding rate constant ln k versus urea concentration. Above 5 
M urea the plot is linear, suggesting two state folding in these conditions. (D) Time course of 
BP absorbance recorded at 283 nm in the presence of native Sso AcP. (E) Time course of en-
zymatic activity of native Sso AcP, calculated as the opposite of the first order derivative of 
the trace reported in panel D (see section 2.4). The continuous line represents the best fit to 
equation 2.3. (F) Ratio between the main folding rate constant recorded in the presence of 
phosphate (○) or phenyl phosphate (●) (kobs) and that recorded without substrate-analogue 
in the sample (k0) plotted versus substrate-analogue concentration. (G) BP absorbance re-
corded at 283 nm after dilution of GdnHCl-unfolded Sso AcP into a refolding buffer; final 
conditions are 0.275 M GdnHCl (continuous line) and 0.275 M GdnHCl, 7 M urea (dotted 
line). The inset shows the first second of recording. (H) Development of relative enzymatic 
activity, calculated as the opposite of the first order derivative of the traces reported in panel 
G (see section 2.4), during Sso AcP refolding in the absence (●) and presence (□) of 7 M urea. 
The continuous lines represent the best fits to equation 2.3. The activities of fully folded, par-
tially folded and unfolded states are shown. (I) Comparison between the time courses of re-
covery of native conformation (reported as fraction folded, □) and enzymatic activity (re-
ported as fraction of the native protein activity, ■). After 3.6milliseconds, when the partially 
folded ensemble is populated more than 99%, Sso AcP exhibits already 79% of the native en-
zymatic activity. 
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2.2 Results 
2.2.1 The partially folded state populated during folding of Sso AcP shows acylphos-
phatase activity 
Sso AcP possesses one tryptophan in the N-terminal tail and seven tyrosines at vari-
ous positions along the sequence, mainly positioned in the β-sheet (figure 2.1). Fig-
ure 2.2A shows the change of intrinsic fluorescence when one volume of Sso AcP un-
folded in 5.5 M guanidinium hydrochloride (GdnHCl) is mixed with 19 volumes of 
refolding buffer. This trace, which is in very good agreement with that previously 
reported (Bemporad et al. 2004), indicates the presence of three phases in the folding 
process. The first phase, which occurs within the dead-time (10ms) of the stopped-
flow device utilised here, leads to an increase of the intrinsic fluorescence of the pro-
tein to a value that is about 40% higher than that of the native state. This initial phase 
was shown to correspond to the conversion of the fully unfolded state into the par-
tially folded state (Bemporad et al. 2004). The following rapid decrease of fluores-
cence with a rate constant (kI→F) of 5.3 ± 1.0 s-1, corresponds to the conversion of this 
state into the fully native conformation, whereas the second slower decrease, with a 
rate constant (k12) of 0.18 ± 0.04 s-1, corresponds to the cis-trans isomerisation of a 
small fraction of protein molecules with the Leu49-Pro50 peptide bond initially in a 
non-native cis configuration (Bemporad et al. 2004). In addition to the transient hy-
per fluorescence signal reported in figure 2.2A, the presence of a rapidly formed par-
tially folded state is also indicated by the downward curvature at low GdnHCl con-
centrations in the Chevron plot showing ln kI→F H2O) versus denaturant concentration 
(figure 2.2B). 
We then studied the time course of recovery of enzymatic activity during Sso AcP 
folding. Since the substrate BP, unlike its hydrolysis products benzoate and phosphate, 
has a significant optical absorption at 283 nm, the rate of catalysed BP hydrolysis can 
be accurately determined by measuring the decay rate of the absorbance at 283 nm (-
dA283 (t)/dt) in the presence of Sso AcP (Chiti et al. 1999a). In a first control experiment, 
a solution containing native Sso AcP was mixed with the refolding buffer containing a 
saturating concentration of BP and a non-denaturing concentration of GdnHCl. Final 
conditions were 0.01 mg ml-1 protein, 10 mM BP, 0.275 M GdnHCl, 50 mM acetate 
buffer, pH 5.5, 37 °C. The absorbance arising from BP at 283 nm was monitored in real 
time and was found to decrease at a constant rate (figure 2.2D). This trace was analysed 
to yield the time course of enzymatic activity, as described in section 2.4.4. As expected, 
the enzymatic activity does not change with time (figure 2.2E). 
To monitor the time course of enzymatic activity during Sso AcP refolding, a sam-
ple of GdnHCl-unfolded Sso AcP was mixed with the refolding buffer containing satu-
rating BP. Final conditions were the same as those described above. The time-
dependent changes of absorbance at 283 nm and of the corresponding enzymatic activ-
ity were determined (figures 2.2G and 2.2H, respectively). Immediately after mixing, 
when the partially folded state is maximally populated, the BP absorbance decay is oc-
curring with considerable rate (see also the enlargement in the inset of figure 2.2G). 
The enzymatic activity is therefore already present, corresponding to 79.3 ± 10% of 
 
Enzymatic activity in non-native Sso AcP 21
Table 2.1: Catalytic parameters for a set of Sso AcP variants measured in 50 mM acetate buffer 
at pH 5.5, 37 °C using BP as a substrate. Values reported in column 3 have been obtained by 
best fits of data shown in figure 2.3 to equation 2.3. Values reported in column 4 have been 
obtained combining data of column 1 and 2. 
variant native state kCAT (s-1) Partially folded state kCAT (s-1) 
activity in the par-
tially  folded state 
(% of that from na-
tive state) 
WT 222 ± 20 175 ± 30 79 ± 10 
V24A 124 ± 10 7 ± 5 5.6 ± 10 
V27A 13 ± 1 0 ± 10 0.0 ± 10 
R30A 7 ± 1 n. d. n. d. 
N48A 2 ± 2 n. d. n. d. 
P50A 137 ± 14 0 ± 10 0.0 ± 10 
G52A 178 ± 18 6 ± 5 3.3 ± 10 
K92A 169 ± 20 111 ± 30 66 ± 10 
 
that of the native protein under the same conditions (Figure 2.2H). The activity then 
shows a small exponential increase with a rate constant of 3.53 ± 1.5 s-1 (figure 1F). 
This value is in reasonable agreement with the rate constant of folding determined with 
intrinsic fluorescence under these conditions (5.33 ± 1.0 s-1) and corresponding to the 
conversion of the partially folded state into the native state. The kinetic traces of enzy-
matic activity and intrinsic fluorescence, both normalised to the values of the native 
protein, are compared in figure 2.2I. After 3.6 milliseconds the activity is equal to 80% 
of the value of the native protein, but the fraction of native protein is less than 4%. 
In another experiment the GdnHCl-unfolded protein was diluted into a refolding 
solution containing urea. Final conditions were the same described above, except for a 
final urea concentration of 7 M. Under these conditions the native protein is still ther-
modynamically more stable than the unfolded state, making it possible to monitor the 
kinetics of folding. In addition, the plot reporting the folding rate constant versus urea 
concentration shows a downward curvature in the range of 0-5 M, indicating that in 7 
M urea the partially folded state is destabilised and the protein folds according to a 
two-state model (figure 2.2C). The results show that the activity is absent immediately 
after mixing, when only the unfolded state is populated (figure 2.2G). Upon refolding, 
the activity then increases with a rate constant of 0.13 ± 0.02 s-1, which is in good 
agreement with the folding rate constant (0.16 ± 0.02 s-1) under these conditions (figure 
2.2G). To rule out the possibility that a substantial fraction of the native state forms in 
the dead time of the stopped flow experiment, a double-jump experiment was carried 
out in which the GdnHCl-unfolded protein was diluted into the refolding buffer (first 
jump, refolding) and then, after 10 ms, transferred again to solutions containing 
GdnHCl at final concentrations ranging from 4.2 to 7 M (second jump, unfolding). Al-
though such final conditions promote the unfolding of native Sso AcP and produce a 
single exponential change of intrinsic fluorescence (Bemporad et al. 2004), no signifi-
cant fluorescence changes were observed in any of these experiments, suggesting that 
the native protein is not present 10 ms after the folding process was initiated when en-
zymatic activity is present. 
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Figure 2.3: The enzymatic activity of the partially folded state of Sso AcP is sensitive to muta-
tions. (A, C, E, G) BP absorbance at 283 nm after dilution of the indicated GdnHCl-unfolded 
mutants into a refolding buffer: the traces for wild type (A, continuous line), K92A (A, dotted 
line), N48A (C, continuous line), R30A (C, dotted line), V24A (E, continuous line), V27A (E, 
dotted line), P50A (G, continuous line) and G52A (G, dotted line) are shown. (B, D, F, H) De-
velopment of relative enzymatic activity, calculated as the opposite of the first order derivative 
of the corresponding traces reported in the corresponding panels on the left (see section 
2.4.4), during the refolding of the indicated Sso AcP mutants. The traces for wild type (B, ●), 
K92A (B, □), N48A (D, ●), R30A (D, □), V24A (F, ●), V27A (F, □), P50A (H, ●) and G52A (H, 
□) are shown. The continuous lines represent the best fits to equation 2.3. The various mu-
tants are labelled in the panels. 
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Figure 2.4: Folding thermodynamics and kinetics of Sso AcP variants. (A) Equilibrium unfold-
ing curves for a set of Sso AcP variants in 50 mM acetate buffer, pH 5.5, 37 °C. The continuous 
lines represent the best fits to the equation reported by Santoro and Bolen (Santoro and 
Bolen 1988). The obtained parameters of conformational stability are reported in Table 2. (B) 
Folding traces recorded in 0.275 M GdnHCl, 50 mM acetate buffer at pH 5.5, 37 °C. (C) Un-
folding traces recorded in 6 M GdnHCl, 50 mM acetate buffer at pH 5.5, 37 °C. The inset 
shows the first 5 seconds of recording. In all plots the traces refer to wild type (black), R71A, 
(blue), A46G (orange), L65A (red) and V20A (green) Sso AcP. 
 
In order to further rule out the possibility that folding of Sso AcP is accelerated by 
BP and that the enzymatic activity observed at the beginning of the folding process is 
due to an early substrate-induced folding of the protein, Sso AcP refolding was also 
followed using intrinsic fluorescence in the presence of phosphate and phenyl phos-
phate, two competitive inhibitors of Sso AcP that are stable analogues of BP. Experi-
mental conditions were the same as for the enzymatic activity experiments with no 
added urea. The folding rate constant is not affected by either compound (figure 2.2F). 
Taken together, these data indicate that the partially folded ensemble accumulating dur-
ing folding of Sso AcP possesses significant enzymatic activity. 
2.2.2 The acylphosphatase activity observed in the Sso AcP partially folded state is 
highly sensitive to mutations 
The recovery of enzymatic activity during folding was also recorded for 7mutants of 
Sso AcP. The K92A variant showed behaviour similar to that of the wild type protein 
with enzymatic activity detected for both the partially folded and native states (figures 
2.3A and 2.3B; table 2.1). By contrast, the traces recorded for the N48A and R30A vari-
ants showed full inactivation of their partially folded and native states (figures 2.3C 
and 2.3D; table 2.1). These results confirm the key role of these two highly conserved 
residues in the catalysis of the native state of acylphosphatases (Stefani et al. 1997) and 
suggest their major role in the catalytic mechanism of the partially folded state as well. 
The partially structured ensembles of the V24A and V27A mutants do not show sig-
nificant residual enzymatic activity (figures 2.3E and 2.3F; table 2.1). In the case of 
V24A, the enzymatic activity increases upon folding with a rate constant of 3.2 ± 1.0 s-1, 
a value that is, within experimental error, similar to that measured by following fold-
ing of the mutant using intrinsic fluorescence (table 2.3).  Similarly, two variants with 
mutations within the 49-52 loop (P50A and G52A) display fully inactive partially 
folded states, but native structures with significant activity that is recovered with rate 
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constants highly consistent with those measured for folding using intrinsic fluores-
cence (figures 2.3G and 2.3H; tables 2.1 and 2.3). Hence, unlike the wild type protein, 
the recovery of enzymatic activity for the V24A, P50A and G52A mutants occurs con-
comitantly with the conversion of the partially folded ensemble into the native state. 
These data show that the ability to hydrolyse the substrate of the partially folded en-
semble is more sensitive to mutations than the native state and provide in sight into re-
gions of the structure that are more important for enabling enzymatic activity. 
 
Table 2.2: Equilibrium unfolding data for a set of Sso AcP variants. ΔΔGU-FH2O values have 
been calculated according to equation 2.4, using the average m value over the m values re-
ported in column 3. 
variant position Cm (M) m (KJ mol-1 M-1) ΔΔGU-FH2O (KJ mol-1) 
WT - 4.23±0.07 11.3±1.1 - 
R15A β-sheet 1 3.88±0.07 11.9±1.2 3.90±1.10 
M16A β-sheet 1 3.10±0.07 11.0±1.1 12.59±1.13 
A18G β-sheet 1 3.21±0.07 10.3±1.0 11.36±1.12 
R19A β-sheet 1 3.56±0.07 10.4±1.0 7.46±1.11 
V20A β-sheet 1 3.78±0.07 11.7±1.2 5.01±1.11 
V24A loop 3.28±0.07 9.7±1.0 10.58±1.12 
V27A loop 3.78±0.07 11.1±1.1 5.01±1.11 
F29L α-helix 1 3.58±0.07 10.9±1.1 7.24±1.11 
R30A α-helix 1 4.41±0.07 12.2±1.2 -2.00±1.10 
A37G α-helix 1 3.36±0.07 10.1±1.0 9.69±1.12 
I42V loop 4.11±0.07 11.5±1.1 1.34±1.10 
A46G β-sheet 2 3.07±0.07 9.9±1.0 12.92±1.13 
N48A β-sheet 2 4.34±0.07 11.2±1.1 -1.23±1.10 
L49A β-sheet 2 3.73±0.07 11.2±1.1 5.57±1.11 
P50A loop 4.20±0.07 11.8±1.2 0.33±1.10 
G52A loop 3.34±0.07 11.3±1.1 9.91±1.12 
V54A β-sheet 3 3.11±0.07 10.6±1.1 12.47±1.13 
A58G β-sheet 3 3.89±0.07 10.6±1.1 3.79±1.10 
E59A β-sheet 3 3.52±0.07 12.0±1.2 7.91±1.11 
Y61A β-sheet 3 4.18±0.07 14.5±1.4 0.56±1.10 
Y61L β-sheet 3 4.18±0.07 14.0±1.4 0.56±1.10 
L65A α-helix 2 2.59±0.07 10.3±1.0 18.27±1.15 
L68A α-helix 2 2.54±0.07 10.0±1.0 18.82±1.15 
R71A α-helix 2 4.52±0.07 12.6±1.3 -3.23±1.10 
I72V α-helix 2 3.78±0.07 11.8±1.2 5.01±1.11 
P76A loop 3.73±0.07 12.1±1.2 5.57±1.11 
P77A loop 4.19±0.07 10.1±1.0 0.45±1.10 
V81A β-sheet 4 3.13±0.07 10.0±1.0 12.25±1.12 
V84A β-sheet 4 3.26±0.07 10.6±1.1 10.80±1.12 
F88A β-sheet 4 2.92±0.07 12.7±1.3 14.59±1.13 
S89A β-sheet 4 4.17±0.07 11.2±1.1 0.67±1.10 
K92A loop 4.07±0.07 10.1±1.0 1.78±1.10 
G93A loop 4.05±0.07 10.8±1.1 2.00±1.10 
F98L β-sheet 5 3.01±0.07 8.2±0.8 13.59±1.13 
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2.2.3 Investigation of the partially folded and transition states of Sso AcP using Φ value 
analysis 
To characterise the folding pathway of Sso AcP and obtain structural information on 
the partially folded and transition states we carried out a Φ value analysis using 34 sin-
gle mutants (see table 2.2 for a complete list). Mutations were chosen to probe (1) the 
hydrophobic core (18 mutations involve residues contributing to the hydrophobic core 
of the native protein), (2) the active site (4 of the investigated mutations, namely R30A, 
N48A, V24A and V27A involve the catalytic site of the acylphosphatases and were 
found here to abolish or decrease dramatically the enzymatic activity of Sso AcP), (3) 
the salt bridges that are present on the protein surface and contribute to the enhanced 
structural stability of the protein (we studied R15A and E59A to probe the cluster 
formed by Lys14, Arg15, Glu59, Glu62, and Glu94; R19A to probe the cluster formed 
by Tyr17,Arg19, Tyr45, Lys47,Asp51, andGlu55; R71Ato probe the charged interac-
tionwithGlu70; R30A to follow the salt bridge with the C-terminal carboxylate of the 
polypeptide chain (Corazza et al. 2006)). 
 
Table 2.3: Folding and unfolding kinetics data for a set of Sso AcP protein variants. Φ values 
have been calculated according to equation 2.7 and 2.8. 
variant kI→FH2O (s-1) kF→UH2O (s-1) ΦIH2O Φ‡H2O 
WT 5.436±0.272 (6.10±0.30)106 - - 
R15A 3.012±0.151 (2.07±0.10)105 -0.20±0.35 0.19±0.23 
M16A 7.179±0.359 (2.04±0.10)104 0.34±0.06 0.28±0.07 
A18G 4.249±0.212 (3.21±0.16)105 0.57±0.05 0.62±0.04 
R19A 0.652±0.033 (2.25±0.11)105 -0.18±0.18 0.55±0.07 
V20A 1.477±0.074 (3.30±0.17)106 0.64±0.09 1.31±0.08 
V24A 4.290±0.214 (1.94±0.10)104 0.10±0.10 0.16±0.09 
V27A 6.473±0.324 (4.43±0.22)105 0.07±0.21 -0.02±0.23 
F29L 6.421±0.321 (1.47±0.07)104 -0.07±0.17 -0.13±0.18 
A37G 4.996±0.250 (1.43±0.07)104 0.14±0.10 0.16±0.10 
A46G 0.855±0.043 (1.66±0.08)104 -0.03±0.09 0.34±0.06 
L49A 1.422±0.071 (1.49±0.07)105 -0.03±0.21 0.59±0.09 
G52A 0.181±0.009 (1.21±0.06)105 -0.06±0.12 0.82±0.03 
V54A 0.754±0.038 (1.81±0.09)104 -0.11±0.10 0.30±0.06 
A58G 1.567±0.078 (6.14±0.31)106 0.15±0.26 1.00±0.05 
E59A 2.343±0.117 (5.49±0.27)105 0.01±0.14 0.28±0.10 
L65A 2.354±0.118 (2.78±0.14)104 0.34±0.04 0.46±0.04 
L68A 1.064±0.053 (3.35±0.17)104 0.23±0.05 0.45±0.04 
R71A 10.090±0.504 (7.01±0.35)106 0.62±0.15 1.11±0.07 
I72V 4.364±0.218 (2.22±0.11)105 0.22±0.18 0.34±0.15 
P76A 5.003±0.250 (3.83±0.19)104 -0.96±0.39 -0.92±0.38 
V81A 4.761±0.238 (7.72±0.38)104 -0.05±0.10 -0.02±0.09 
V84A 4.729±0.236 (2.98±1.49)104 0.04±0.10 0.07±0.10 
F88A 5.176±0.259 (2.01±0.10)103 -0.03±0.08 -0.02±0.08 
F98L 4.211±0.211 (7.61±3.80)103 0.04±0.08 0.08±0.08 
 
An equilibrium GdnHCl-induced denaturation experiment was carried out for 
each mutant to yield the change in conformational stability upon mutation ΔGU-FH2O) 
(see section 2.4.5). Final conditions were 50 mM acetate buffer, pH 5.5, 37 °C. Figure 
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2.4A shows representative equilibrium unfolding curves for the wild type protein, the 
only mutant found to be stabilised relative to the wild type (R71A), and three destabi-
lised mutants, V20A, A46G, L65A. All plots have been analysed with equation 2.4 (see 
section 2.4.5). The results show that several mutants are destabilised (table 2.2). 
The destabilised (or stabilised) mutants with ΔGU-FH2O values higher than 3.2 KJ 
mol or lower than -3.2 KJ mol were analysed to obtain the Φ values of the corre-
sponding mutations for the partially folded (ΦIH2O) and transition states (Φ‡H2O). For 
each of these mutants kinetic traces for folding and unfolding were acquired at various 
denaturant concentrations, using intrinsic fluorescence and far-UV ellipticity as probes 
for folding and unfolding, respectively. Figures 2.4B and 2.4C show representative 
traces for folding and unfolding, respectively. All mutants showed, at low denaturant 
 
Figure 2.5: Native Sso AcP colour-coded to show the obtained ΦIH2O (left) and Φ‡H2O (right) 
values. Residues are shown in yellow if their Φ value is lower than 0.3, orange if the value is be-
tween 0.3 and 0.8 and red if the value is greater than 0.8. In the latter case the residue is la-
belled and shown also in a ribbon representation. The figures have been drawn with VMD 
1.8.3 for win32 (Humphrey et al. 1996). 
concentrations, a downward curvature in the folding limb of the plot reporting the 
folding/unfolding rate constant versus denaturant concentration. This deviation from 
the two-state model is similar to that observed for the wild type protein (figure 2.2B) 
and suggests that the partially folded ensemble forms in all the mutants that we studied. 
For each mutant, the various kinetic traces were analysed as described in the (see sec-
tions 2.4.6 and 2.4.7) to yield the folding and unfolding rate constants in the absence of 
denaturant (kI→FH2O refers to the rate of formation of the native state regardless of the 
on- or off-pathway nature of the partially folded state, while kF→UH2O refers to the un-
folding rate constant). A complete list of the kI→FH2O and kF→UH2O values obtained for all 
the analysed mutants is reported in table 2.3. The thermodynamic and kinetic data were 
combined to obtain the Φ values for the partially folded and transition states. The Φ 
values for the partially folded ensemble (ΦIH2O) are generally lower than the corre-
sponding ones for the transition state (Φ‡H2O), showing a gain of structure along the 
folding coordinate (table 2.3). In the partially folded state the catalytic site does not ap-
pear to be fully structured. The R30A and N48A variants were not analysed, due to 
their low ΔGU-FH2O value. Nevertheless, the ΦIH2O values obtained for the V24A and 
V27A variants are close to 0, suggesting that the catalytic 22-28 loop does not display a  
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Figure 2.6: Structural properties of the partially folded (PFE) and transition state (TSE) ensem-
bles of Sso AcP. (A) Profiles of the experimentally determined Φ values (Φexp) and those calcu-
lated from the simulations (Φcalc) for PFE and TSE of Sso AcP. The ensemble average Φcalc values 
of the PFE and TSE are shown in red and blue, respectively. Φexp values of the PFE and TSE are 
indicated as green and yellow diamonds, respectively. (B) Comparison of the representative 
structures of the four biggest clusters in the PFE (left) and TSE (middle) with the X-ray structure 
of the native state (right); the “scaffold region” (residues 13-23 and 60-90) is shown in red, the 
region around the catalytic site (residues 24-59) in blue; residues Arg30 and Asn48 are highlighted 
in yellow. (C) Energy maps of PFE (left) and TSE (right). The pair wise interaction energies of the 
native state are shown above the diagonal, those of the PFE and TSE below the diagonal. The 
interaction between Arg30 and Asn48 is highlighted by blue squares. 
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native like structure in this ensemble. These data suggest that the catalytic properties of 
the partially folded ensemble do not arise from an overall native-like structural forma-
tion of the active site in this state. However, even if the double-jump experiment de-
scribed above rules out the occurrence of global folding associated with binding, it is 
possible that the substrate directly participates to this positioning by binding the cata-
lytic residues in the partially folded state and hence determining a local folding of the 
active site. 
Moreover, the analysis of all mutants used in this study enables the folding pathway of 
Sso AcP to be characterised. The region that appears most structured in the ensemble of 
partially folded conformations is the interface between the first β-strand and the second 
α-helix (figure 2.5). The rest of the molecule shows Φ values close to 0. The transition 
state displays a more compact structure, with generally increased Φ values (figure 2.5; 
table 2.3). In this state, the establishment of native contacts is propagated to the β-
hairpin formed by β-strands 2 and 3. Four residues (Val20, Gly52, Ala58 and Arg71) 
appear to drive structure formation in the transition state ensemble (figure 2.5). Inter-
estingly, Arg71 does not appear important for the overall structure stabilisation, sug-
gesting a specific role for this residue in transition state formation. 
 
Figure 2.7: The high heterogeneity of the partially folded state is due to the catalytic region. 
(A, B) Distribution of the Cα-RMSD of the entire sequence (black), the scaffold region (red), 
and the catalytic region (blue) from the X-ray structure in PFE (A) and TSE (B). (C): The Cα-
RMSD per residue of the PFE (red) and TSE (black) from the native state. The region around 
the catalytic residue Asn48 is structurally very different from the native state in PFE and be-
comes more native-like in the TSE. 
2.3 Discussion 
2.3.1 Structure of the partially folded state and of the transition state 
In a collaboration with the University of Cambridge (UK) we have used molecular dy-
namics simulations with Φ value restraints (Vendruscolo et al. 2001; Gsponer et al. 
2006) to generate two ensembles of structures representing the partially folded and the 
transition states, respectively (figure 2.6A and 2.6B and section 2.4.8). The 
CHARMM22 force-field (Mac Kerell et al. 1998), an all-atom protein representation, 
the TIP3P water model and periodic boundary conditions have been used. The partially 
folded state is characterised by a significant structural heterogeneity and by the pres-
ence of several non-native interactions. The native topology is, however, rather well 
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preserved, as shown by the comparison of the structures of the intermediate and the na-
tive state (figure 2.6B) and by the energy maps, which provide an illustration of the 
most strongly interacting regions (figure 2.6C). The catalytic site (formed by residues 
in α-helix 1, β-strand 2 and the loop between β-strand 1 and α-helix 1) is very flexible, 
although, importantly, theArg30 andAsn48 residues, which are the most important for 
the catalytic activity, remain in more than 20% of the structures closer than 6 Å to each 
other. Overall, the native architecture is particularly well conserved in the region of α-
helix 2 and β-strand 1 and 4. By contrast, the regions corresponding to α-helix 1, β-
strand 2, 5 and 3 are much less well structured. To quantify these observations, we have 
considered the protein structure as divided into two parts, the first one corresponding 
to α-helix 1 and β-strands 5, 2 and 3 (catalytic region) and the second one correspond-
ing to α-helix 2 and β-strands 1 and 4 and we calculated the probability distributions 
of the Cα -carbon root mean square distance from the native state (Cα-RMSD) (figure 
2.7A and 2.7B). The results show that the high heterogeneity of the partially folded 
state is due to the catalytic region (blue), which shows distances comparable to that of 
the entire protein (black), while the remainder of the molecule (red) virtually shows a 
native-like fold, with an average distance from the native state equal to about 2 Å. We 
refer to this region as the “scaffold region”. The presence of this scaffold region implies 
that, although the catalytic residues and the catalytic loop are highly dynamic in the 
partially folded ensemble, the overall topology of the protein is already formed in this 
state and this decreases the number of its accessible conformations, that is its entropy. 
Thus, the structure determination that we present here provides a result that is not ap-
parent from an immediate inspection of the experimental Φ values that are all small in 
this region. This analysis provides a structural basis for rationalising the maintenance 
of the catalytic activity in the partially folded state. For comparison, the transition state 
is much more native-like and comprises a particularly well structured region that in-
cludes parts of β-strands 1, 2, 3 and 4, α-helices 1 and 2, bearing a more folded catalytic 
site (figure 2.6C and 2.7C). 
2.3.2 Enzymatic activity in the presence of a highly dynamic catalytic site 
We have shown that the partially structured ensemble of Sso AcP accumulating during 
folding prior to the formation of the native state is enzymatically active. This conclu-
sion was reached through the series of experiments that we summarise here. We first 
used a technique based on the monitoring of the absorbance of the substrate to assess 
the catalytic activity in real time. Prior to performing experiments on the activity of 
the intermediate we monitored the time course over 20 seconds of the substrate absor-
bance under native conditions, which provided the reference rate of disappearance of 
the substrate (figures 2.2D and 2.2E). We then followed for a similar time the same ab-
sorbance signal under refolding conditions, which resulted in a similar trend (figures 
2.2G and 2.2H). In particular, after the first four milliseconds of the refolding process 
less than 1%of the protein molecules are fully folded and about 80% of the native en-
zymatic activity was recorded (figures 2.2G, 2.2H and 2.2I). As a control experiment 
we carried out the refolding reaction in 7 M urea. Under these conditions the folding of 
Sso AcP takes place without intermediates, and, correspondingly, we detected a devel-
opment of the enzymatic activity with a rate very close to the folding rate (figures 2.2G 
and 2.2H). As a second control experiment we performed a double-jump experiment 
that ruled out the presence of a significant fraction of fully folded molecules during the 
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first 10ms of the refolding process. The possibility of a substrate induced folding was 
also ruled out through a third control experiment in which two competitive inhibitors 
of enzymatic activity of Sso AcP were shown to leave the folding rate unaffected (figure 
2.2F). 
A few systems have been shown to bear enzymatic activity in the absence of folded 
structure. An intermediate in the folding of ribonucleaseT1 is characterised by exten-
sive secondary and tertiary structure, a hydrophobic core with low solvent accessibil-
ity and partial enzymatic activity (Kiefhaber et al. 1992). A monomeric chorismate mu-
tase obtained by topological redesign of a dimeric helical bundle enzyme from Metha-
nococcus jannaschii shows properties typical of a molten globule state. This protein is 
enzymatically active and its activity is coupled with a substrate-induced folding 
(Vamvaca et al. 2004). Moreover, the complex formed upon binding of substrate re-
tains high flexibility (Pervushin et al. 2007). Two variants of dihydrofolate reductase 
are enzymatically active and show molten globule features. They gain native-like struc-
ture in the presence of methotrexate and NADPH (Uversky et al. 1996). The catalytic 
site of Sso AcP that we characterised here is highly heterogeneous in the partially 
folded ensemble. This conclusion follows from the observation that Φ values of resi-
dues in the catalytic 22-28 loop are close to 0. Moreover, the overall structural analysis 
carried out with all of the experimentally determined Φ values confirms that the cata-
lytic site of the protein is not yet fully structured, although it may become so upon 
binding of the ligand. Importantly, the folding is not accelerated in the presence of sub-
strate analogues, suggesting that no global substrate-induced folding occurs, even 
though a local reorganisation of the catalytic region cannot be ruled out. 
These findings indicate that an enzyme can be an efficient catalyst even in the ab-
sence of its stable native conformation and provides clues to the characterisation of the 
structural and dynamic features of a protein that allow the catalysis to take place in the 
absence of a fully structured catalytic site. Indeed, we have shown that the presence of a 
scaffold region, whose structure is already formed in the partially folded state, deter-
mines the topology of the entire molecule; thus, the catalytic residues, albeit highly dy-
namic, remain in close proximity and can hydrolyse the substrate. We have found that 
the activity of the partially folded state is highly sensitive to mutations, suggesting that 
in the partially structured ensemble a small number of native contacts stabilises the 
overall structure and enables the protein to hydrolyse the substrate; substitutions may 
therefore cause a higher degree of flexibility and allow a full inactivation of the enzyme 
due to an increase in entropy. 
The importance of conformational changes and flexibility in enzyme catalysis has 
been widely recognised (Osborne et al. 2001; Eisenmesser et al. 2002; Benkovic and 
Hammes-Schiffer 2003; Poulsen et al. 2003; Garcia-Viloca et al. 2004). The detection 
of enzymatic activity in the absence of a structured catalytic site and the ability to de-
termine the distribution of structures in these non-native states represent a key step 
forward in the elucidation of the protein dynamics that are required for enzyme cataly-
sis. In addition, the identification of a highly dynamic functional site in the presence of 
a scaffold region that restricts the conformational space of the flexible region suggests 
a potentially important concept in molecular biology. It has been shown, for example, 
that it is possible to change the catalytic activity of an existing protein scaffold by sub-
stituting several loops and then introducing point mutations to tune the enzyme activ-
ity (Park et al. 2006). Moreover, it has been proposed that the order of formation of na-
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tive contacts during folding recapitulates the emergence of topology in molecular evo-
lution (Nagao et al. 2005). The fact that the catalytic site of Sso AcP is highly heteroge-
neous in the partially folded ensemble and folds afterwards -i.e. concomitantly to the 
formation of the native state- indicates the presence of an efficient evolutionary mecha-
nism in which the scaffold of a protein is maintained and the regions or residues di-
rectly involved in function (for example in catalysis or binding) are allowed to mutate 
without compromising the overall stability of the structure. This mechanism may help 
to increase the rate of development of new activities and could explain how proteins 
with the same topology can possess very different functions. 
2.3.3 Biological function in the absence of a three-dimensional fold 
It has been proposed that a considerable fraction of eukaryotic proteins are either fully 
unstructured or contain significant portions of their sequence -i.e. regions longer than 
50 residues- in an unstructured state (Dunker et al. 2001; Fink 2005). Intriguingly, 
these natively unfolded polypeptide chains are mostly involved in fundamental bio-
logical processes, such as transcription, translation and regulation of the cell cycle 
(Nakayama et al. 2001). The existence of such natively unfolded regions, however, is at 
first sight surprising as proteins have a high propensity to aggregate into deleterious 
misfolded structures under these conformational states (Dobson 2003). It has been 
suggested that, because of their high flexibility, these polypeptide chains are able to 
bind many substrates and interact with many targets (Uversky 2002); this is consistent 
with the observation that many “hubs” (i.e. proteins with a large number of interaction 
partners) in protein interaction networks are constituted by proteins either completely 
or partially disordered in solution (Dunker et al. 2005). It has also been proposed that, 
since natively unfolded proteins need to fold before binding, they can couple high 
specificity with a low affinity (Dunker et al. 2001). These proteins overcome steric re-
strictions, giving rise to interaction surfaces larger than those obtained from a native 
state (Dunker et al. 2005) and their flexibility increases the rate of specific macromo-
lecular association (Uversky 2002). The disorder of these peptides speeds up their 
turnover and this favours rapid response to cell signalling in fundamental points of the 
protein network (Fink 2005). The widespread presence of natively unfolded proteins in 
living organisms suggests that proteins do not have to adopt necessarily compact 
globular structures to be functional, at least for the molecular recognition of their tar-
gets. 
In this work we have reported evidence that a conformational state structurally dis-
tant from the native structure -particularly in those loops or residues that form the 
substrate binding and catalytic site- is able to bind substrates, carry out catalysis and 
release products. These findings extend the spectrum of possible biological functions 
carried out in the absence of a folded state to include enzyme catalysis. If confirmed, the 
results that we have presented will suggest an extension of the paradigm that specific 
biological functions can only be associated with unique three-dimensional folds, and 
thus provide an important conceptual tool for a better understanding of the complex 
network of biological functions, protein-protein interactions and regulatory mecha-
nisms that are at the basis of the function of the cell. 
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2.4 Materials and methods 
2.4.1 Mutagenesis 
The gene encoding wild type Sso AcP was initially inserted in a pGEX-2T plasmid. 
Mutants of Sso AcP were produced by using the Quick Change site-directed mutagene-
sis kit® from Stratagene. In particular, the following protocol was applied to achieve de-
sired mutation (figure 2.8):  
1. Wild type plasmid was extracted from DH5-α E. coli cells using the QIA 
quick extraction kit (see figure 2.8B). 
Figure 2.8: Agarose gel at 1% (w/v) showing the steps of mutagenesis. (A) 1Kb standard; length 
values corresponding to bands are shown on the left. (B) The extracted, supercoiled, template 
plasmid. (C) Result of the amplification reaction: the product is not supercoiled; a band is 
visible corresponding to supercoiled plasmid due to the presence of the template. (D) Result 
of treatment with Dpn I; the band of the template is now not visible. (E) Plasmid extracted 
from transformed cells. The plasmid is supercoiled. 
 
2. A mutagenic PCR was carried out with 10 ng of pGEX-2T plasmid carrying 
the gene encoding wild type Sso AcP as template. Primers were designed to 
contain the desired mutation in the middle with about 15 bases of correct se-
quence on both sides. The melting temperature Tm was calculated to be ≥ 78 °C 
according to the following formula: 
where %GC is the relative content of G and C bases and N is the primer length 
in bases. 125 ng of both primers and 2.5 UI of Pfu Turbo DNA polymerase 
were used. 19 polymerisation cycles were carried out with the following pro-
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tocol: (1) 30 seconds at 95 °C; (2) one minute at 55 °C; (3) 10 minutes at 68 °C 
(figure 2.8C). 
3. After amplification reaction, the sample was treated with Dpn I (10 UI/μ l) at 
37 °C for one hour to digest the parental supercoiled double strand DNA (fig-
ure 2.8D). 
4. XL1-Blue supercompetent cells were transformed with 1 ml of the sample. 
Cells were grown on LB plates containing 0.1 μg ml-1 ampicillin. 
5. The plasmid carrying the desired mutation was extracted from colonies (figure 
2.8E). Presence of the desired mutation was assessed by DNA sequencing. 
Cells were stored in glycerol at -80 °C. 
 
 
Figure 2.9: SDS-polyacrilammide gel electrophoresis showing the different steps of purifica-
tion. (A) Sigma wide range standard; mass values in kDa corresponding to bands are shown on 
the left. (B and C) Pellet (B) and supernatant (C) separated by centrifugation after cell lysis; 
the band at 37 kDa corresponds to the GST-Sso AcP fusion protein (see text). (D) Flow-
through harvested at the bottom of the column after application of the supernatant contain-
ing GST-Sso AcP fusion protein. The 37 kDa band has disappeared as fusion protein is bound 
to the resin. (E and F) Two washing steps with PBS (E) and TRIS (F) buffer. After the second 
step non-specific proteins are not present in the column. (G) Sso AcP eluted after thrombin 
cleavage. (H) GST eluted after washing the column with glutathione. 
 
2.4.2 Protein expression and purification 
Expression and purification of wild type protein and mutants were carried out by affin-
ity chromatography as previously described (Modesti et al. 1995). In particular the fol-
lowing protocol was applied (figure 2.9): 
1. Plasmid carrying the gene encoding the Sso AcP protein variant was extracted 
and transformed into BL21 E. coli competent cells. 
2. Cells were grown over night in a LB medium with 0.1 μg ml-1 ampicillin. 
3. Expression of Glutathione-S-transferase/Sso AcP fusion protein (GST-Sso 
AcP) was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG, Inalco, 
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Milan, Italy) at a final concentration equal to 50 mg ml-1. After three hours of 
expression cells were separated from medium by centrifugation (15 minutes at 
7,000g) and resuspended with a 20 mM sodium phosphate and 250 mM 
NaCl buffer at pH 7.3 (PBS) with ethylenediaminetetraacetic acid (EDTA) 
1mM, β-mercaptoethanol 1 mM and phenylmethylsulfonyl fluoride (PMSF) 
0.1 mM. Cells were stored at -20 °C. 
4. Cell lysis was carried in three steps: (1) thawing cells; (2) adding lysozyme to a 
final concentration of 1 mg ml-1; (3) 6 sonication cycles of 30 seconds. The ob-
tained sample was centrifuged for 40minutes at 39,000g (figure 2.9B and 
2.9C). 
5. The supernatant was applied to a column containing glutathione-agarose resin 
(Sigma) (figure 2.9D). 
6. After two washing steps with buffers (figure 2.9E and 2.9F), 10 ml of a 50 mM 
2-amino-2-hydroxymethyl-1,3-propanediol (TRIS) and 150 mM NaCl buffer 
at pH 8.0 containing 50 UI of human thrombin (Sigma) were added to the col-
umn. Thrombin cleavage was carried out over night. 
7. The eluted proteinwas concentratedwith centriplus (Millipore) and checked by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
electrospray mass spectrometry (figure 2.9G and 2.9H). Protein concentration 
c was measured according to the Lambert-Beer law: 
Where A280 is the absorbance at 280 nm measured in a JascoV-630 spectropho-
tometer (Tokio, Japan) spectrophotometer, ε280 is the extinction coefficient cal-
culated as reported (Gill and von Hippel 1989) and l is the cell length. Protein 
was stored at -20 °C. 
2.4.3 Enzymatic activity essay 
Enzymatic activity of native Sso AcP was measured in a continuous optical test at 283 
nm using benzoyl-phosphate (BP) as a substrate ((Ramponi et al. 1966) and figure 1.6I) 
with a Lambda 4V Perkin Elmer spectrophotometer (Wellesley, Massachusetts). Ex-
perimental conditions were 2.0 μg ml-1 Sso AcP, 5.0 mM BP, 50 mM acetate buffer at 
pH 5.5, 37 °C. BP was synthesised as previously described (Camici et al. 1976) and 
freshly dissolved before enzymatic activity measurements. 
2.4.4 Development of enzymatic activity during folding 
A Bio-logic SFM-3 stopped-flow device (Claix, France) coupled with an absorbance 
detection system and thermostated with a RTE-200 water circulating bath from Neslab 
(Newington, New Hampshire) was used to measure the recovery of enzymatic activity 
during folding. Sso AcP was initially unfolded at a concentration equal to 0.4 mg ml-1 
in 5.5 M GdnHCl (Sigma-Aldrich), 50 mM acetate buffer, pH 5.5, at 37 °C. 20 μl ali-
quots of this sample were mixed with 380 μl of a solution containing 5.27 mM BP, 50 
mM acetate buffer, pH 5.5. Final conditions in the assay test were 0.02 mg ml-1 Sso 
AcP, 0.275 M GdnHCl, 10 mM BP, 50mMacetate buffer, pH5.5, 37 °C. The experi-
mental dead time ranged from 4 to 20 ms. The cuvette length was 1 cm. The signal at 
283 nm (A283) was acquired during protein refolding. Since the decrease of this signal is 
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proportional to the enzyme activity, for each obtained trace the decay rate of absor-
bance at 283 nm was calculated, after a smoothing on a 0.02 s sliding window, as the 
opposite of the first order derivative (-dA283(t)/dt). The obtained values were normal-
ised to the activity of the native wild type protein, plotted versus time and fitted to the 
following equation: 
 
where t is the time, -dA283(t)/dt is the enzymatic activity measured during folding, Ctot 
is the total protein concentration, kCATF and kCATI are kCAT of native and partially 
folded states and kI→F is the main folding rate. Derivation of equation 2.3 is reported 
in appendix A (see section A.4). 
2.4.5 Equilibrium GdnHCl-induced unfolding curves 
For each mutational variant of Sso AcP, 28 samples containing 0.2 mg ml-1 of the 
tested protein, 50mMacetate buffer, pH 5.5 and a GdnHCl concentration ranging 
from 0 to 7.2 M, were incubated for 2 h at 37 °C to reach equilibrium. After this time, 
the circular dichroism (CD) signal at 222 nm was acquired for all samples using a 0.1 
cm path-length cuvette in a Jasco J-810 CD spectropolarimeter (Great Dunmow, Es-
sex, United Kingdom) thermostated with a C25P Thermo Haake water circulating 
bath (Karlsruhe, Germany). The mean residue ellipticity was plotted versus GdnHCl 
concentration. The obtained plots were fitted to a two state transition according to 
the equation described by Santoro and Bolen (Santoro and Bolen 1988) to obtain the 
free energy difference between the unfolded and the native states in the absence of 
denaturant !GU-FH2O), the dependence of the !GU-FH2O on GdnHCl concentration (m 
value) and the midpoint of denaturation (Cm). 
The fraction folded at each GdnHCl concentration was calculated as described 
(Chiti et al. 1998). For each mutant, the change in conformational stability upon mu-
tation, !!GU-FH2O was calculated according to 
where C’m and Cm are the mid-denaturation concentrations for the considered mu-
tant and the wild type, respectively, and m is the average m value over the wild type 
and 34 mutants that we studied here. The average m value was used following 
(Matouschek and Fersht 1991), since the m value obtained by the best fit of a single 
mutant to the Santoro & Bolen model arises from the few points in the transition 
zone of the plot (see figure 2.4A) and is therefore highly sensitive to the experimental 
error. Cm, !GU-FH2O and individually calculated m values are reported in table 2.2. 
2.4.6 Folding kinetics 
Folding experiments were carried out using the Bio-logic SFM-3 stopped flow device 
(Claix, France) equipped with a fluorescence detection system and thermostated with a 
RTE-200 water circulating bath from Neslab (Newington, New Hampshire). An excita-
tion wavelength of 280 nm and a band-pass filter to monitor emitted fluorescence above 
320 nm were used. The cuvette path-length was 0.15 cm. 20 μl aliquots of 0.4 mg ml-1 pro-
tein unfolded in 5.5 M GdnHCl were mixed with 380 μl of refolding buffer. Final condi-
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tions were 0.02 mg ml-1 protein, 50 mM acetate buffer, pH 5.5, a GdnHCl concentration 
ranging from 0.2 to 2.5 M, 37 °C. The experimental dead time was 10.4 ms. The obtained 
traces were fitted to a double exponential equation of the following form: 
  
where f(t) is the fluorescence as a function of time t, A1 and A2 are amplitudes, q is the 
equilibrium signal and k12 and kI→F are folding constants. Derivation of equation 2.5 is 
reported in appendix A (section A.2.1). The main folding rate constant was then plot-
ted versus denaturant concentration to extrapolate the folding rate constant in the ab-
sence of denaturant (kI→FH2O) as reported in appendix A (section A.2.3). However, 
kI→FH2O refers to the rate of formation of the native state regardless of the on- or off-
pathway nature of the partially folded state. In another set of experiments 20 μl aliquots 
of 0.4 mg ml-1 wild type Sso AcP unfolded in 5.5 MGdnHCl were mixed with 380 μl of 
refolding buffer containing different concentrations of inorganic phosphate and phenyl 
phosphate. Final conditions were 0.02 mg ml-1 Sso AcP, 0.275 M GdnHCl, 50 mM ace-
tate buffer, pH 5.5, a phosphate and phenyl phosphate concentration ranging from 0.1 
to 10 mM, 37 °C. The resulting traces were fitted to equation 2.5. 
2.4.7 Unfolding kinetics 
Unfolding experiments were carried out using a Bio-logic SFM-20 stopped flow de-
vice (Claix, France) equipped with a Jasco J-810 circular dichroism detection system 
(Great Dunmow, Essex, United Kingdom) and thermostated with a C25P Thermo 
Haake water circulating bath (Karlsruhe, Germany). The signal was recorded at 230 
nm with a slit window of 4.0 nm. The cuvette path-length was 0.2 cm. 85 μl aliquots 
of 1.4 mg ml-1 protein in 1.0 M GdnHCl were mixed with 215 μl of a solution con-
taining 8.0 M GdnHCl, 50 mM acetate, pH 5.5. Final conditions were 0.4 mg ml-1 
protein, 50 mM acetate buffer, pH 5.5, 6.0 M GdnHCl, 37 °C. The experimental dead 
time was 74 ms. To obtain the unfolding rate constant (kF→U), 6 to 10 traces were av-
eraged and fitted to a single exponential equation of the following form: 
where ["](t) is the CD signal as a function of time t, A is the amplitude and q is the equi-
librium signal. Derivation of equation 2.6 is reported in appendix A (section A.2.2). The 
unfolding rate constant in the absence of denaturant (kF→UH2O) was obtained with a linear 
extrapolation method using a previously obtained slope (Bemporad et al. 2004). 
2.4.8 # value analysis 
A # value analysis was carried out on the partially folded state and the transition state en-
semble populated during the Sso AcP folding process. The # values for the transition 
state ensemble (Matouschek and Fersht 1991), #‡H2O, were calculated according to 
where C’m and Cm are the mid-denaturation concentrations for the considered mutant 
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and the wild type, respectively, R is the ideal gas constant (8.314 J mol-1 K-1), T is the 
temperature in K (310.15 K), k’F→UH2O and kF→UH2O are the unfolding rate constants in the 
absence of denaturant for the mutant and the wild type protein, respectively. Derivation 
of equation 2.7 is shown in appendix A (see section A.3). Φ values for the partly folded 
state, ΦIH2O (Matouschek et al. 1992) were calculated according to 
 
 
where k’I→FH2O and kI→FH2O are the folding rate constants in the absence of denaturant for 
the mutant and the wild type protein, respectively. Derivation of equation 2.8 is shown 
in appendix A (see section A.3). 
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Chapter 3  
Aggregation studies on Sso AcP 
3.1 Introduction 
3.1.1 Aggregation from native states 
As introduced in section 1.3.2 the “conformational change hypothesis” can account for 
the aggregation of most peptides. Nevertheless, evidence is now emerging that native 
folded states retain a significant, albeit small, propensity to aggregate (section 1.3.2 and 
(Bemporad et al. 2006; Chiti and Dobson 2006)). Indeed, edge β-strands are potentially 
dangerous as they are already in the right conformation to interact with any other β-
strand they encounter. This can be the initial step that triggers the formation of amy-
loid-like aggregates. This natural tendency to aggregate of proteins and edge β-strands 
is kept under control by several evolutionary strategies (Richardson and Richardson 
2002; Monsellier and Chiti 2007; Monsellier et al. 2007). For example, α-helix pro-
teins cover their β-sheet ends with loops of different length and structure. In many 
cases, edge β-strands are protected by presence of particular structure, such as β-bulges 
or particular residues, such as proline, that force the strand in a conformation with low 
propensity to aggregate (Richardson and Richardson 2002). Finally, in some cases edge 
β-strands are very short and this prevents their aggregation (Richardson and 
Richardson 2002). 
Despite the existence of evolutionary strategies to keep under control this process, 
some systems are able to aggregate starting from an ensemble of native-like conforma-
tions (Bemporad et al. 2006; Chiti and Dobson 2006). In the case of insulin, for exam-
ple, aggregation at low pH is preceded by an oligomerization step in which a native-
like content of α-helical structure is almost completely retained, and aggregates with a 
morphology reminiscent of amyloid protofibrils and with a high content of β-
structure appear only later in the process (Bouchard et al. 2000). In the case of ataxin-3, 
the protein associated with spinocerebellar ataxia type-3, a polyglutamine insertion 
strongly enhances aggregation propensity but does not affect native state stability. This 
led the authors to propose a model for amyloid aggregation in which the pathways of 
unfolding and misfolding are distinct and separate (Chow et al. 2004). In addition, the 
S6 protein from Thermus thermophilus adopts a quasi-native state at pH 2.0, 0.4 M 
NaCl, and 42 °C. Under stirring, the protein grows into fibrils after several days. Inter-
estingly, kinetic analysis revealed that longer lag phases in aggregation correlate with 
faster unfolding rates in a number of variants, suggesting that the native-like state 
rather than an ensemble of highly fluctuating conformations, participates in the nuclea-
tion of the fibrillation process (Pedersen et al. 2004). Finally, in the case of the yeast 
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prionUre2p, it was shown that a native-like conformation is retained also in the fibrils, 
suggesting a native-like state as the initial conformer that initiates amyloid-like ag-
gregation (Bousset et al. 2002; Bousset et al. 2004a; Bousset et al. 2004b). 
 
Figure 3.1: Aggregation of Sso AcP; reprinted from (Plakoutsi et al. 2005). (A) The aggregation 
process of Sso AcP. An ensemble of native-like conformations gives rise to the formation of 
early aggregates in which the native structure is retained. These convert afterwards in amyloid-
like protofibrils. (B) Electron micrograph at two different magnifications of negatively stained 
Sso AcP aggregates formed after one hour in 20% (v/v) TFE, 50 mM sodium acetate at pH 5.5 
and 25 °C. Small aggregates consisting of globules and short thin fibrils are visible throughout 
the samples and form the background of the grid. These species have diameters of 3-5 nm. 
Elongated protofibrils are indicated by arrows. 
 
The ability to aggregate of native conformations is not surprising if we consider 
that native states are actually ensembles of a multitude of conformers (Lindorff-Larsen 
et al. 2005a). Some of these conformers will be only transiently populated but could be 
significant for aggregation just as they are for the hydrogen exchange of their main-
chain amide groups (Chiti and Dobson 2006). 
3.1.2 Aggregation of Sso AcP 
Two members of the acylphosphatase family (section 1.4.1) aggregate starting from an 
ensemble of native-like conformations (Bemporad et al. 2006). The acylphosphatase 
from Drosophila melanogaster (AcP Dro2) forms amyloid-like fibrils under condi-
tions in which the protein has initially a secondary structure, hydrodynamic diameter, 
catalytic activity, and packing around hydrophobic residues indistinguishable from 
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those of the native state (Soldi et al. 2006a). Importantly, conformational stabilities 
measured in native and aggregation promoting conditions do not significantly differ 
and the protein does not need to unfold to initiate aggregation (Soldi et al. 2006a). 
 
Figure 3.2: Structure of Sso AcP. Ribbon representation of the Sso AcP structure (Corazza et 
al. 2006). The regions that were shown to be important in amyloid-like aggregation are de-
picted in red. These correspond to N-terminal segment and fourth β-strand (Plakoutsi et al. 
2006). The figure has been drawn with VMD 1.8.3 for win32 (Humphrey et al. 1996). 
 
The acylphosphatase from Sulfolobus solfataricus (Sso AcP) aggregates starting 
from an ensemble of native-like conformations as well. The protein is able to give rise 
to amyloid-like protofibrils in about one hour, in 15-25 % 2,2,2-Trifluoroethanol 
(TFE) at pH 5.5 and 25 °C (Plakoutsi et al. 2004; Plakoutsi et al. 2005). Importantly, in 
these conditions, before aggregation occurs, Sso AcP has a considerable enzymatic ac-
tivity (Plakoutsi et al. 2004) and native-like far- and near-UV circular dichroism (CD) 
spectra (Plakoutsi et al. 2006). Moreover, folding is faster than unfolding (Plakoutsi et 
al. 2004). Aggregation occurs from this native-like state in two phases (see figure 3.1). 
1. In a first phase the Sso AcP molecules interact giving rise to an aggregated 
species, referred to as early aggregates, that retain native-like CD spectra and 
enzymatic activity ((Plakoutsi et al. 2005) and figure 3.1A). Importantly, this 
species does not bind to Congo red (CR) and Thioflavin T (ThT) dies, suggest-
ing no amyloid-like conformation (Plakoutsi et al. 2005). Finally, early aggre-
gates do not show any increase in β-structure, as observed by means of Fourier 
transform infrared (FTIR) spectroscopy (Plakoutsi et al. 2005). 
2. Only afterwards, in a second phase, the early aggregates convert into amyloid-
like protofibrils (figure 3.1B). These species do not show enzymatic activity 
(Plakoutsi et al. 2005). Importantly, they bind both ThT and CR dies and pos-
sess extensive β-structure (Plakoutsi et al. 2005). The rate of this phase does 
not seem to depend on protein concentration, suggesting that this phase is an 
intra-molecular reorganisation rather than an elongation phase (Plakoutsi et 
al. 2005). Finally, protofibrils appear as thin filaments with a diameter of 3-5 
nm(figure 3.1B),when analysed with transmission electron microscopy (TEM) 
(Plakoutsi et al. 2005). 
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In a recent study, we tried to investigate in detail the mechanism of aggregation of Sso 
AcP and the regions that promote aggregation of the protein. As introduced in section 
1.3.2 Sso AcP possesses an 11 residue, unstructured N-terminal segment ((Corazza et 
al. 2006)  and figure 3.2). Importantly, neither the unstructured segment nor the globu-
lar part of Sso AcP without segment (ΔN11 Sso AcP) are able to aggregate in condi-
tions that promote aggregation of the wild type protein (Plakoutsi et al. 2006). This 
clearly suggests that the N-terminal segment plays a major role in promoting aggrega-
tion of Sso AcP. Moreover, limited proteolysis data, coupled to hydrogen/deuterium 
exchange experiments and equilibrium unfolding experiments carried out on a set of 
Sso AcP protein variants, allowed the fourth β-strand of the molecule to be identified 
as an important region in promoting the aggregation of the molecule (Plakoutsi et al. 
2006). Importantly, this strand is an edge β-strand of Sso AcP, confirming the impor-
tance of protecting these regions in prevention of native state aggregation. 
Despite the identification of these two regions as major determinants of the amy-
loid-like aggregation of Sso AcP (see figure 3.2), the aggregation mechanism of the 
protein is still unclear. Moreover, it was shown that ΔN11 Sso AcP has a conforma-
tional stability higher than wild type protein (Plakoutsi et al. 2006). This could suggest 
that this segment induces aggregation of the molecule through a destabilisation effect. 
Finally, no information on the structure of early aggregates and protofibrils has been 
so far collected. In the following sections we shall get further insight into the role of the 
N-terminal segment in the process studying the effect of changing its position in the 
sequence on the aggregation rate and mechanism. Moreover, we shall investigate the 
ability of this segment to affect wild type and ΔN11 Sso AcP behaviour in aggregation 
promoting conditions. The role of the destabilisation induced by the N-terminal seg-
ment and the dependence of the rates of the two aggregation phases on Sso AcP concen-
tration shall be studied. Finally, we shall use a fluorescent probe, acrylodan, to get fur-
ther insight into the regions buried in early aggregates and protofibrils. The obtained 
results allow to rule out several models reported in appendix B and shall be discussed 
on section 3.3 to obtain a model for the aggregation of Sso AcP that recapitulates all the 
experimental evidences collected so far on this system. 
3.2 Results 
3.2.1 Sso AcP aggregates regardless of the position of the N-terminal segment 
As mentioned above, the aggregation properties of Sso AcP suggest a major role in the 
process for the 11 residue unstructured N-terminal segment and for the fourth β-
strand, positioned at the edge of the protein (figure 3.2 and (Plakoutsi et al. 2006)). 
However, the role played by these two regions in the aggregation process is still un-
clear (Plakoutsi et al. 2006). To get insights into the mechanism of amyloid-like aggre-
gation of Sso AcP, we have produced a mutant in which the unstructured segment is 
moved from N-terminus to C-terminus. Importantly, in this mutant the primary se-
quence of both segment and the globular part of Sso AcP do not change. However, N-
terminus and C-terminus are far from each other (figure 3.2) and this different posi-
tioning offers an unique opportunity to check possible intra-molecular interactions be-
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tween unstructured segment and globular part of Sso AcP. We will refer to this mutant 
as C-tail Sso AcP. 
 
Figure 3.3: Properties of native C-tail Sso AcP. (A) Far UV circular dichroism spectra of wild 
type (continuous line) and C-tail (dashed line) Sso AcP in 10 mM TRIS buffer at pH 8.0, 25 °C. 
Mean residue ellipticity is shown versus wavelength. The overlapping of spectra suggests simi-
lar secondary structure contents in native states of these protein variants. (B) Dynamic light 
scattering spectra of wild type (continuous line) and C-tail (dashed line) Sso AcP in 10 mM 
TRIS buffer at pH 8.0, 25 °C. An apparent diameter equal to 3.7 ± 0.1 nm has been measured 
for both monomers. (C) Equilibrium unfolding curves of wild type (filled circles) and C-tail 
(empty circles) Sso AcP carried out in 50 mM acetate buffer at pH 5.5, 37 °C. The relative 
amount of native protein (folded fraction) is reported versus denaturant concentration. Con-
tinuous and dashed lines represent best fits of experimental data to the Santoro & Bolen 
model for wild type and C-tail Sso AcP, respectively ((Santoro and Bolen 1988) and section 
A.1.1). 
 
Since the aggregation of Sso AcP starts from an ensemble of native-like conformations 
we have checked the effect of the mutation on the native state of the protein. Figure 3.3A 
shows a comparison between far-UV CD spectra of wild type Sso AcP and C-tail Sso 
AcP recorded in 10 mM TRIS buffer at pH 8.0 and 25 °C. Both spectra are typical CD 
spectra of α + β globular proteins. Moreover, the overlapping of these spectra suggests 
that moving the 11 residue segment from N-terminus to C-terminus does not affect the 
secondary structure content of the globular part of the molecule. In a second experi-
ment we have measured the hydrodynamic diameter of wild type Sso AcP and C-tail 
Sso AcP in 10 mM TRIS buffer at pH 8.0 and 25 °C (figure 3.3B). Both proteins show a 
peak at 3.7 ± 0.1 nm. This value is consistent, within the experimental error, with the 
average diameter determined by 1H-NMR (Corazza et al. 2006). This result shows that 
the mutation inserted in C-tail Sso AcP does not affect the compactness of the native 
state. Then, we have measured the conformational stability of C-tail Sso AcP in an 
equilibrium unfolding experiment carried out in 50 mM acetate buffer at pH 5.5 and 37 
°C. The obtained plot is reminiscent of a two-state cooperative transition. Thus, it has 
been analysed with the method provided by Santoro & Bolen ((Santoro and Bolen 1988) 
and section A.1.1; figure 3.3C). Results of this analysis show an m value equal to 11.4 ± 
0.5 KJ mol-1 M-1 for both wild type and C-tail Sso AcP. The concentration of middle 
denaturation (Cm) is 4.2 ± 0.1 M and 3.8 ± 0.1 M for wild type and C-tail Sso AcP, re-
spectively. The free energy change upon denaturation (ΔGU-FH2O) 43.0 ± 2 KJ mol-1 for 
C-tail Sso AcP. The ΔGU-FH2O value for wild type Sso AcP determined in the same con-
ditions is equal to 48.0 ± 2.0 KJ mol-1 (Bemporad et al. 2004; Corazza et al. 2006). This 
shows that moving the unstructured segment from N-terminus to C-terminus induces 
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a slight destabilisation of the protein. Finally, we have measured the enzymatic activity 
of C-tail Sso AcP in 50 mM acetate buffer at pH 5.5 and 25 °C using benzoyl-
phosphate (BP) as a substrate. The obtained values are 190 ± 20 s-1 for wild type Sso 
AcP (Corazza et al. 2006) and 152 ± 20 s-1 for C-tail Sso AcP. This decrease in enzy-
matic activity is probably due to a steric effect induced by moving the unstructured 
segment to the C-terminus, which is much closer to the catalytic site of Sso AcP than 
N-terminus (Corazza et al. 2006). Taken together, these results show that moving the 
unstructured segment from the N-terminus to the C-terminus does not affect the struc-
tural parameters of the globular part of Sso AcP. 
 
Figure 3.4: Aggregation of C-tail Sso AcP. (A) ThT fluorescence during aggregation of wild 
type (●) and C-tail (○) Sso AcP 34 μM in 50 mM acetate buffer at pH 5.5, 20% (v/v) TFE, 25 
°C. The ThT signal has been normalised to the plateau value. Lines represent best fits of ex-
perimental data to equation 3.3. (B) Circular dichroism spectra, reported as mean residue ellip-
ticity versus wavelength, of wild type (continuous lines) and C-tail (dashed lines) Sso AcP. 
Spectra are shown for native proteins (black lines) in 10mMTRIS buffer at pH 8.0 and 25 °C, 
early aggregates (dark grey lines) and protofibrils (light grey lines) in 50 mM acetate buffer at 
pH 5.5, 20% (v/v) TFE 25 °C. Early aggregates spectra have been extrapolated using equation 
3.2 as reported in section 3.4. The inset shows the change in mean residue ellipticity at 208 nm 
over aggregation time for wild type (●) and C-tail (○) Sso AcP 34 μM in 50 mM acetate buffer 
at pH 5.5, 20% (v/v) TFE, 25 °C. Continuous lines represent best fits of experimental data to 
equation 3.2. (C) CR staining of C-tail Sso AcP. Spectra for CR alone, aggregates alone and CR 
red in the presence of protofibrils are labelled. The inset shows the spectra obtained subtract-
ing the contributions of CR alone and aggregates alone from the spectrum of CR in the pres-
ence of aggregates, for wild type (continuous line) and C-tail (dashed line) Sso AcP. The pres-
ence of the peak at 540 nm suggests ordered aggregates. 
 
We have studied the behaviour of C-tail Sso AcP in conditions that induce amy-
loid-like aggregation of wild type protein, that is 34 μM protein in 50 mM acetate 
buffer at pH 5.5, 20% (v/v) TFE, 25 °C (figure 3.4). Both first and second phase have 
been investigated. The results show that, in aggregation conditions, C-tail Sso AcP in-
duces the same increase in ThT fluorescence as the wild type protein ((Plakoutsi et al. 
2004; Plakoutsi et al. 2005) and figure 3.4A). Aggregation rate constants, determined 
by best fits of experimental data to equation 3.3 are (3.7 ± 0.4) · 10-3 s-1 for wild type Sso 
AcP and (2.5 ± 0.3) · 10-3 s-1for C-tail Sso AcP (figure 3.4A). Moreover, the species 
populated by C-tail Sso AcP at the plateau of the ThT kinetic experiment binds to CR 
dye inducing the same shift in peak wavelength as the wild type protein (Plakoutsi et al. 
2004) (figure 3.4C). To monitor formation of early aggregates, aggregation of C-tail 
Sso AcP has been followed also with circular dichroism. Similarly to wild type pro-
tein, recorded traces show two distinct phases (inset in figure 3.4B). The first phase 
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corresponds to the formation of early aggregates. Aggregation rate constants are (2.5 ± 
0.3) · 10-2 s-1 for wild type Sso AcP and (2.6 ± 0.3) · 10-2 s-1 for C-tail Sso AcP. The sec-
ond phase corresponds to the process monitored by ThT kinetics. Aggregation rate 
constants determined by best fits of experimental data to equation 3.2 are (3.0 ± 0.3) · 
10-3 s-1 for wild type Sso AcP and (2.9 ± 0.3) · 10-3 s-1 for C-tail Sso AcP. These values 
are consistent, within the experimental error, with values determined by ThT kinetics. 
CD spectrum of early aggregates formed by C-tail Sso AcP shows properties similar 
to the spectrum recorded for early aggregates formed by wild type Sso AcP, with a sin-
gle negative peak at about 224 nm (figure 3.4B). Taken together, these data show that 
the positioning of the unstructured segment of Sso AcP does not affect the aggregation 
process. These observations rule out possible models for the aggregation mechanism 
of the protein in which a specific intra-molecular interaction is supposed to be the fun-
damental step that leads to the formation of an aggregation prone monomer (see mod-
els B.2.5 and B.2.11 in appendix B). In fact, N-terminus and C-terminus are far from 
each other and moving the segment to a different position should affect any specific in-
teraction. 
 
Figure 3.5: Investigation on the effect on Sso AcP aggregation of destabilisation induced by N-
terminal segment. (A) Equilibrium unfolding curves of wild type (●) ΔN11 (■) and I72V-ΔN11 
(◆) Sso AcP carried out in 50 mM acetate buffer at pH 5.5, 37 °C. The relative amount of na-
tive protein (folded fraction) is reported versus denaturant concentration. Continuous lines 
represent best fits of experimental data to the Santoro & Bolen model (Santoro and Bolen 
1988). Elimination of a methyl group from the hydrophobic core of the Sso AcP globular part 
results in a protein variant more destabilised than the protein lacking the unstructured N-
terminus. (B) Determination of Ki of Sso AcP and phosphate. Michaelis-Menten plot of 5 μM 
ΔN11 Sso AcP in 50 mM acetate buffer pH 5.5 with 20% (v/v) TFE in the absence (●) and in 
the presence (◆) of 1.5 mM phosphate. Apparent KM values are shown. (C) ThT fluorescence 
during aggregation of Sso AcP in different conditions. Traces are shown for wild type 34 μM 
in 50 mM acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C (●), wild type 34 μM in 44.1 mM 
acetate and 4.8 mM phosphate buffer at pH 5.5, 20% (v/v) TFE and 25 °C (▲), I72V-ΔN11 34 
μM in 50 mM acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C (◆). The inset shows the first 
hour of recording. Continuous lines represent best fits of experimental data to equation 3.3. 
3.2.2 N-terminal segment does not induce Sso AcP aggregation via a destabilising effect 
As mentioned above, we previously showed that the Sso AcP protein variant lacking 
the 11 residue N-terminal tail (ΔN11 Sso AcP) is characterised by a conformational 
stability higher than wild type Sso AcP (figure 3.5Aand (Plakoutsi et al. 2006)). ΔGU-
F
H2O values are equal to 48.0 ± 2.0 KJ mol-1 and 52.0 ± 1.7 KJ mol-1 for wild type 
(Bemporad et al. 2004) and ΔN11 (Plakoutsi et al. 2006) Sso AcP, respectively. Since 
the latter protein variant is not able to aggregate in conditions that promote aggrega-
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tion of wild type Sso AcP, it is possible that the role played by the unstructured seg-
ment in the aggregation process is related to its destabilising effect on the protein. To 
verify this hypothesis, we have studied Sso AcP aggregation both in conditions that de-
crease the conformational stability of ΔN11 protein variant and in conditions that in-
crease the conformational stability of wild type protein. 
In order to destabilise ΔN11 Sso AcP we have applied a protein engineering strat-
egy (figure 3.5). In particular, we have introduced an isoleucine to valine single point 
mutation in the hydrophobic core of the molecule to eliminate a methyl group from 
Ile72. We will refer to the obtained mutant as I72V-ΔN11 Sso AcP. The equilibrium 
unfolding curve carried out in 50 mM acetate buffer at pH 5.5 and 37 °C on this mutant 
shows that the elimination of the methyl group results in a significant destabilisation 
of the protein (figure 3.5A). The ΔGU-FH2O value is equal to 43.1 ± 1.6 KJ mol-1. Thus, 
I72V-ΔN11 Sso AcP is a protein variant without unstructured segment with a confor-
mational stability lower than wild type protein. The change in ThT fluorescence over 
time after dilution of this mutant in the buffer that induces aggregation of wild type 
protein (see above) is shown in figure 3.5B. This mutant induces the same change in 
fluorescence as wild type protein does. However, it is important to observe that the 
process is three orders of magnitude slower than the one observed for wild type pro-
tein. The aggregation rate constant, determined by best fit of experimental data to equa-
tion 3.3, is equal to (8.1 ± 0.8) · 10-6 s-1. The species populated at the plateau of the ki-
netic experiment binds to CR dye (data not shown). 
Stabilisation of wild type protein has been achieved taking advantage of the cata-
lytic properties of Sso AcP. This protein is an enzyme able to hydrolyse phosphoanhy-
dridic bonds of acylphosphates (Corazza et al. 2006). All proteins belonging to acyl-
phosphatase superfamily follow standard Michaelis-Menten kinetic theory and phos-
phate ion is a well known competitive inhibitor of their activity (Stefani et al. 1997). In 
the presence of phosphate the amount of native protein will increase and the resulting 
stabilisation ΔΔGU-FPi can be calculated as follows: 
where CPi is the phosphate concentration, Ki is the affinity constant of phosphate, R is 
the ideal gas constant and T is the temperature. Derivation of this equation is shown in 
appendix A (see section A.1.2). Equation 3.1 allows the phosphate concentration to be 
calculated that induces the desired stabilisation on Sso AcP. We have determined the 
affinity constant of Sso AcP for phosphate ion in the aggregation promoting condi-
tions. In these conditions Ki is equal to 1.12 ± 0.1 mM (data not shown). Then we have 
followed ThT fluorescence in the presence of 34 μM wild type protein in 44.1 mM ace-
tate and 4.8 mM phosphate buffer at pH 5.5, 20% (v/v) TFE and 25 °C (figure 3.5B). In 
these conditions wild type protein has the same conformational stability as ΔN11 Sso 
AcP, as determined by equation 3.1, while the overall ionic strength does not vary. The 
fluorescence of the dye increases to reach a plateau in a single exponential phase. Ag-
gregation rate constant, determined by best fit of experimental data to equation 3.3, is 
equal to (2.6 ± 0.3) · 10-6 s-1. The species populated at the plateau of the kinetic experi-
ment binds to CR dye (data not shown). 
These experiments show that phosphate slows down amyloid-like aggregation of 
wild type Sso AcP. This is probably due to the ability of this ion to bind to the catalytic 
site and to decrease the conformational fluctuations (Soldi et al. 2006b). Moreover, de-
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stabilising ΔN11 Sso AcP induces its aggregation. Nevertheless, aggregation rate con-
stant determined for the stabilized wild type protein is significantly higher than the one 
obtained for destabilised ΔN11 Sso AcP. These observations rule out models for the 
aggregation mechanism of the protein in which the fundamental force that leads to 
formation of early aggregates is the destabilisation induced by the N-terminal unstruc-
tured segment on the globular part of Sso AcP (see models B.2.10 and B.2.13 in appen-
dix B). 
 
Figure 3.6: Aggregation of wild type Sso AcP in the presence of ΔN11 Sso AcP. (A) Aggrega-
tion of 34 μM Sso AcP in 50 mM acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C monitored 
by means of mean residue ellipticity at 208 nm. Although the total amount of protein is con-
stant, the traces show different relative amounts of protein with N-terminal segment (wild 
type Sso AcP) and without N-terminal segment (ΔN11 Sso AcP). Continuous lines represent 
best fits of experimental data to equation 3.2. (B) Aggregation of 34 μM Sso AcP in 50 mM 
acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C monitored by means of ThT fluorescence. 
The signal is shown relative to ThT fluorescence in the presence of the blank solution, i. e. 50 
mM acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C. Although the total amount of protein 
is constant, the traces show different relative amounts of protein with N-terminal segment 
(wild type Sso AcP) and without N-terminal segment (ΔN11 Sso AcP). Continuous lines repre-
sent best fits of experimental data to equation 3.3. (C) Plateau circular dichroism (●) and ThT 
fluorescence (■) versus wild type relative content in the experiments reported in panels (A) 
and (B). Continuous lines represent best linear fits of experimental data. 
3.2.3 A specific inter-molecular interaction between N-terminal segment and globular 
Sso AcP leads to the formation of early aggregates 
We showed in our previous experiments that neither the globular part nor the N-
terminal segment of Sso AcP are able to aggregate when separated from the remaining 
of the molecule (Plakoutsi et al. 2006). However, whether or not the unstructured seg-
ment gives rise to specific interactions in the early aggregates and the intermolecular 
or intra-molecular nature of these interactions is still unclear. To get insight into the 
aggregation mechanism of Sso AcP we have studied the behaviour, in conditions that 
promote aggregation, of solutions containing different relative amounts of wild type 
Sso AcP, ΔN11 Sso AcP and four short peptides. 
In a first set of experiments we have checked if the aggregation nucleus whose for-
mation is led by the N-terminal segment is able to sequester the protein variant lacking 
this portion (figure 3.6). That is, we have investigated the effect of mixing  wild type 
Sso AcP with ΔN11 Sso AcP on the two phases of the process. In this experiment the 
Sso AcP concentration remains equal to 34 μM in all tested samples. However, the 
relative amount of the two protein variants varies ranging from 0% to 100% of wild 
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type. These two latter conditions represent control experiments. Figure 3.6A shows 
aggregation kinetics followed by mean residue ellipticity at 208 nm. Mixing different 
relative amounts of the protein variant carrying the N-terminal segment with the one 
lacking this segment does not affect the rate of formation of protofibrils, as determined 
by best fits of experimental data to equation 3.2 (data not shown). There is instead a 
significant correlation between aggregation rate constant k1 and wild type content. 
Most importantly, the secondary structure content present at the end of the kinetic ex-
periment, as inferred from the value reached at the plateau of the trace, increases as the 
relative amount of ΔN11 Sso AcP in the sample increases. Similar results have been 
obtained following the process by ThT fluorescence (figure 3.6B). The aggregation rate 
constant k2, determined by best fits of experimental data to equation 3.3, does not show 
significant changes as the relative amounts of the protein variants change. However, an 
increase of the wild type content in the sample results in a higher fluorescence at the 
plateau of the experiment (figure 3.6B). Plateau values measured in ThT and mean resi-
due ellipticity kinetics have been plotted versus wild type relative content in figure 
3.6C. The figure shows a significant linear correlation between these values and the 
content of protein carrying the N-terminal segment. This confirms that only wild type 
Sso AcP is able to aggregate and that this variant is not able to hijack the protein lack-
ing the N-terminal segment into initial aggregates. Thus, presence of this segment is 
required not only in nucleation of the process, but also in the elongation of early aggre-
gates. Moreover, these observations rule out models based on the idea that the N-
terminal segment leads to the formation of large early aggregates in which globular 
portion of the molecules interact as well (see model B.2.3 and B.2.4 in appendix B). 
To get further information into the role of the N-terminal segment we have studied 
the effect on Sso AcP aggregation of the four following molecules: 
1. An 11 residue peptide bearing the sequence of the Sso AcP N-terminal seg-
ment, MKKWSDTEVFE. We will refer to this peptide as tail-11. 
2. A 14 residue peptide bearing the sequence of the Sso AcP N-terminal segment 
and the initial three residues of the first β-strand, MKKWSDTEVFEMLK. We 
will refer to this molecule as tail-14. 
3. An 11 residue peptide bearing the same amino-acid content as tail-11 but a dif-
ferent sequence, TMFKDWESEKV. We will refer to this molecule as scram-
bled peptide. 
4. An 11 residue peptide designed to be soluble and charged at pH 5.5. The se-
quence of the peptide is KSRAHNGKSAQ. We will refer to this molecule as 
control peptide. 
The peptide tail-14 has been used to check the possibility that in the aggregation pro-
moting conditions a partial unfolding occurs that exposes to the solvent a portion of 
the molecule longer than the segment. The scrambled peptide has been used to check if 
the possible effects induced by tail-11 are due to its primary sequence or to its overall 
physico-chemical properties. Finally, the control peptide has been used to control pos-
sible effects on the aggregation due to molecular crowding. 
We have investigated in detail possible effects induced by tail-11 and tail-14 pep-
tides on the behaviour shown by ΔN11 Sso AcP. In fact, this protein variant does not 
undergo any conformational modification in conditions that promote aggregation of 
wild type protein. The hydrodynamic diameter of the molecule shows a small decrease  
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Figure 3.7: Effect of peptides on the aggregation of Sso AcP. (A) Dynamic light scattering spectra of 
34 μM ΔN11 Sso AcP in 10mMTRIS buffer at pH8 and 25 °C (black continuous line), in 50 mM 
acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C (black dashed line), in 50 mM acetate buffer at 
pH 5.5, 20% (v/v) TFE and 25 °C with a 4 fold molar excess of tail-11 (red line) and scrambled (blue 
line) peptides. The inset shows circular dichroism spectra of 34 μM ΔN11 Sso AcP in 10 mM TRIS 
buffer at pH 8 and 25 °C (continuous line) and in 50 mM acetate buffer at pH 5.5, 20% (v/v) TFE 
and 25 °C (dashed line). (B) ThT fluorescence, reported as fold-increase relative to the blank (50 
mM acetate buffer at pH 5.5, 20% (v/v) TFE) during incubation of ΔN11 Sso AcP in 50 mM acetate 
buffer at pH 5.5, 20% (v/v) TFE and 25 °C in the presence of different molar excesses of tail-11 
(filled symbols) and tail-14 (empty symbols) peptides. The trace for wild type Sso AcP in the same 
conditions (●) is shown for comparison. Continuous line represents best fit of experimental data to 
equation 3.3. (C) First phase of aggregation of 34 μM wild type Sso AcP in 50 mM acetate buffer at 
pH 5.5, 20% (v/v) TFE and 25 °C in the presence of 4 fold molar excesses of peptides. Static light 
scattering signal recorded at 208 nm normalised to the maximum value is shown versus time in this 
panel. Traces are shown for Sso AcP alone (●), Sso AcP and tail-11 peptide (○), Sso AcP and tail-14 
peptide (●), Sso AcP and scrambled peptide (●), Sso AcP and soluble peptide (○). Continuous lines 
represent best fits of experimental data to equation 3.4. (D) Second phase of aggregation moni-
tored by ThT fluorescence normalised to the plateau value, of 34 μM wild type Sso AcP in 50 mM 
acetate buffer at pH 5.5, 20% (v/v) TFE and 25 °C in the presence of 10 fold molar excesses of pep-
tides. Traces are shown for Sso AcP alone (●), Sso AcP and tail-11 peptide (○), Sso AcP and tail-14 
peptide (●), Sso AcP and scrambled peptide (●), Sso AcP and soluble peptide (○). Continuous lines 
represent best fits to equation 3.3 of experimental data. 
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when a sample containing native protein is diluted into a 50 mM acetate buffer at pH 
5.5, TFE 20% (v/v) and 25 °C. This is probably due to a change in solvent conditions 
and suggests that no partial unfolding or decrease in compactness (figure 3.7A) occurs. 
The secondary structure content of the protein, as assessed by far-UV CD, does not 
significantly change (inset to figure 3.7A). Thus, we have checked the effect of tail-11 
and scrambled peptide on the hydrodynamic diameter of the protein. 
The results show that incubating ΔN11 Sso AcP in the presence of an equimolar 
amount of both peptides does not induce increase in protein dimensions compatible 
with dimeric or oligomeric species (figure 3.7A). The observed slight increase relative 
to the control can be due to imprecision in data fitting induced by the presence of the 
peptides or to the interaction between peptide and ΔN11 molecule. Since ΔN11 Sso AcP 
is stable in the aggregation conditions, we have checked whether increasing the relative 
amount of peptides is able to induce aggregation of the protein. In particular, we have 
followed the ThT fluorescence induced by samples containing 34 μM ΔN11 Sso AcP in 
50 mM acetate buffer at pH 5.5, 20% (v/v) TFE, 25 °C and in the presence of tail-11 and 
tail-14 molar excesses ranging from 1 fold to 25 fold. The results show that, while the 
aggregation of wild type protein reaches a plateau in about one hour, there are no sig-
nificant changes in ThT fluorescence when incubating ΔN11 Sso AcP in the presence of 
these peptide excesses for a week (figure 3.7B). These observations allow to rule out 
aggregation mechanisms based on a bridging effect of the N-terminal segment between 
two Sso AcP molecules (models B.2.2, B.2.3, and B.2.9 in appendix B) and models based 
on intra-molecular interactions between unstructured segment and globular part of Sso 
AcP that give rise to an aggregation prone state (models B.2.5, B.2.6, B.2.11 and B.2.12 
in appendix B). Finally, the absence of oligomers when ΔN11 Sso AcP is incubated in 
aggregation conditions rules out models in which two molecules interact through their 
globular parts (models B.2.7 and B.2.8 in appendix B). 
The effect of peptides has been also studied on the aggregation of wild type Sso 
AcP. We have followed both first phase of aggregation via static light scattering signal 
at 208 nm and second phase via ThT fluorescence (see section 3.4). In the presence of a 
fourfold molar excess of tail-11 and tail-14 formation of early aggregates is signifi-
cantly slower (figure 3.7C). Aggregation rate constants k1, determined by best fits of 
experimental data to equation 3.4, are equal to (3.4 ± 0.3) · 10-2 s-1, (1.8 ± 0.2) · 10-2 s-1 
and (1.7 ± 0.2) · 10-2 s-1for wild type alone, wild type in the presence of a fourfold molar 
excess of tail-11and wild type in the presence of a fourfold molar excess of tail-14, re-
spectively. Most importantly, the scrambled peptide is not able to induce the same ef-
fect on the process (figure 3.7C). Aggregation rate constant k1 for wild type protein in 
the presence of a fourfold molar excess of scrambled peptide is (3.0 ± 0.3) · 10-2 s-1. This 
value is, within the experimental error, compatible with aggregation rate constant of 
wild type protein alone. Finally, we have also checked the effect of molecular crowding 
on formation of early aggregates. Aggregation rate constant k1 for wild type protein in 
the presence of a fourfold molar excess of control peptide is (3.4 ± 0.3) · 10-2 s-1, show-
ing no effects on the process. Similar conclusions can be made for the second phase of 
aggregation, which has been studied by means of ThT kinetics (figure 3.7D). Adding a 
10 molar excess of tail-11 or tail-14 peptides significantly slows down formation of 
protofibrils. Aggregation rate constants k2, determined by best fits of experimental to 
data equation 3.3, are equal to (3.7 ± 0.3) · 10-3 s-1 and (8.5 ± 0.8) · 10-4 s-1for wild type 
alone and wild type in the presence of a 10 fold molar excess of either peptide, respec-
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tively. In fact, no significant differences have been found between the effects of tail-11 
and tail-14. By contrast, the scrambled peptide does not show a similar effect on the ag-
gregation of the protein. Aggregation rate constant k2 for wild type Sso AcP in the 
presence of a 10 fold molar excess of scrambled peptide is (4.7 ± 0.4) · 10-3 s-1, showing 
a light, albeit significant, acceleration of the process. 
 
Figure 3.8: Dependence of k1 and k2 on Sso AcP concentration. In this figure the ratio is 
shown between the observed first phase (■) and second phase (●) aggregation rate constants 
at a given protein concentration and the value measured at 0.1 mg ml-1. Continuous lines rep-
resent best linear fits of experimental data. 
However, this effect is probably due to the crowding in the solution as the control 
peptide shows a similar effect. Aggregation rate constant k2 for wild type Sso AcP in 
the presence of a 10 fold molar excess of control peptide is (5.8 ± 0.5) · 10-3 s-1. 
Taken together, these results show that tail-11 and tail-14 peptides compete with 
the N-terminal Sso AcP segment for binding to a specific sequence as aggregation is 
affected by the presence of either molecule and that this interaction leads to amyloid 
aggregation. The interaction seems to be an inter-molecular one as peptides induce a 
deceleration instead of an acceleration of the process. 
3.2.4 Formation of initial aggregates depends on protein concentration 
The analysis of the experiments reported in figure 3.6A suggests that formation of 
early aggregates depends on protein concentration while formation of protofibrils does 
not. To get further insight into the aggregation process, we have studied the dependence 
of the two aggregation rate constants k1 and k2 on protein concentration. In this experi-
ment only wild type protein is present in the samples, albeit in different concentrations. 
The process has been followed by means of mean residue ellipticity at 208 nm (data not 
shown) and the recorded traces have been analysed with equation 3.2. Figure 3.8 shows 
the ratio between measured aggregation rate constants at a given protein concentration, 
k1 (squares) and k2 (circles), and the corresponding value measured at the lowest inves-
tigated concentration, 0.1 mg ml-1. The results confirm that, as we previously showed 
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(Plakoutsi et al. 2005), for protein concentrations ranging from 0.1 to 1 mg ml-1 k2 val-
ues do not significantly change. However, a different trend has been observed for for-
mation of early aggregates. Aggregation rate constant k1 linearly increases as Sso AcP 
concentration increases. This experiment suggests that formation of early aggregates is 
an inter-molecular process whose rate depends on the concentration of free molecules 
in the solvent. By contrast, the second phase of the process, the formation of protofi-
brils, is likely to be an intra-molecular process in which the native-like fold of the pro-
tein converts into a ThT binding state characterised by increase in β-structure. 
 
Figure 3.9: Properties of 6-acryloyl-2-dimethylaminonaphthalene (acrylodan). (A) Structure of 
acrylodan and its reaction with sulphydrylic group of cysteine. (B) Determination of the molar 
extinction coefficient of acrylodan. The figure shows dependence of absorbance at 360 nm 
(●) and 390 (■) nm on acrylodan concentration. Measurements have been performed in 50 
mM phosphate buffer at pH 7, 25 °C. (C) Fluorescence spectra of 34 μM acrylodan bound 
and unbound to glutathione in 50 mM acetate buffer at pH 5.5 and 25 °C. (D) Fluorescence 
spectra of 34 μM acrylodan in 50 mM acetate buffer at pH 5.5 and different TFE concentra-
tions, ranging from 0% (v/v) to 30% (v/v). 
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3.2.5 Experiments with acrylodan 
The experiments presented in the previous sections give kinetic results that allow the 
role of the tail in the aggregation of Sso AcP to be clarified. Moreover, they can be used 
to propose a possible model for the aggregation mechanism of this protein (see section 
3.3). Nevertheless, these experiments do not give any information about the most 
structured regions in the early aggregates and amyloid-like protofibrils. 
 
Figure 3.10: Preliminary aggregation studies on acrylodan labelled Sso AcP protein variants. (A) 
ribbon representation of Sso AcP to show the labelled residues. (B) Absorbance spectrum of a 
cysteine variant of Sso AcP labelled with acrylodan. E70C variant is shown. The degree of la-
belling, calculated as reported in section 3.4, is equal to 1.10 ± 0.05. (C) and (D) Preliminary 
aggregation studies on labelled proteins. Data for E70C (●) and wild type (●) are shown. First 
phase (C) has been monitored with normalised light scattering; second phase (D) has been 
monitored with ThT fluorescence. 
 
To perform a structural analysis on the species transiently populated along the ag-
gregation pathway of Sso AcP, we performed fluorescence studies using 6-acryloyl-2-
dimethylaminonaphthalene (acrylodan; figure 3.9A). This molecule emits fluorescence 
between 400 and 600 nm when excited at 390 nm and has peculiar properties. First, it is 
able to react with sulphydrylic groups of cysteine residues while it does not react with 
side chains of other amino acids. This is particularly important in the view that wild 
type Sso AcP does not possess any cysteine and therefore that different amino acids can 
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be substituted with a cysteine through a single point mutation. This feature allows la-
belling with acrylodan in specific positions of the sequence to be performed without 
risk of non-specific binding. Thus, the fluorescence of the bound probe can be studied 
during aggregation of the protein. The presence of the probe can be verified by absor-
bance measurements as the probe has an extinction coefficient at 360 nm equal to 14500 
± 200 M-1 cm-1 (see figure 3.9B). A second important property of this molecule is that 
fluorescence of acrylodan bound to cysteine residues is more than 100-fold higher than 
fluorescence of unbound acrylodan (figure 3.9C). This is fundamental in order to avoid 
artefacts in the measurements due to the presence of unbound probe that has not been 
removed from the sample. 
 
Table 3.1: Aggregation kinetic data for a set of Sso AcP cysteine variants labelled with acrylo-
dan. Aggregation rate constants k1 have been determined by best fits of experimental data to 
equation 3.4. Aggregation rate constants k2 have been determined by best fits of experimental 
data to equation 3.3. 
protein variant position k1  (s-1) k2  (s-1) 
WT - (3.4 ± 0.4) · 10-2 (3.7 ± 0.4) · 10-3 
D6C tail (3.6 ± 0.4) · 10-2 (2.2 ± 0.2) · 10-3 
G26C loop α1-β1 (2.9 ± 0.6) · 10-1 (3.2 ± 0.4) · 10-3 
K31C α1 (7.4 ± 0.7) · 10-2 (2.4 ± 0.2) · 10-2 
K47C β2 (1.1 ± 0.2) · 10-1 (2.0 ± 0.3) · 10-2 
P50C loop β2-β3 (5.6 ± 0.6) · 10-2 (1.1 ± 0.2) · 10-3 
E70C α2 (2.2 ± 0.3) · 10-2 (6.7 ± 0.7) · 10-3 
P77C loop α2-β4 (2.2 ± 0.3) · 10-1 (2.0 ± 0.3) · 10-2 
D85C β4 (4.0 ± 1.0) · 10-1 (1.2 ± 0.2) · 10-2 
E96C loop β4-β5 (8.4 ± 0.8) · 10-2 (1.4 ± 0.2) · 10-3 
E99C β5 (1.1 ± 0.2) · 10-1 (2.2 ± 0.2) · 10-2 
 
The fluorescence of acrylodan is sensitive to the local environment. In particular, 
when the molecule is in a polar environment it emits fluorescence with a peak of about 
520 nm. When the probe is instead in an apolar environment, its fluorescence shows 
significant blue shift (with a peak that reaches 470 nm) and increase in intensity 
(Krishnan and Lindquist 2005; Sun et al. 2007). This allows the local environment of 
the regions labelled with the probe to be investigated. In particular, in the case of amy-
loid aggregation studies, this feature allows the region buried in the different phases of 
aggregation to be found. However, it is important to observe that the fluorescence of 
acrylodan is not only sensitive on the solvent exposure of the labelled moiety. The sig-
nal depends also on the physico-chemical properties of the solvent. Figure 3.9D shows 
the dependence of acrylodan fluorescence spectra on TFE concentration. The graph 
shows that increasing the concentration of this cosolvent, which possesses two ali-
phatic carbons, induces an increase and a blue shift of the probe fluorescence. This be-
haviour must be taken into account during analysis of the data as TFE is the solvent 
used to induce aggregation of Sso AcP. 
We have produced 10 variants of Sso AcP carrying a cysteine in different positions 
(figure 3.10A, table 3.1). Residues to be mutated have been chosen to have the following 
properties: (1) Mutated residues are exposed to the solvent. Solvent accessibility is im-
portant to reach the equilibrium of the labelling reaction in which the entire protein 
population is labelled. Moreover, the aggregation of Sso AcP starts from an ensemble 
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of native-like conformations and the regions of the sequence that initiate the process 
are likely to be solvent exposed in the native state. (2) Mutated residues span different 
secondary structure elements of Sso AcP. Mutations have been chosen in order to in-
vestigate the two edge β-strands, the two α-helices and the N-terminal unstructured 
segment. (3) Mutated residues are positioned in loops. Four of the 10 investigated po-
sitions are loop residues. Labelling reaction has been carried out as reported in section 
3.4.10. Presence and purity of the labelled protein has been verified by MALDI-TOF 
mass spectrometry; labelling degree has been calculated with equation 3.5. In all cases 
the degree of labelling has been higher than 98% (figure 3.10B). Purity of samples is 
important to avoid the presence of two subpopulations of the protein in the sample that 
can show two different aggregation mechanisms. 
 
Table 3.2: Peaks of acrylodan fluorescence spectra of cysteine mutants of Sso AcP. Data for 
native proteins have been acquired in 10mMTRIS buffer at pH 8.0 and 25 °C. Data for early 
aggregates and protofibrils have been acquired at the beginning and at the plateau of the ThT 
kinetics, respectively. Conditions have been 20% (v/v) TFE and 50 mM acetate buffer at pH 
5.5, 25 °C. 
protein variant Peak in native protein (nm) 
Peak in early 
aggregates (nm) 
Peak in protofibrils 
(nm) 
D6C 504.2 ± 0.5 503.5 ± 0.5 496.5 ± 0.5 
G26C 508.4 ± 0.5 495.6 ± 0.5 495.3 ± 0.5 
K31C 513.9 ± 0.5 496.5 ± 0.5 494.0 ± 0.5 
K47C 514.8 ± 0.5 498.1 ± 0.5 492.2 ± 0.5 
P50C 520.3 ± 0.5 505.0 ± 0.5 496.2 ± 0.5 
E70C 517.1 ± 0.5 503.9 ± 0.5 501.2 ± 0.5 
P77C 503.7 ± 0.5 499.1 ± 0.5 497.2 ± 0.5 
D85C 519.5 ± 0.5 501.3 ± 0.5 500.3 ± 0.5 
E96C 519.3 ± 0.5 503.1 ± 0.5 496.9 ± 0.5 
E99C 518.2 ± 0.5 499.9 ± 0.5 497.7 ± 0.5 
 
In order to verify that the presence of the probe on the protein surface does not af-
fect the amyloid-like aggregation process, a set of preliminary experiments has been 
carried out on the labelled protein variants (table 3.1). In particular: 
• Static light scattering kinetics: To monitor the first phase of the process, aggrega-
tion of 34 μM labelled protein variants in 20% (v/v) and 50 mM acetate buffer at pH 
5.5 and 25 °C has been followed by static light scattering signal at 208 nm (figure 
3.10C). The results (table 3.1) show that all but one variants show a significant, in 
some cases remarkable, increase of the aggregation rate constant k1 determined with 
equation 3.4. This effect is not surprising as the presence of a large, hydrophobic 
moiety on the surface of the globular part of Sso AcP increases the 
ability to interact of two Sso AcP molecules. Moreover, it is possible that the muta-
tion introduced has a destabilising effect on native Sso AcP and it has been observed 
that the extent of destabilisation is correlated with the aggregation rate of the pro-
tein (Plakoutsi et al. 2006). 
• ThT fluorescence kinetics: To monitor the second phase of the process, aggrega-
tion of 34 μM labelled protein variants in 20% (v/v) and 50 mM acetate buffer at pH 
5.5 and 25 °C has been followed by ThT fluorescence at 485 nm (figure 3.10D). As 
verified for the first phase, in most  cases kinetic rate constants k2 determined by 
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best fits to equation 3.3 show that the presence of the probe on the protein surface 
speeds up the process (table 3.1). However, this increase in aggregation rate k2 is 
likely to be an effect of the increase of k1 constant, as we have shown that the rate of 
the second phase does not depend on peptide concentration (see section 3.2.4). Im-
portantly, all protein variants show the same increase in ThT fluorescence that has 
been observed for wild type protein, suggesting that the species populated at the 
plateau of the ThT kinetic experiment is not affected by the presence of acrylodan. 
• CR staining: The species populated at the plateau of the ThT kinetics have been 
stained with CR. In all cases presence of a peak at 550 nm can be observed (data not 
shown). Similar behaviour was shown for wild type protein (Plakoutsi et al. 2004), 
suggesting that protein variants labelled with acrylodan give rise to protofibrils 
with regular structure. 
Taken together, these results show that the presence of the probe on the protein 
surface speeds up the aggregation process but does not affect the aggregation mecha-
nism that leads to the formation of protofibrils. 
Once investigated the aggregation properties of the cysteine variants produced and 
labelled, we have studied fluorescence of the probe during aggregation (table 3.2). In 
particular, the following spectra have been acquired for each mutant: 
• native protein: A spectrum between 400 nm and 700 nm with an excitation wave-
length of 390 nm has been acquired for each mutant. Conditions are 34 μM protein 
in 10 mM TRIS at pH 8.0 and 25 °C (table 3.2). In these conditions the protein vari-
ants are enzymatically active (data not shown). Thus, this spectrum is important to 
verify the fluorescence of the probe in conditions in which the protein is native and 
monomeric. 
• early aggregates: For each mutant a set of spectra has been acquired over time in 
conditions that induce aggregation of Sso AcP, that is 34 μM protein in 20% (v/v) 
TFE and 50 mM acetate buffer at pH 5.5, 25 °C. Fluorescence has been recorded be-
tween 450 nm and 550 nm, with an excitation wavelength of 390 nm (table 3.2). 
Since the fluorescence at every wavelength has shown exponential behaviour, the 
value at the beginning of the experiment (corresponding to the early aggregates) has 
been extrapolated using equation 3.3. 
• protofibrils: Finally, the spectrum of protofibrils has been obtained using the same 
set of spectra used for early aggregates. For each wavelength, the plateau value of the 
probe fluorescence has been measured in order to obtain the plateau spectrum (table 
3.2). 
Native proteins show a fluorescence peak similar to the peak of acrylodan bound to 
glutathione in aggregation promoting conditions (518.0 ± 0.5 nm). In these conditions 
acrylodan is completely exposed to the solvent. This confirms that in the native states, 
after labelling, the probe is still on the protein surface. In the early aggregates we ob-
serve, as expected, a blue shift in the fluorescence peak. This shift ranges from 13 nm 
for G26C to 20 nm for P50C (table 3.2). In protofibrils, further blue shift of the fluo-
rescence peak can be observed (table 3.2). Nevertheless, it must be noticed that the ob-
served changes are not position dependent. All investigated regions show similar be-
haviours. This clearly suggests that the structural reorganisation that the globular part 
of Sso AcP undergoes during aggregation is a general one. The first phase of aggrega-
tion consists of a general collapse of the structure in which the entire globular Sso AcP 
is sequestered from the solvent. Moreover, the observed values are not remarkable, al-
beit significant. In the case of Sup35p, residues labelled with acrylodan and buried in 
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protofilaments show fluorescence peak equal to about 470 nm (Krishnan and Lindquist 
2005). In the case of prion PrP all labelled residues show fluorescence peaks in fibrils 
that range from 460 nm to 470 nm (Sun et al. 2007). This is compatible with the fact 
that in the two mentioned cases experiments were performed on mature fibrils, while 
in the case of Sso AcP we have worked on prefibrillar aggregates. Finally, the increase 
in fluorescence during aggregation is not remarkable. This is probably due to the pres-
ence of water molecules in the aggregates, which act as quencher of fluorescence and 
thus decrease its quantum yield. During the second phase, part of these molecules is ex-
pelled from aggregates and the fluorescence increases. However, it is also possible that 
the light is scattered by the aggregates that form clusters and that the probe in the ag-
gregates is excited to a lower extent than in the native monomeric state. 
 
Figure 3.11: A possible model for aggregation of Sso AcP. (A) in the first phase the unstruc-
tured N-terminal segment interacts with a region of the globular part of Sso AcP (for instance 
the fourth β-strand is shown) and this interaction leads to the formation of the early aggre-
gates. Fourth β-strand and unstructured segment are depicted in red. (B) The early aggregates 
are characterised by a global collapse of the structure and all the regions of the sequence re-
tain a native-like conformation. In the second phase an intra-molecular reorganisation leads 
to the formation of protofibrillar aggregates that bind ThT, CR and possess extensive β-sheet 
structure. The unstructured N-terminal segment and the fourth β-strand are depicted in blue 
and red, respectively. 
Francesco Bemporad 58 
3.3 Conclusions: a possible aggregation mechanism for Sso AcP 
In this chapter we have investigated the aggregation mechanism of Sso AcP. The results 
can be summarised as follows. (1) The N-terminal unstructured segment of Sso AcP is 
able to induce aggregation of the molecule regardless of its position (section 3.2.1). (2) 
The N-terminal unstructured segment of the protein is able to induce aggregation only 
when it is bound to the globular part of the molecule. In fact, this segment is not able to 
restore aggregation of ΔN11 Sso AcP, even if it is added in large excess (section 3.2.3). 
(3) The aggregation properties of the N-terminal segment of Sso AcP are not due to the 
destabilising effect that this peptide has on the molecule as a stabilised variant of the 
protein with N-terminal segment aggregates faster than a destabilised protein variant 
lacking the segment (section 3.2.2). (4) A peptide carrying the sequence of N-terminal 
segment slows down the aggregation of wild type Sso AcP and this feature is due to its 
primary sequence, as a scrambled peptide does not show the same properties (section 
3.2.3). (5) The first phase of the process depends on protein concentration while the 
second one does not (section 3.2.4). This suggests inter-molecular recognition as a ma-
jor event in the first phase and intra-molecular reorganisation as the mechanism that 
leads to the formation of protofibrils in the second phase. (6) During aggregation of 
Sso AcP the whole sequence collapses and participates to the formation of the early ag-
gregates. Water molecules are present in the aggregates and are expelled only later on 
(section 3.2.5). 
These results allow a possible model for the aggregation of Sso AcP to be pro-
posed. The model (this model is not discussed in appendix B) can be summarized in 
three points: 
1. Once diluted in aggregation promoting conditions, Sso AcP undergoes con-
formational modifications that lead to the formation of a native-like ensemble. 
It is possible that in this ensemble some regions buried in the native state are 
exposed to the solvent. Otherwise, it is possible that some regions undergo 
conformational modifications and become more flexible and prone to aggre-
gate. According to previous experiments carried out in our lab the fourth β-
strand plays a major role in the aggregation (Plakoutsi et al. 2006). It is possi-
ble that this region is important in the initial conformational modification 
event. 
2. The native-like ensemble gives rise to the early aggregates. Our experiments 
suggest that the major event in this phase is a specific inter-molecular interac-
tion between the unstructured N-terminal segment of one molecule of Sso AcP 
and the globular part of another molecule (figure 3.11A). The interaction is an 
inter-molecular one because a peptide corresponding to the N-terminal seg-
ment slows down the process. Moreover, if the interaction were intra-
molecular, the fact that shifting the N-terminal segment does not affect the 
process would be in contrast with the evidence that the interaction is specifi-
cally due to the sequence of the segment. The interaction cannot be between 
two unstructured segments as we previously showed that the segment alone is 
not able to aggregate (Plakoutsi et al. 2006). Finally, the interaction is specifi-
cally due to the particular sequence of the segment. This is clearly shown by 
the fact that a scrambled peptide is not able to slow down the process as the 
peptide corresponding to the N-terminal segment does. Figure 3.11A shows 
an interaction between the unstructured segment and the fourth β-strand. Al-
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though this interaction cannot be ruled out on the basis of our experiments, it 
must be noticed that it is possible that residues on this segment are fundamen-
tal only for the initial conformational modification that leads to native-like 
ensemble, and that in this state another region gets exposed to the solvent and 
flexible. Thus, figure 3.11A proposes only one of the possible interactions be-
tween unstructured segment and globular part. The early aggregates that form 
do not possess extensive  β-structure and do not bind CR and ThT (Plakoutsi 
et al. 2004; Plakoutsi et al. 2005). Sso AcP molecules are instead still native-
like and enzymatically active (Plakoutsi et al. 2004; Plakoutsi et al. 2005). Our 
experiments with acrylodan suggest that the entire globular part of Sso AcP is 
collapsed in their structure (figure 3.11B) and that water molecules are still 
present between Sso AcP molecules. 
3. In the second phase of aggregation early aggregates undergo intra-molecular 
modifications (figure 3.11B). This is shown by the fact the kinetic rate constant 
of this phase does not depend on protein concentration. During this phase Sso 
ACP molecules loose their native-like topology (Plakoutsi et al. 2005). The 
aggregates loose enzymatic activity and acquire extensive β-sheet structure 
and ability to bind CR and ThT dies (Plakoutsi et al. 2004; Plakoutsi et al. 
2006). Finally, our data show that part of the water molecules are expelled dur-
ing this phase as acrylodan fluorescence increases during the process. 
The model presented in this section for the aggregation mechanism of Sso AcP is con-
sistent with all the experimental evidences presented in this chapter and in our previ-
ous work (Plakoutsi et al. 2004; Plakoutsi et al. 2005; Plakoutsi et al. 2006). Although 
the model is in contrast with the evidence that in most fibrils parallel β-sheets form 
between the same segments of different molecules (Tycko 2004; Kajava et al. 2005; 
Krishnan and Lindquist 2005; Chiti and Dobson 2006), an interaction between two un-
structured segments is impossible in our case on the basis of our experiments and on 
the basis of the experiments that we previously carried out (Plakoutsi et al. 2006). The 
target region of the segment remains still unclear. Nevertheless, only further experi-
ments will allow to find out, at atomic level, the regions that interact in the early aggre-
gates and in the protofibrils formed by Sso AcP. However, these experiments are par-
ticularly important as they give detailed information for studies of aggregation start-
ing from native states. Moreover, the data presented here are relevant for the study of 
protein dynamics in solution. 
3.4 Materials and methods 
3.4.1 Materials 
Guanidine hydrochloride, 2,2,2-trifluoroethanol, ThT and CR were purchased from 
Sigma. The synthetic peptides were purchased from Genscript Corporation (Pis-
cataway, New Jersey, USA) and had amidated C-termini. The purity of samples was in 
all cases ≥ 95%. Benzoyl-phosphate was synthesised as previously described (Camici 
et al. 1976). Oligonucleotides for site directed mutagenesis were purchased from 
MWG (Ebersberg, Germany). 6-acryloyl-2-dimethylaminonaphthalene (acrylodan) 
was purchased from Molecular Probes. 
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3.4.2 Mutagenesis, protein expression and purification 
Wild type Sso AcP and !N11 Sso AcP were expressed and purified as previously de-
scribed ((Bemporad et al. 2004; Plakoutsi et al. 2006) and section 2.4.2). The genes encod-
ing for C-tail Sso AcP and I72V-!N11 Sso AcP were obtained starting from the pGEX-2T 
plasmid carrying the gene of !N11 Sso AcP and using Quick Change Site-Directed 
Mutagenesis Kit from Stratagene (see section 2.4.1). In the case of C-tail Sso AcP three 
consecutive insertions were made to reach the final insertion of 11 residues. The desired 
mutations were verified by DNA sequencing. The encoded proteins were expressed and 
purified as wild type Sso AcP (Bemporad et al. 2004). Purity of samples was checked by 
SDS-PAGE and mass spectrometry. Protein concentration was calculated using extinc-
tion coefficients at 280 nm (Gill and von Hippel 1989) and Lambert-Beer law. 
3.4.3 Far-UV Circular dichroism  
Far-UV CD spectra were acquired at 25 °C with a Jasco J-810 spectropolarimeter (To-
kyo, Japan) equipped with a thermostated cell holder and a quartz cell of 1 mm path 
length. Spectra of wild type Sso AcP, !N11 Sso AcP and Sso AcP were acquired at a 
protein concentration equal to 34 μM in a 10 mM TRIS buffer at pH 8.0 and 25 °C. 
Spectra of !N11 Sso AcP were also acquired at a protein concentration equal to 34 μM 
in 50 mM acetate buffer at pH 5.5 with 20% (v/v) TFE and 25 C. In another set of ex-
periments the change of signal at 208 nm over time was recorded in the 1mmcell using 
the J-810 instrument during aggregation of three types samples. (1) Samples containing 
different relative amounts of wild type and !N11 Sso AcP. In this case the total protein 
concentration was 34 μM in all cases. (2) Samples containing wild type Sso AcP in the 
presence of four fold molar excesses of the four peptides. Sso AcP concentration was 34 
μM. (3) Samples containing different amounts of wild type Sso AcP ranging from 0.1 to 
1.0 mg ml-1. The recorded traces were analysed using the following equation: 
where ["]208(t) represents the CD signal at 208 nm as a function of time, q represents 
the plateau signal, A1, A2, k1 and k2 are amplitudes and rate constants of the first and 
second aggregation phase, respectively. Best fits of experimental data to equation 3.2 
allowed quantitative estimations of aggregation rate constants to be obtained. 
3.4.4 Thioflavin T fluorescence 
crAggregation kinetics followed by ThT fluorescence were performed as previously re-
ported (Plakoutsi et al. 2004; Plakoutsi et al. 2005; Plakoutsi et al. 2006). The experi-
ments were carried out in 50 mM acetate buffer at pH 5.5 with 20% (v/v) TFE and 25 
°C on the following samples: (1) 34 μM wild type Sso AcP alone; (2) 34 μM wild type 
Sso AcP in the presence of 10 fold molar excesses of the four peptides; (3) 34 μM !N11 
Sso AcP in the presence of the four peptides in molar excesses ranging from 1 fold to 25 
fold. In another experiment ThT fluorescence was measured in the presence of wild 34 
μM type Sso AcP incubated in a 44.1 mM acetate and 4.8 mM phosphate buffer at pH 
5.5, 20% (v/v) TFE and 25 °C. Two different types of plots were produced. (1) In figures 
3.4 and 3.5 ThT fluorescence intensity in the absence of protein was subtracted from all 
the fluorescence measurements in the presence of the tested sample and 
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the resulting values were normalised so that the final fluorescence intensity at the end-
point of the kinetic trace was 100%. (2) In figures 3.6 and 3.7 ThT fluorescence inten-
sity in the presence of the tested sample was directly reported as fold increase relative 
to signal in the presence of blank solution. The obtained plots were analysed using the 
following equation: 
 
 
where f(t) represents the fluorescence as a function of time, A is the amplitude of the ob-
served phase and k2 is the kinetic rate constant for the conversion of early aggregates 
into amyloid-like protofibrils. Best fits of experimental data to equation 3.3 gave quan-
titative estimations of aggregation rate constant k2. 
3.4.5 Aggregation kinetics followed by static light scattering 
The presence of peptides resulted in a significant increase of the absorbance of samples 
and thus in a reduction of the signal to noise ratio of the traces recorded with the Jasco 
spectropolarimeter. As a consequence, formation of early aggregates in the presence of 
these molecules could not be followed by means of mean residue ellipticity. Formation 
of early aggregates in the presence of peptides was followed with static light scattering 
at 208 nm in a Jasco V-630 spectrophotometer (Tokio, Japan) with a 0.1 cm cuvette. The 
signal was followed after dilution of wild type Sso AcP into an aggregation buffer. Fi-
nal conditions were 34 μM Sso AcP in 50 mM acetate buffer at pH 5.5 with 20% (v/v) 
TFE at 25 °C. In another set of experiments the signal was followed for wild type pro-
tein in the presence of a fourfold molar excess of the tested peptides. The obtained trace 
was normalised to the observed linear decrease in signal due to precipitation of sample. 
The plot was analysed with the following equation: 
  
where A208(t) is the absorbance as a function of time, A is the amplitude of the observed 
phase, k1 is the rate of formation of the early aggregates and q is the equilibrium value. 
Best fits of experimental data to equation 3.4 allowed the aggregation rate constant k1 to 
be measured. 
3.4.6 Congo red staining 
Species populated at the plateau of the ThT kinetics were tested for CR binding. Ali-
quots of 60 μl of each protein solution were mixed with 440 μl of solutions containing 
20 μM CR, 5 mM phosphate buffer, 150 mM NaCl, pH 7.4. After sample equilibration, 
optical absorption spectra were acquired from 400 to 700 nm with the Jasco spectro-
photometer. A 5 mm path length cuvette was used. Solutions without tested sample and 
solutions without CR were used as controls. 
3.4.7 Enzymatic activity measurements 
Enzymatic activity of wild type and C-tail Sso AcP protein variants was measured in a 
continuous optical test at 283 nm using BP as a substrate (Ramponi et al. 1966) with a 
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Lambda 4V Perkin Elmer spectrophotometer (Wellesley, Massachusetts). Experimen-
tal conditions were 2.0 μg ml-1 Sso AcP, 5.0 mM BP, 50 mM acetate buffer at pH 5.5, 37 
°C. BP was freshly dissolved before enzymatic activity measurements. In another set of 
experiments enzymatic activity of 2.0 μg ml-1 ΔN11 Sso AcP was measured at 25 °C in 
50 mM acetate buffer at pH 5.5, TFE with 20% (v/v) and a BP concentration ranging 
from 0.2 to 8 mM. The experiment was carried out both in the absence and in the pres-
ence of 1.5 mM phosphate ion. Affinity constant for phosphate was calculated using 
standard Michaelis-Menten theory. 
3.4.8 Equilibrium unfolding 
28 samples of the tested protein variant (8.5 μM) were incubated for 1 hr in 50mM ace-
tate at pH 5.5, 37 °C, and different concentrations of GdnHCl ranging from 0 to 7.2 M. 
The values of mean residue ellipticity at 222 nm ([Θ]222) of the samples were measured 
with the Jasco J-810 CD. The cell length was 1 mm. The plot of [Θ]222 versus GdnHCl 
concentration was fitted to a two-state transition equation, as described ((Santoro and 
Bolen 1988) and section A.1.1) to determine the free energy change upon unfolding in 
the absence of denaturant (ΔGU-FH2O), the dependence of ΔGU-FH2O on GdnHCl concen-
tration (m value), and the midpoint of unfolding (Cm). 
3.4.9 Dynamic light scattering 
Hydrodynamic diameter was measured for wild type Sso AcP, C-tail Sso AcP and 
ΔN11 Sso AcP in 10 mM TRIS buffer at pH 8.0 and 25 °C. In another set of experi-
ments DLS measurements were performed on 34 μM ΔN11 Sso AcP in the absence and 
in the presence of equimolar amounts of tail-11 and tail-14 peptides. Experimental 
conditions were 50mMacetate buffer at pH5.5, TFE with 20% (v/v). Size distributions 
by light scattering intensity were acquired with a Zetasizer Nano S DLS device from 
Malvern Instruments (Malvern, Worcestershire, UK). Low volume 12.5  45 mm 
disposable cuvettes were used. A Peltier thermostating system maintained the tem-
perature at 25 °C. The viscosity and refractive index parameters were set for each solu-
tion. The buffer and stock protein solutions were centrifuged (16,000×g for 5 minutes) 
and filtered with 0.02 mm Anotop 10 filters (Whatman, Maidstone, UK) before the 
measurements. 
3.4.10 Cysteine labelling 
Ten Sso AcP protein variants were produced as reported above (see section 3.4.2). 
These were labelled with 6-acryloyl-2-dimethylaminonaphthalene (acrylodan). The 
following protocol was applied for each mutant: 
1. Reaction between acrylodan and free cysteine was carried out with 300 μM 
protein in a solution containing 3mM acrylodan, 600 μM trycarboxyethil-
phosphine (TCEP), 10% (v/v) dimethylformammide (DMF) 50 mM phos-
phate at pH 7. Samples were incubated for three hours at 25 °C. The use of 
TCEP is recommended to avoid contemporaneously dimerisation of the pro-
tein, which carries a free cysteine on its surface, and reaction between the re-
ducing agent and cysteine. Unlike β-mercaptoethanol and DTT, TCEP is able 
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to reduce dimerised cysteine without binding the protein. Thus, TCEP does 
not compete with acrylodan for labelling reaction. 
2. Samples were centrifuged for 8 minutes at 16,000×g in order to separate su-
pernatant from the pellet, that contained both precipitated probe and Sso AcP 
variant. 
3. Unlabelled probe was removed from samples through size exclusion chroma-
tography. SephadexTM G-25 medium in a PD-10 desalting column (GEHealth-
care) was used. Labelled protein was diluted into 10mMTRIS buffer at pH 8.0, 
in which Sso AcP is stable. 
4. Labelling of the protein was assessed in two ways. (1) AMALDI-TOF mass 
spectrum was acquired for each mutant to show the presence of the labelled 
protein. In all cases no unlabelled protein was detected, suggesting that at the 
equilibrium only labelled protein was present. (2) An absorbance spectrum 
was acquired for each labelled protein between 250 nm and 500 nm using the 
Jasco V-630 spectrophotometer (see figure 3.10B). The concentration of bound 
acrylodan was calculated from the signal at 360 nm using Lambert-Beer law 
and a molar extinction coefficient ε360 equal to 14500 M-1 cm-1. The contribu-
tion of the probe at 280 nm was then subtracted by comparing the acquired 
spectrum with a reference spectrum of acrylodan alone. Finally, the protein 
concentration was calculated as reported above (section 3.4.2). The degree of 
labelling r was calculated according to the following equation: 
where [acrylodan] and [SsoAcP] are molar concentrations of probe (supposing 
that all the acrylodan molecules are bound to the protein) and Sso AcP. In all 
cases r resulted ≥98%. 
5. Labelled samples were stored at -80 °C. 
 
Francesco Bemporad 64 
 
65 
 
Chapter 4   
Role of π-stacking in amyloidoses 
4.1 Aromatic residues and amyloidoses 
4.1.1 Introduction 
As introduced in section 1.3, a wide range of human diseases is associated with the con-
version of specific peptides or proteins from their soluble state into highly organised 
aggregates known as amyloid fibrils (Stefani and Dobson 2003; Dobson 2004). These 
include Alzheimer’s disease, type 2 diabetes mellitus, and several systemic amyloi-
doses. The fibrillar aggregates in these diseases show some typical features, such as a 
long and unbranched morphology, a cross-β X-ray pattern diffraction pattern (Sunde 
and Blake 1997; Jimenez et al. 1999), and peculiar tinctorial properties upon binding 
with Congo Red (CR) and Thioflavin T (ThT) ((Klunk et al. 1989; LeVine III 1995) and 
section 1.3.1). While it has been widely demonstrated that under appropriate condi-
tions many, if not all, polypeptide chains can convert into amyloid-like fibrils 
(Guijarro et al. 1998; Chiti et al. 1999c), it is also clear that they do so with very differ-
ent propensities. Therefore, an understanding of the parameters that modulate the ag-
gregation propensity of a polypeptide chain and of the mechanism by which it forms 
fibrils is fundamental to gain insight into the pathogenesis of protein deposition dis-
eases and to better understand the process of amyloid formation of polypeptide chains 
more generally. A great effort has been expended in the past few years to predicting the 
key determinants of the aggregation propensity and the aggregation-prone regions of a 
given sequence. The hydrophobic content of a sequence has been suggested as a deter-
minant of the aggregation rate of an unstructured polypeptide chain (Calamai et al. 
2003; Chiti et al. 2003; DuBay et al. 2004). Other authors have shown that sequences 
designed to share an identical pattern of alternating polar and non-polar residues are 
able to promote aggregation into amyloid-like fibrils (West et al. 1999). Indeed, this 
particular pattern is highly prone to form β-sheets, the underlying type of secondary 
structure observed in amyloid fibrils. The role of the propensity to form secondary 
structure has been extensively investigated by many other investigators. It has been 
shown that several proteins forming amyloid structures under physiological condi-
tions present a α-helix in a segment that has rather a high propensity to form a β-
strand according to secondary structure predictions (Kallberg et al. 2001). Various 
mutants of the activation domain of human procarboxypeptidase A2 (ADA2h) de-
signed to increase the local stability of the two helical regions have been found to be 
less prone to form fibrils and this is due to a decreased aggregation propensity of the 
unfolded state (Villegas et al. 2000). It has also been shown that destabilising the α-
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conformer of a given sequence is not enough to start the aggregation and that only an 
increase of the β-sheet propensity can favour aggregation (Ciani et al. 2002). 
Moreover, it has been demonstrated that a highly significant inverse correlation 
exists between the rates of aggregation in a set of protein mutants under denaturing 
conditions and their overall net charge, clearly suggesting the protein charge as a major 
determinant for amyloid formation (Chiti et al. 2002a). Accordingly, it has been dem-
onstrated that the tetrapeptide KFFE is able to aggregate whereas KFFK and EFFE are 
not (Tjernberg et al. 2002). Taking into account the parameters mentioned above, some 
algorithms have been proposed to predict the effects of mutations on the aggregation 
rate of an unstructured polypeptide chain (provided that the mutation falls within the 
aggregation prone regions) (Chiti et al. 2003; Tartaglia et al. 2004), the absolute aggre-
gation rate (DuBay et al. 2004), and the aggregation-prone regions of an unfolded pro-
tein (Fernandez-Escamilla et al. 2004; Pawar et al. 2005) solely on the basis of its pri-
mary structure. 
4.1.2 A possible role for π-stacking in amyloid-like aggregation 
It was also suggested that the presence of aromatic residues, particularly phenylalanine 
and tyrosine, promotes amyloid formation and stabilises the resulting amyloid fibrils 
(Azriel and Gazit 2001; Chelli et al. 2002; Gazit 2002; Porat et al. 2003; Porat et al. 
2004). Usually, the interactions formed by several aromatic ring planes that are parallel 
to each other are referred to as π-stacking (Gazit 2002). A possible role of π-stacking in 
protein aggregation has been initially prompted by the observation that substitution of 
Phe23 with alanine in the most amyloidogenic segment of amylin (the segment 
NFGAILSS, corresponding to residues 22-29) results in a dramatically decreased ag-
gregation propensity (Azriel and Gazit 2001). A molecular dynamics simulation has 
suggested that Phe23 may potentially allow a coherent association between sheets by 
cementing the macromolecular assemblies due to its low conformational flexibility 
when interacting with other aliphatic residues (Zanuy et al. 2004). Given the high fre-
quency of aromatic residues in aggregation-prone fragments deriving from disease-
related proteins, it was concluded that aromatic residues play a major role in the mo-
lecular recognition, which is likely to be a fundamental step in amyloid formation 
(Gazit 2002). Based on these data, an algorithm which predicts the change of aggrega-
tion rate upon mutation has been developed by taking into account aromaticity as an 
additional parameter (Tartaglia et al. 2004). 
As evidence was accumulating on the possible role of π-stacking in amyloid for-
mation, other authors have reported results that induce the importance of aromatic-
aromatic interactions in amyloid assembly to be reconsidered (Tracz et al. 2004). A Phe 
to Leu substitution in the NNFGAILSS amylin segment (residues 21-29) does not pre-
vent aggregation and formation of fibrils as observed with Fourier transform infrared 
spectroscopy (FTIR), transmission electron microscopy (TEM), and CR staining (Tracz 
et al. 2004). The F23L variant of the NFGAIL segment also results in amyloid forma-
tion at low and high pH values (Tracz et al. 2004). Substitution of the phenylalanine 
with an alanine results in a segment that is less prone to form fibrils than the corre-
sponding wild type and F23L variants (Tracz et al. 2004). Aromatic residues are charac-
terised by a high hydrophobicity and propensity to form β-sheet structure. Both  
 
Role of π-stacking in amyloidoses 67
Figure 4.1: (A) The sequence of mt AcP. Regions in rectangles have been demonstrated to be 
important for the aggregation of the protein from a partially unfolded ensemble (Chiti et al. 
2002b). Apart fromPhe94, which does not seem to play a role in aggregation, the aromatic 
residues belonging to these two segments and mutated in the present analysis are shown in 
bold and italic. (B) The proposed aggregation pathway of mt AcP. Aggregation starts from an 
ensemble of partially unfolded conformations and involves formation of β-structured and 
ThT-binding protofibrils that convert later into long protofilaments and fibrils; reprinted, 
with permission, from (Chiti et al. 1999c), copyright 1993-2005 by the National Academy of 
Sciences of the USA. No detailed structural model has been proposed for the protofibrils; for 
descriptive purposes they are depicted in this figure as parallel β-sheets rich oligomers. 
 
leucine and alanine residues are non-aromatic; the only difference is that leucine pos-
sesses a hydrophobicity and a β-sheet propensity greater than those of alanine; based on 
these results it was proposed that aromatic residues only affect aggregation because of 
these features rather than for their ability to form π-stacking. These conflicting reports 
raise the question as to whether aromaticity performs any role in the mechanism of 
amyloid formation and on the nature of the stabilising interactions in the resulting 
amyloid fibrils. 
4.1.3 mt AcP as a model for investigating π-stacking 
To answer to these questions we have focused our attention on human muscle acyl-
phosphatase (mt AcP), a 98 residue enzyme introduced above (section 1.4.1 and 
(Pastore et al. 1992; Stefani et al. 1997)) whose sequence is shown in figure 4.1A. As in-
troduced in section 1.4.2, although mt AcP is not associated with any known human 
disease, it can form aggregates which show an extensive β-sheet structure, as revealed 
by circular dichroism (CD) and FTIR spectroscopy, tinctorial properties typical of 
amyloid, such as a yellow-green birefringence under cross-polarised light in the pres-
ence of CR and a high fluorescence in the presence of ThT and a fibrillar appearance as 
detected with TEM (Chiti et al. 1999c). Initially, when incubated in a solution contain-
ing moderate concentrations of 2,2,2-Trifluoroethanol (TFE), mt AcP converts, on a 
time scale of a few seconds, into an ensemble of partially unfolded conformations with 
a far-UV CD spectrum indicative of extensive α-helical content. Within 1-2 h the pro-
tein shows a transition from this state to an aggregated state that appears to be rich in 
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β-sheet structure, with increased fluorescence with ThT, but lacking evidence for ex-
tended fibrils. No structural models have been proposed for these aggregates and it is 
not still clear whether their strands are parallel or anti-parallel. After 1-2 months elec-
tron micrographs show isolated as well as bundles of 3-5 nm wide protofilaments, 
which display CR birefringence (Chiti et al. 1999c). This sequential appearance of spe-
cies during mt AcP aggregation is shown in figure 4.1B. A protein engineering ap-
proach has allowed the regions of the sequence that promote the conversion of the par-
tially unfolded ensemble into β-structured aggregates to be determined (Chiti et al. 
2002b). All the mutations that significantly alter the aggregation rate have been found 
in two regions of the primary structure corresponding to residues 16-31 and 87-98 
(figure 4.1A). These two segments correspond to two insoluble peptides when dis-
sected from the remainder of the sequence (Chiti et al. 2002b). Moreover, they have 
values of β-sheet propensity and hydrophobicity above the average values calculated 
from the entire mt AcP sequence (Chiti et al. 2002b) and appear to be solvent-exposed 
and/or flexible in the initial partially unfolded state (Monti et al. 2004). 
The ability of mt AcP to convert into β-structured oligomers and fibrils, under 
conditions in which the protein is initially in a partially unfolded state, and the pres-
ence of aromatic residues within the two segments that promote such conversion make 
mt AcP a good model-system to study the importance of aromaticity in amyloid ag-
gregation. Here we have determined the aggregation rate for a series of single point 
mutants of mt AcP in which aromatic residues have been substituted with other resi-
dues. The data have been analysed to assess the importance of aromatic residues in ag-
gregation and to distinguish between aromaticity and other more generic effects in the 
possible aggregation-promoting action of these residues. 
4.2 Results 
4.2.1 Strategy employed 
Two regions of the sequence of mt AcP have previously been found to promote the 
conversion of the partially unfolded ensemble populated in the presence of moderate 
concentrations of TFE into structured amyloid aggregates (Chiti et al. 2002b). These 
encompass residues 16-31 and 87-98 (figure 4.1A). These two segments contain five 
aromatic residues: Phe22, Tyr25, Tyr91, Phe94, and Tyr98. Phe94 was suggested to 
play a critical role in the folding mechanism of the molecule and in the stabilisation of 
the folding transition state and native structures (Chiti et al. 1999b; Vendruscolo et al. 
2001). However, it does not seem to play a significant role in promoting aggregation 
directly, probably because the side chain of this residue is buried in the partially un-
folded ensemble (Chiti et al. 2002b). In contrast, the four remaining aromatic residues 
appear to significantly influence aggregation, with the rate of assembly changing when 
they are mutated to other residues (Chiti et al. 2002b). For each of these four residues a 
set of single mutants has been produced with the wild type residue substituted with a 
large hydrophobic (leucine), a small hydrophobic (alanine), a hydrophilic (serine or 
glutamine), and a charged (arginine) residue. Table 1 reports a list of the produced vari-
ants. 
The rate of conversion of the TFE-denatured state into aggregates rich in β-sheet 
and able to bind ThT was measured for each variant. This was achieved by incubating 
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all variants separately in 50 mM acetate buffer, 25% TFE, pH 5.5, 25 °C and monitor-
ing the formation of aggregates using the ThT assay. Under this condition wild type 
and destabilised variants of mt AcP are known to denature rapidly on the time scale of a 
few seconds (Chiti et al. 1999c). The process of aggregation that is therefore monitored 
in the following minutes and hours consists in the conversion of the denatured ensem-
ble into aggregates. The apparent change of aggregation rate following mutation is 
hence fully attributable to the effect of the amino acid substitution on this process 
rather than on the conformational destabilisation of the native state. 
 
Figure 4.2: Aggregation kinetics for mutants of Phe22 (A), Tyr25 (B), Tyr91 (C), and Tyr98 (D). 
All panels show data for the wild type protein (●) and for mutations to leucine (○), alanine 
(■), a hydrophilic residue (□), and arginine (▲). The insets show the first day of recording. The 
lines represent best fits of collected data to single exponential equations (see section 4.5.2 and 
equation 4.1). The obtained rate constants v (s-1) are shown in table 4.1. 
 
4.2.2 Phenylalanine 22 
Four mutants have been purified for this residue, with substitutions to leucine, alanine, 
serine, and arginine (table 4.1). The results show that the substitution of the phenyla-
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lanine at this position results in a dramatically decreased aggregation rate (figure 
4.2A). 
The kinetic constants measured for all of the four mutants are significantly lower 
than that of the wild type (table 4.1). The most intense effect is observed for the F22R 
mutant, while the least effective deceleration is obtained when substituting phenyla-
lanine with leucine. Mutations to alanine and serine result in similar effects, although 
substitution of the wild type residue with a hydrophilic one displays a slightly greater 
change in the aggregation rate. 
 
Table 4.1: Kinetic data for a set of aromatic mutants of mt AcP. Observed ln (vmut/vwt) values 
have been obtained from best fits of experimental data to equation 4.1. Theoretical ln 
(vmut/vwt) values have been obtained from equation 4.2. 
protein variant experimental v (s-1) observed ln (vmut/vwt) 
theoretical 
ln (vmut/vwt) 
WT (8.9 ± 1.2) · 104 - - 
F22L (1.7 ± 0.2) · 104 1.7 ± 0.3 0.87 
F22A (3.2 ± 0.4) · 105 3.3 ± 0.3 2.31 
F22S (2.5 ± 0.3) · 105 3.6 ± 0.3 2.14 
F22R (1.5 ± 0.2) · 105 4.1 ± 0.3 5.02 
Y25L (1.2 ± 0.2) · 104 2.0 ± 0.3 0.00 
Y25A (4.8 ± 0.6) · 105 2.9 ± 0.3 1.80 
Y25S (2.7 ± 0.3) · 105 3.5 ± 0.3 1.69 
Y91A (3.4 ± 0.4) · 105 3.3 ± 0.3 2.31 
Y91Q (3.2 ± 0.4) · 105 3.3 ± 0.3 2.16 
Y91R (2.0 ± 0.3) · 105 3.8 ± 0.3 5.00 
Y98A (3.0 ± 0.4) · 105 3.4 ± 0.3 1.66 
Y98Q (8.5 ± 1.1) · 105 2.3 ± 0.3 2.41 
Y98R (1.5 ± 0.2) · 105 4.1 ± 0.3 4.57 
 
4.2.3 Tyrosine 25 
This residue has been substituted with leucine, alanine, and serine. Results are similar 
to those obtained for phenylalanine 22, with all substitutions resulting in slower ag-
gregation (figure 4.2B; table 4.1). By comparing the Y25L and Y25S mutants we can see 
that the latter is much less prone to aggregate. Indeed, the kinetic constants vmut are re-
duced by factors equal to 7.4 and 33, respectively. Similar decelerations were obtained 
for the F22L and F22S variants. 
4.2.4 Tyrosine 91 
Tyr91 is located in the second aggregation-promoting segment (figure 4.1A). For this 
residue we have collected the kinetic profiles for the Y91A, Y91Q, and Y91R mutants 
(figure 4.2C). We have also designed an Y91L mutant, but it was not analysed due to 
purification problems. The results of the analysis of these mutants are shown in Figure 
2C. The replacement of Tyr91 with a small hydrophobic residue or with a hydrophilic 
one results, within experimental error, in an identical effect (table 4.1). Interestingly, 
the order of aggregation speed is similar for the variants involving Phe22 and Tyr91: 
substitution of either residue to alanine or a hydrophilic group leads to decelerations 
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that are fairly similar to each other and comparable in the two sets of variants. In addi-
tion, in both cases, replacement to arginine leads to the most remarkable deceleration 
effect, with the aggregation reaction reaching equilibrium after many days. 
 
Figure 4.3: Calculated Vs observed change of aggregation rate upon mutation ln (vmut/vwt) for 
a set of mutants of mt AcP involving substitution of aromatic residues (●) along with a set of 
other mutants of mt AcP involving non-aromatic residues (○) (Chiti et al. 2003). The ln 
(vmut/vwt) data have been calculated using equation 4.2. The continuous and dotted lines rep-
resent the best linear fits obtained using all and only non-aromatic mutants, respectively. 
4.2.5 Tyrosine 98 
The aggregation kinetic profiles for mutants Y98Q, Y98A, and Y98R were also re-
corded (figure 4.2D). As for tyrosine 91, the Y98L variant could not be purified due to 
aggregation into inclusion bodies after expression in Escherichia coli. Although all 
mutations resulted in slower aggregation, along the lines observed for the other sets of 
variants, mutation to glutamine results in a less marked deceleration compared to the 
mutation of Tyr98 to alanine and also of Tyr91 to glutamine (table 4.1). Since tyrosine 
98 is the C-terminal residue, it is possible that the C-terminal carboxyl group masks 
some of the effects observed for mutations at other positions. Apart from this effect, it 
is still evident that the most anti-amyloidogenic mutation is obtained if a charge resi-
due is added, i.e., in the Y98R variant. 
4.2.6 Statistical analysis 
The results presented here clearly showthat aromatic residues play a fundamental role 
in promoting aggregation of mt AcP. Indeed, in all cases elimination of an aromatic 
residue results in a significant, sometimes remarkable, decrease of the aggregation rate. 
Francesco Bemporad 72 
Nevertheless, it is important to understand if aromatic residues favour amyloid forma-
tion because of their high hydrophobicity and propensity to form β-structure, or by 
forming aromatic-aromatic interactions. To address this issue, we have compared the 
experimentally obtained aggregation rates with those calculated theoretically by using 
a previously described algorithm (Chiti et al. 2003). The equation is reported in section 
4.5.3 as equation 4.2 and allows the natural logarithm of the ratio of the aggregation 
rates for the mutant and wild type, ln (vmut/vwt), to be calculated. The equation contains 
terms for hydrophobicity, net charge and free energy variation when a residue changes 
its conformation from an α-helix to a β-strand. Moreover, the equation was derived by 
considering mainly mutations that did not involve aromatic residues (Chiti et al. 
2003). 
A summary of the experimental and theoretical values of ln (vmut/vwt) are reported 
in Table 1 and figure 4.3. In figure 4.3, we compare the data for the mutants which we 
have examined here (●) with those for other mt AcP mutants involving non-aromatic 
residues (○). These mutants have been previously used to develop the algorithm men-
tioned above (Chiti et al. 2003). Thus, if the experimental ln (vmut/vwt) values for aro-
matic mutants deviated from the expected behaviour, our conclusion would be that 
aromatic residues play a role in amyloid formation different from that expected on the 
basis of their hydrophobicity and ability to form secondary structure. By using equa-
tion 4.2 we notice that some experimental values of ln (vmut/vwt) are slightly lower or 
slightly higher than those calculated by taking into consideration only hydrophobicity, 
ability to form secondary structure, and net charge as parameters (figure 4.3). More 
importantly, the calculated aggregation rates of the mutants are not systematically 
higher than the observed values (figure 4.3). The data points for aromatic mutants are 
scattered around the line of best fit to a degree comparable with those of the non-
aromatic variants. The p-parameter calculated for the best linear fit carried out with 
aromatic residues (continuous line) is lower than 0.05% (figure 4.3); the same result is 
obtained if the data from aromatic mutants are not included in the analysis (dotted line). 
A χ2 test has also been carried out for the data set. The test yields the probability to ob-
tain the distribution if the studied phenomenon is well represented by the tested law. A 
probability value lower than 5% has been obtained when equation 2 has been used. This 
suggests that it is not necessary to add an aromaticity term in the equation to improve 
the correlation between experimental and theoretical values. 
4.3 Discussion 
4.3.1 Aromatic residues promote amyloid aggregation of mt AcP due to their hydro-
phobicity and β-sheet propensity 
The aim of this work is to characterise the role of aromatic residues in amyloid forma-
tion and to understand whether the capability of aromatic residues to promote aggrega-
tion arises from their aromaticity or rather from their high hydrophobicity and β-
sheet propensity. On the one hand the side chains of phenylalanine and tyrosine contain 
seven carbons. These residues, particularly phenylalanine, are ranked as highly hydro-
phobic according to all scales of hydrophobicity so far edited (Creighton 1993). On the 
other hand, it has been shown that the avoidance of steric clashes between the side chain 
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and its local backbone causes the β-sheet propensity of aromatic residues to be particu-
larly high (Street and Mayo 1999). The high occurrence of phenylalanine and tyrosine 
residues in natural β-sheets of proteins also confirms the high propensity of these resi-
dues to form β-structure (Chou and Fasman 1974). In addition to having a high hydro-
phobicity and a high propensity to form β-sheet structure, phenylalanine and tyrosine 
residues also contain planar rings with six covalently bonded carbon atoms and a delo-
calised π system. This chemical characteristic, termed aromaticity, has been proposed 
to be responsible for the ability of these residues to promote amyloid fibril formation. 
Our results show that substitution of any of the four aromatic residues present in 
the aggregation promoting stretches of mt AcP invariably results in a slower aggrega-
tion process of the entire molecule (figure 4.2; Table1). These observations confirm 
previous reports that phenylalanine and tyrosine side chains promote amyloid aggre-
gation very effectively. However, our analysis rules out that aromaticity is responsible 
per se for the aggregating potential of these residues. An equation derived from muta-
tions involving predominantly non-aromatic residues and considering physicochemi-
cal factors other than aromaticity can account for the observed reductions of aggrega-
tion rates when the aromatic residues of mt AcP are substituted with others (figure 
4.3). The observed decelerations can be entirely attributed to the decrease of hydropho-
bicity and β-sheet propensity (and increase of net charge if applicable) following sub-
stitution. The effectiveness of aromatic residues in promoting amyloid formation has 
probably to be sought in these, rather than other, chemical characteristics of their side 
chains. Importantly, the scales of hydrophobicity and β-sheet propensity values for the 
20 amino acid residues used in the algorithm were derived from partition coefficients 
between water and octanol (Creighton 1993) and effective stabilities when adopting a 
β-sheet structure in monomeric proteins (Street and Mayo 1999), respectively. These 
factors and the resulting algorithm are not therefore indirectly influenced by π-
stacking or other types of aromatic-aromatic interactions. 
4.3.2 Aromatic residues are frequent in the cross-β core of fibrils but are not necessar-
ily required 
Although aromaticity does not seem to be the origin of the efficacy of aromatic resi-
dues to promote aggregation, the fact remains that they can establish a network of hy-
drophobic interactions and can pay the minimal entropic cost in formation of the 
cross-β structure. For these reasons they may have a significant stabilising effect in the 
resulting fibrils and it is not surprising that they are highly recurrent in amyloi-
dogenic sequences. X-ray studies have led to a detailed characterisation of the crystals 
formed by assemblies of an amyloidogenic 12-mer peptide (Makin et al. 2005) and a 7-
residue peptide derived from the yeast prion Sup35p (Nelson et al. 2005). In the first 
case stacking between phenylalanine residues is found to stabilise the inter-sheet pack-
ing of the structure (Makin et al. 2005), while in the second report tyrosine side chains 
stack on the solvent-exposed faces of the two sheets, presumably forming stabilising 
interactions (Nelson et al. 2005). 
Several peptides containing residues 16-20 of the amyloid β peptide (Aβ) readily 
form fibrils: The sequence of this segment, KLVFF, presents two aromatic residues 
(Tjernberg et al. 1999). A search for the residues that promote the aggregation of the 
entire Aβ peptide has shown the importance of Phe19 (Wurth et al. 2002). More inter-
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estingly, solid state nuclear magnetic resonance (SS-NMR) experiments have led some 
authors to a model of the Aβ 1-40 protofilaments in which two β-strands formed by 
residues 12-24 and 30-40 give rise to two in register parallel β-sheets which interact 
through side chain-side chain contacts (Petkova et al. 2002). This structure clearly 
shows that Phe19 and Phe20 form inter-strand π-stacking (Petkova et al. 2002). 
The contacts between phenylalanine residues in fibrils formed from the amylin-
derived NFGAIL peptide are thought to be important stabilising interactions (Azriel 
and Gazit 2001; Gazit 2002; Porat et al. 2003; Porat et al. 2004). In the recently pro-
posed structure of fibrils from full-length amylin any individual peptide molecule 
contributes to three β-strands, each of which is parallel and in register with the corre-
sponding ones from other molecules (Kajava et al. 2005). In this structure not just 
Phe23, but also Phe15, His18, and Tyr37 are stacked along the axis of the fibril to form 
long rows of intermolecular interactions (Kajava et al. 2005). 
Phe23 and Tyr37 form additional intra-molecular interactions in each peptide. It 
was suggested that in the NFGAIL segment the phenylalanine residue directs ordered 
β-sheet stacking through both specific interactions between aromatic rings and non-
specific clustering of phenylalanine with other hydrophobic residues (Wu et al. 2005). 
This suggests that the hydrophobic properties of this residue are able to favour the ag-
gregation of the entire segment without invoking its ability to form specific interac-
tions. 
If many peptides and proteins aggregate via interactions of aromatic residues, 
many others have been shown to promptly aggregate without any involvement of aro-
matic residues. A saturation mutagenesis analysis on the de novo designed amyloid 
peptide STVIIE has allowed an aggregation prone sequence pattern to be determined 
(Lopez de la Paz and Serrano 2004). Although each position of this sequence can be mu-
tated to aromatic residues without losing the ability of the hexapeptide to aggregate, the 
presence of aromatic residues does not seem to be an essential requirement for the ag-
gregation of the hexapeptide (Lopez de la Paz and Serrano 2004). In α-synuclein, a pro-
tein whose aggregation is related to Parkinson’s disease, several short segments of 10 
residues have been found to aggregate even if separated from the remainder of the se-
quence, for example the 71-82 (Giasson et al. 2001), 66-74 (Du et al. 2003), and 69-79 
sequences (El-Agnaf and Irvine 2002). These three segments, whose sequences largely 
overlap to each other allowing an aggregation-prone region of the entire protein to be 
identified, do not contain aromatic residues. It has been proposed that the 31-37 region 
of the Aβ sequence is important in aggregation of the full-length Aβ peptide as muta-
tions to proline in this region cause a significant decrease in the stability of the result-
ing fibrils (Williams et al. 2004). Accordingly, other authors have shown that the seg-
ment spanning approximately residues 30-38 gives rise to a β-strand in fibrils 
(Petkova et al. 2002; Torok et al. 2002). This segment does not contain aromatic resi-
dues. 
Recently, the structure of the amyloid fibrils formed by HET-s from Podospora 
anserina has been investigated with SS-NMR, quenched hydrogen exchange and fluo-
rescence (Ritter et al. 2005). The proposed structure shows two β-strand-turn-β-strand 
motifs interconnected by a long loop (Ritter et al. 2005). Only β-strand 4 contains one 
aromatic residue, Tyr281. This residue interacts with a non-aromatic residue from β-
strand 2 and does not form aromatic-aromatic interactions (Ritter et al. 2005). X-ray 
studies carried out on the crystals derived from assemblies of the amyloidogenic seg-
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ment 1-24 from barnase show that the various phenylalanine residues at position 7 
from different molecules do not form intermolecular interactions (Saiki et al. 2005). 
They seem to participate to a specific pattern in which Phe7 and Val10 residues are al-
ternating on one face of the sheet (Saiki et al. 2005). Similarly, a pattern of alternating 
Tyr13 and Ile4 is present on the other side of the sheet. 
4.4 Conclusions 
Our results on mt AcP confirm that aromatic residues have fundamental importance in 
amyloid assembly. Moreover, a survey of the amyloid fibril structures that have been 
determined with atomic or nearly atomic resolution in the past three years shows that 
the intermolecular interactions between the side chains of these residues appear to be 
highly frequent. However, the establishment of specific contacts between the aromatic 
rings of these residues is not an essential requirement to initiate aggregation and stabi-
lise the resulting fibrils. When present, the forces that maintain in close contact the side 
chains of aromatic residues and stabilise the whole fibril do not arise from specific in-
teractions involving the π-electrons or the aromatic nature of these residues but, rather, 
from their high hydrophobicity and high tendency to form β-sheets. We believe that 
the elucidation of the precise role played by aromatic moieties in determining the 
mechanism of amyloid fibril formation, the rate by which this process occurs, and the 
stability of the resulting fibrils is fundamental to gaining a better understanding of the 
processes occurring in amyloidogenesis. Such an understanding would also be crucial 
for improving the accuracy of the existing algorithms in determining aggregation rates 
and aggregation-promoting regions within polypeptide sequences. 
4.5 Materials and methods 
4.5.1 Mutagenesis, protein expression and purification 
The gene encoding mt AcP was initially inserted in a pGEX-2T plasmid (Amersham, 
Little Chalfont, England) and the resulting construct used to transform DH5-α E. coli 
cells (Invitrogen, Carlsbad, California). Mutated genes were obtained using the Quick 
Change site-directed mutagenesis kit® from Stratagene (La Jolla, California) (see sec-
tion 2.4.1). The presence of the desired mutations was assessed by DNA sequencing. 
Expression and purification of the wild type and mutant proteins were carried out ac-
cording to the protocol of the pGEX-2T manufacturer. Protein purity was checked by 
SDS-polyacrylamide gel electrophoresis. The extinction coefficient at 280 nm (ε280) for 
each mutant was calculated as previously described (Gill and von Hippel 1989). 
4.5.2 Aggregation kinetics with Thioflavin T fluorescence 
Aggregation kinetics of mt AcP and its variants were carried out as previously de-
scribed (Chiti et al. 2002b). In brief, the reaction was started by diluting the native pro-
tein into a solution to reach a final concentration equal to 0.4 mg ml-1 in 25% (v/v) TFE, 
50 mM acetate buffer (pH 5.5), and 25 °C. At several times, 60 μl of the sample were 
added to 440 μl of 25 mM ThT, 25 mM phosphate buffer (pH 6.0), at 25 °C. The result-
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ing fluorescence was measured with a Perkin-Elmer LS-55 fluorometer and thermo-
stated with a Thermo-HAAKE F8 bath. Excitation and emission wavelengths were 440 
nm and 485 nm, respectively. The resulting plot of the ThT fluorescence, expressed as 
percentage of the maximum value versus time, was fitted to a single exponential equa-
tion of the following form: 
where A is the ThT fluorescence at the apparent equilibrium, B is the change of ThT 
fluorescence during the exponential phase, v is the apparent rate constant, and t is the 
time. Before starting the experiment, the sample was centrifuged at 20,000×g for 5 
minutes and the protein concentration was measured using an extinction coefficient at 
280 nm ε280 value calculated as previously described (Gill and von Hippel 1989). 
4.5.3 Data calculation 
The change of aggregation rate upon mutation is reported as ln (vmut/vwt), where vmut is 
the experimentally obtained aggregation rate constant of the considered protein variant 
and vwt is the corresponding value for the wild type. For the calculation of the theoreti-
cal values of ln (vmut/vwt) the following equation was used (Chiti et al. 2003): 
where ΔHydr, ΔΔGcoil-α, ΔΔGβ-coil, and Δcharge are the change of hydrophobicity, α-
helical propensity, β-sheet propensity, and charge upon mutation, respectively. 
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Chapter 5  
Final remarks 
5.1 Conformational states distinct from the fully folded structure can present enzy-
matic activity 
As introduced in section 1.4.1, the acylphosphatase from Sulfolobus solfataricus (Sso 
AcP) is an enzyme able to hydrolyse benzoyl-phosphate (BP), with formation of benzo-
ate and phosphate ions (Ramponi et al. 1966; Ramponi 1975; Camici et al. 1976; Co-
razza et al. 2006). In this thesis we have characterised in detail both folding (chapter 2) 
and amyloid-like aggregation (chapter 3) processes of this protein. In the first case we 
have studied a partially folded state that forms in the dead time of the stopped-flow re-
folding experiments (section 2.2). In the second case we have studied in further detail 
the role of an unstructured N-terminal segment in the mechanism of aggregation of the 
protein (section 3.2). Interestingly, in both cases a conformational state different from 
the native and folded one, yet presenting enzymatic activity comparable to the native 
state, is transiently populated. 
In the case of amyloid-like aggregation of the protein it was previously shown that 
two distinct phases can be spectroscopically detected during process (Plakoutsi et al. 
2005). At the end of the first phase, monitored by far-UV circular dichroism(CD) or 
light scattering, the protein transiently populates an aggregated state in which the Sso 
AcP molecules lack regular amyloid-like structure, as inferred from Fourier transform 
infrared (FTIR) spectroscopy, far-UV CD, Congo red (CR) and Thioflavin T (ThT) 
binding assays (Plakoutsi et al. 2005). Formation of these early aggregates is induced 
by an inter-molecular interaction between the unstructured N-terminal segment and 
the globular part of another molecule (section 3.2). Importantly, such early aggregates 
possess about 60% of the enzymatic activity of the native and monomeric protein; this 
enzymatic activity is completely absent after filtration, confirming that catalysis is due 
to the early aggregates and not to native protein still present in solution at the end of 
the process (Plakoutsi et al. 2005). The activity then decreases during the second phase 
of aggregation, when the native-like aggregates convert into protofibrils with regular 
amyloid-like structure (Plakoutsi et al. 2005). 
An enzymatically active conformational state also forms transiently during the 
folding process. The folding process of Sso AcP in 50 mM acetate buffer at pH 5.5 and 
37 °C is characterised by the formation of a partially folded state (Bemporad et al. 
2004). This ensemble forms within the dead time of the stopped flow kinetic experi-
ments and converts later into the fully native structure. The partially folded ensemble 
binds to 8-anilino-1-naphthalenesulfonic acid, suggesting the presence of hydrophobic 
clusters exposed to the solvent, and presents a far-UV mean residue ellipticity compa-
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rable to that of the fully native state, indicating a native-like secondary structure com-
parable to that of the native state (Bemporad et al. 2004). In section 2.2 we have shown 
that this partially folded state is characterised by enzymatic activity equal to 80% of the 
fully folded state value. Further experiments have ruled out the possibility that the 
measured activity arises from presence of folded or unfolded protein. This activity is 
highly sensitive to mutations as the partially folded state is highly dynamic. Impor-
tantly, the catalytic site is not structured in the absence of substrate in the partially 
folded intermediate. Although folding and catalysis can be coupled in some cases 
(Vamvaca et al. 2004) and this possibility cannot be ruled out in our case, Sso AcP fold-
ing is not accelerated by the presence of substrate, suggesting that BP does not induce a 
global collapse of the structure. Finally, molecular dynamics simulations guided by 
experimentally obtained Φ values suggest that this enzymatic activity is possible as in 
the partially folded ensemble the scaffold of the protein is already formed and this 
forces catalytic residues to be close to each other and able to carry out the catalytic cycle 
(section 2.3). 
Importantly, there is no experimental evidence of any correlation between these 
two conformational states. They form in processes as different as folding and amyloid-
like aggregation and in different experimental conditions such as in the absence and in 
the presence of 2,2,2-trifluoroethanol. Nevertheless, the general picture that derives 
from these experimental observations is that enzymatic activity can be more common 
than previously thought. Conformational states different from fully folded one can 
bind to the substrate, catalyse the reaction and release products to an extent comparable 
to folded structures. Since the first mechanism proposed for catalysis, usually referred 
to as “lock and key mechanism”, it became clear in the 60s that the substrate induces 
some changes in the enzyme structure (Koshland 1958). It is now clear the importance 
of dynamics during catalysis (Kiefhaber et al. 1992; Eisenmesser et al. 2002). The re-
sults presented in this thesis may extend this concept as highly dynamic and aggregated 
states can be active enzymes. Further studies are needed to clarify the biological rele-
vance and distribution of such a feature. Nevertheless, these results are relevant as they 
extend our knowledge about properties of proteins in solution and give important in-
formation about their dynamics. 
5.2 A comparison between the transition state ensembles of mt AcP and Sso AcP 
In chapter 2 we have described an investigation, using Φ value analysis, of the transi-
tion state ensemble (TSE) for folding of Sso AcP (see section 2.2.3). The results show 
that residues with Φ‡ values higher than 0.8 are Val20, Gly52, Ala58 and Arg71. 
Moreover, the obtained set of Φ values (figure 2.5 and table 2.3) has been used in sec-
tion 2.3 as a restraint in molecular dynamics simulations to obtain an ensemble of pos-
sible structures representing the TSE. The results show that the most structured region 
in TSE of Sso AcP corresponds to the interface between β-strand 1 and α-helix 2. 
Moreover, a considerable amount of structure is also present in the β-hairpin between 
β-strand 2 and β-strand 3 (table 2.3). Structure formation in these regions forces the 
topology in the remainder of the molecule to be native-like. The regions structured in 
TSE of Sso AcP are also shown also in figure 5.1A. 
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Figure 5.1: A comparison between folding transition states of Sso AcP and mt AcP. (A) a sec-
tion view of the topology of Sso AcP and mt AcP. Regions structured in TSEs are highlighted 
in gray. (B) and (C) A comparison between Φ‡ values of Sso AcP and mt AcP. In (B) each mt 
AcP Φ‡ value is plotted versus the Φ‡ value of the corresponding residue of Sso AcP. The line 
represents the expected plot for two identical TSEs. In (C) the average values in the secondary 
structure elements are shown for mt AcP (gray) and Sso AcP (black). Values for mt AcP are 
reported in (Chiti et al. 1999b). 
Many of the positions investigated in this work correspond to positions previ-
ously investigated in the TSE of mt AcP (Chiti et al. 1999b). In the case of mt AcP it 
was shown that the transition state structure is an expanded form of the native confor-
mation, lacking persistent interactions but showing the topology characteristic of the 
native state (Chiti et al. 1999b). The most structured region in the TSE is the central 
section of the β-sheet (β-strands 1 and 3). The C-terminal β-strand (β-strand 5) and the 
loop connecting β-strands 2 and 3 also appear well formed in the transition state en-
semble. The positions that present Φ‡ values higher than 0.7 correspond to Tyr11, 
Pro54, Phe94 (Chiti et al. 1999b). 
The folding TSEs of mt AcP and Sso AcP present some similar features. In both 
cases the most structured region is the central part of the β-sheet, formed by β-strands 
1 and 3 (figure 5.1A and C). Starting from these regions the structure propagates to the 
remaining secondary structure elements and to the loops. Tyr11 in mt AcP shows a Φ‡ 
value equal to 0.83 ± 0.07 (Chiti et al. 1999b). The corresponding Sso AcP residue 
(Ala18) shows a Φ‡ value equal to 0.62 ± 0.04 (table 2.3). Importantly, Val20, a residue 
close to Ala18, displays a Φ‡ value equal to 1.31 ± 0.08, suggesting structure formation 
in the region of Sso AcP that corresponds to the one structured in mt AcP. Moreover, 
in both transition states the least native-like secondary structure element is β-strand 4 
((Chiti et al. 1999b), table 2.3 and figure 5.1C). 
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However, some important features of these two TSEs significantly differ. In the 
case of Sso Acp the second α-helix is rather structured, with three Φ‡ values signifi-
cantly higher than 0 and one Φ‡ value (Arg71) equal to 1. By contrast, the interactions 
formed by residues located in the two α-helices of mt AcP appear to be less consoli-
dated (Chiti et al. 1999b). An important interaction is formed in the TSE of mt AcP by 
Phe94, which is positioned in β-strand 5. The corresponding position of Sso AcP dis-
plays a Φ‡ value close to 0, showing that this region is not structured in this protein. 
Finally, Tyr61 is the position of Sso AcP that corresponds to Pro54, the other struc-
tured residue in TSE of mt AcP. This residue could not be investigated due to the low 
destabilisation measured. Nevertheless, the plot representing the two Φ‡ datasets shows 
significant deviation from the trend expected for identical TSEs (figure 5.1B). 
The TSE of mt AcP was found to be remarkably similar in structure to that of the 
activation domain of procarboxypeptidase A2 (ADA2h), a protein having the same 
overall topology but sharing only 13% sequence identity with mt AcP (Villegas et al. 
1998; Chiti et al. 1999b). In many other cases similarities were found between folding 
processes and transition states of protein sharing the same fold (Travaglini-Allocatelli 
et al. 2004; Zarrine-Afsar et al. 2005; Chi et al. 2007). In the case of Sso AcP, some fea-
tures make the TSE of the protein similar but not identical to that of the homologous 
protein mt AcP. These two proteins share 25% sequence identity. Nevertheless, they 
are evolutionary distant and the need to be active at high temperature results in higher 
conformational stability for Sso AcP (Corazza et al. 2006). This adaptation could also 
have implications for the folding mechanism. It is also possible that the partially folded 
state formed during folding of Sso AcP induces some constraints that affect the folding 
mechanism and consequently bias the TSE structure. Further characterisation of this 
state will shed light on the folding mechanism of Sso AcP and of the acylphosphatase-
like family. 
5.3 Different regions of the sequence are involved in protein folding and amyloid-like 
aggregation 
It was previously shown that different regions play major roles in the amyloid-like ag-
gregation and in the folding process of mt AcP (Chiti et al. 2002b). β-strands 1 and 3 
and Phe94 are the most structured regions in the folding nucleus of this protein, 
whereas all the mutations that significantly alter the aggregation rate are located in two 
regions of the mt AcP primary structure corresponding to residues 16-31 and 87-98 
(figure 4.1A). The 16-31 segment spans the loop that follows β-strand 1 and α-helix 2. 
The 87-98 segment spans the loop that follows β-strand 4 and β-strand 5. These two 
segments correspond to two insoluble peptides when dissected from the remainder of 
the sequence (Chiti et al. 2002b). Moreover, they have values of β-sheet propensity and 
hydrophobicity above the average values calculated from the entire AcP sequence 
(Chiti et al. 2002b) and appear to be solvent-exposed and/or flexible in the initial par-
tially unfolded state (Monti et al. 2004). These data led the authors to conclude that 
there is a kinetic partitioning between folding and aggregation. Starting from the un-
folded state, the propensity of the full length protein to aggregate is reduced by intra-
molecular interactions associated with the formation of the folding nucleus. This sug-
gests that the sequences of natural proteins may have evolved such that partially struc-
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tured states populated during folding have the tendency to resist amyloid-like aggrega-
tion under normal conditions (Chiti et al. 2002b). 
 
Figure 5.2: A comparison between the regions important for folding and amyloid-like aggrega-
tion of Sso AcP. On the top the regions of the sequence structured in the transition state for 
folding are coloured in black. These span β-strands 1, 2 and 3 and α-helix 2. Residues in these 
segments display some Φ‡ values close to 1 and many Φ‡ values significantly higher than 0 (ta-
ble 2.3). On the bottom regions important for amyloid-like aggregation of the protein are col-
oured in black. These span the fourth β-strand and the unstructured N-terminal segment. 
These regions were found flexible and exposed to the solvent and important from protein 
engineering studies ((Plakoutsi et al. 2006) and chapter 3). The figure has been drawn with 
VMD 1.8.3 for win32 (Humphrey et al. 1996). 
 
Interestingly, similar partitioning between regions important for folding and re-
gions that play major roles in the amyloid-like aggregation process can be done for Sso 
AcP as well. As shown in figure 5.2 and mentioned above (section 5.2), in the folding 
transition state structure is present in β-strands 1, 2 and 3 and in α-helix 2. By contrast, 
the regions that play a major role in the mechanism of aggregation of the protein are β-
strand 4 and the N-terminal unstructured segment (section 3.3 and (Plakoutsi et al. 
2006)). Thus, in the case of Sso AcP as well there is a separation between regions that 
participate to folding and regions that participate to aggregation. 
Importantly, Sso AcP aggregates starting from a native-like ensemble. This im-
plies that the biological function supposed for the observed mt AcP partitioning cannot 
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be extended to Sso AcP. The absence of structure in the N-terminal segment explains 
the reason why this region does not play any role in protein folding, while its flexibil-
ity provides an explanation for its importance in amyloid-like aggregation. In the case 
of the fourth β-strand, we have shown that mutations in this region strongly accelerate 
unfolding (table 2.3). This probably implies that in destabilising conditions this strand 
gets much more flexible and prone to aggregate. Concerning the role of β-strand 4 in 
folding, one can speculate that evolution acted on this edge β-strand placing in this re-
gion some gatekeeper residues that reduce aggregation propensity of the native protein, 
as it was shown in the case of some unfolded (Otzen et al. 2000) and folded (Richardson 
and Richardson 2002) proteins. Presence of these residues introduces some constraints 
that force this region to fold only after topology of the protein is formed. 
5.4 Conclusions 
In this thesis we have investigated in detail the processes of protein folding and amy-
loid-like aggregation in the acylphosphatase-like family. These studies are particularly 
important as they provide clues to better understand the dynamics of proteins in solu-
tion. Indeed, the search for the right fold is a crucial event for proteins and any impair-
ment of the mechanisms that regulate equilibria between different conformational 
states can trigger misfolding events and formation of deleterious aggregates related to 
a set of human diseases (Chiti and Dobson 2006). Only more detailed knowledge about 
the mechanisms and the parameters that lead to misfolding will allow the achievement 
of the level of knowledge required to understand and treat these diseases and to design 
novel proteins that are perfectly functional in solution. 
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Appendix A  
Equations and formulas 
 
In this appendix we shall discuss the most important equations that have been used 
for data fitting and analysis in this work. Some passages will be omitted for brevity 
reasons. 
A.1 Equilibrium unfolding experiments 
A.1.1 Equilibrium unfolding with guanidine hydrochloride 
All equilibrium unfolding experiments carried out in this work using guanidine hy-
drochloride as a denaturant have shown a reversible and cooperative transition. 
Thus, they have been analysed using Santoro and Bolen theory (Santoro and Bolen 
1988). According to this model a given protein can populate two conformational 
states, folded (F) and unfolded (U). These states are in equilibrium and no partially 
folded conformations form: 
folded and unfolded protein are characterised by significantly different spectroscopic 
signals. In the experiments presented here the most significant difference between U 
and F has been detected using circular dichroism (CD) signal at 222 nm. The CD sig-
nals for U and F are referred to as [!]222U and [!]222F, respectively. The amount of 
folded and unfolded protein at a given denaturant concentration [D], referred to as 
folded fraction fF and unfolded fraction fU, are given by the following equations: 
where [!]222 is the CD signal observed at the equilibrium at [D], [U] and [F] are the 
concentrations of U and F, respectively. Moreover, an equilibrium constant KU be-
tween U and F can be defined using standard thermodynamics theory: 
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where "GU-F is the free energy change upon denaturation, R is ideal gas constant and 
T is the temperature. It has been shown that "GU-F linearly depends on denaturant 
concentration [D] (Pace 1986): 
where "GU-FH2O is the free energy change upon denaturation in the absence of denaturant 
and m is the slope of the straight line. Combining equations from A.1 to A.4 we obtain: 
Solving equation A.5 in [!]222 we have 
Since the CD signals of folded and unfolded proteins linearly depend on denaturant 
concentration we obtain 
where [!]222F,H2O and [!]222U,H2O are the CD signals in the absence of denaturant respec-
tively for folded and unfolded protein, a1 and a2 are the slopes of the straight lines. Best 
fits of experimental data to equation A.6 give a quantitative measurement of "GU-FH2O and 
m. Finally, we can calculate the concentration of middle denaturation Cm as the denatur-
ant concentration value at which KU = 1 and "GU-F = 0. That is, from equation A.4, 
A.1.2 Equilibrium unfolding with guanidine hydrochloride and phosphate 
Phosphate ion is a well known competitive inhibitor of acylphosphatase activity (Stefani 
et al. 1997). Adding phosphate at a concentration CPi to a sample containing Sso AcP will 
change the apparent equilibrium. In particular U is not able to bind to phosphate P and 
unfolding can occur only following phosphate release from native protein F: 
where FPi represents the folded protein bound to the phosphate, Pi represents the 
unbound phosphate. Moreover, the affinity constant of phosphate Ki is 
where [Pi] represents the concentration of unbound Pi. In the presence of Pi the 
amount of folded protein will increase and this will result in an apparent protein sta-
bilisation. The stabilisation ""GU-FPi due to the presence of Pi is given by: 
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where "GU-FPi and "GU-FH2O are the free energy changes upon denaturation in the ab-
sence of denaturant, and in the presence and in the absence of Pi, respectively. ""GU-
F
Pi can be calculated as follows: 
 
where [Pi] can be approximated to CPi as phosphate is in large excess relative to the 
protein. Thus, the phosphate concentration to be used to obtain a certain stabilisation 
""GU-FPi is given by 
Equation A.12 has been used in section 3.2.2 to calculate the amount of phosphate to 
be added to obtain a certain stabilisation of Sso AcP. 
A.2 Folding and unfolding kinetics 
A.2.1 Folding kinetics with fluorescence 
Folding of wild type Sso AcP was shown to be characterised by three distinct fluores-
cence phases (Bemporad et al. 2004): (1) a rapid increase, escaping the dead time of 
the stopped flow experiments and corresponding to the formation of an ensemble of 
partially folded conformations (PFE); (2) a rapid decrease, corresponding to the fold-
ing of about 90% of the protein; (3) a slow decrease, corresponding to the folding of 
remaining 10% of the protein, which is rate-limited by cis-trans isomerism of Leu49-
Pro50 peptide bond (Bemporad et al. 2004). 
All mutants investigated in this study showed similar fluorescence traces. To ex-
plain such behaviour we have supposed the following equilibrium: 
In this equilibrium Icis and Itrans represent the PFE with the proline in cis and trans, F 
is the native state, k12, k21 and kI→F are kinetic constants. By applying the law of mass 
action to this equilibrium we obtain the following system: 
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This system can be solved with boundary conditions. In particular 
• At a given time t, the total concentration of protein remains constant: 
where Ctot is the total concentration of protein. 
• At the beginning of the process no molecules in the folded conformation ex-
ist; the relative amount of the two PFEs is given by kinetic constants: 
• At the equilibrium only the native state is populated: 
With these conditions system A.13 has the following solution: 
Thus, the fluorescence signal at a given time f(t) is a linear combination of the signals 
of the three considered states: 
where a1, a2 and a3 are proportional to the fluorescence emission intensity of Icis, Itrans 
and F, respectively. Substituting equations A.14 in equation A.15 we have 
Hence, by substituting 
in equation A.16 we obtain 
Equation A.17 is able to reproduce experimental results for both wild type Sso AcP 
and the set of mutants studied. Best fits of experimental data to equation A.17 have 
been used in section 2.2.3 to obtain quantitative measurements of folding rates of 
several Sso AcP variants. 
A.2.2 Unfolding kinetics with circular dichroism 
Unfolding kinetics of Sso AcP were followed by means of circular dichroism signal at 
230 nm. In all cases experimental results showed a single exponential behaviour. This 
can be explained supposing a two state equilibrium between the unfolded state U and 
the folded state F: 
We suppose that folding reaction is much slower in the experimental conditions used 
for unfolding. Thus, applying the law of mass action we obtain the following system: 
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Imposing boundary conditions about the amount of F and U at the beginning of un-
folding one can get the following solutions: 
 
where Ctot is the total protein concentration. As reported above for fluorescence dur-
ing folding (see section A.2.1), we can now calculate the change in signal over time 
[!](t) as: 
where a1 and a2 are proportional to the dicroescence of F and U, respectively. By sub-
stituting 
we obtain 
Equation A.22 is able to reproduce experimental results for both wild type Sso AcP 
and the set of mutants studied. Best fits of experimental data to equation A.17 have 
been used in section 2.2.3 to obtain quantitative measurements of unfolding rates of 
several Sso AcP variants. 
A.2.3 Chevron plots 
The plot reporting natural logarithm of apparent folding and unfolding rate con-
stants ln kapp versus denaturant concentration [D] is usually referred to as chevron 
plot (Jackson and Fersht 1991). In a two state folder the obtained behaviour can be 
explained supposing that folding and unfolding rate constants linearly depend on 
denaturant concentration: 
where ln kU→F and ln kF→U are respectively natural logarithm of folding and unfolding 
rate constants, ln kF→UH2O and ln kU→FH2O are respectively natural logarithm of folding 
and unfolding rate constants in the absence of denaturant, mu and mf are the slopes 
of the straight lines. The apparent constant kapp is the sum of folding and unfolding 
constants: 
Thus, we can calculate ln kapp substituting equations A.23 and A.24 in A.25: 
Equation A.26 reproduces chevron plots for two state folders. However, the chevron 
plots for the Sso AcP variants studied in this work showed a down-ward curvature at 
low denaturant concentrations. This was attributed to the formation of an ensemble 
of partially folded conformations in the dead time of the stopped flow experiments 
(Bemporad et al. 2004). Thus, a modified version of equation A.26 was used: 
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Figure A.1: Schematic representation of free energy G versus reaction coordinate rc during 
folding of Sso AcP in the absence of denaturant. Symbols are defined in the text. The partially 
folded ensemble I is supposed to be on-pathway. The effect of a generic mutation is repre-
sented in red. For simplicity reasons, no effect has been drawn for the transition state between 
unfolded state U and I. Blue colour refers to parameters used in the text to define #IH2O and 
#‡H2O (equation A.28). 
where kI→FH2O is the folding rate constant starting from the partially folded ensemble 
in the absence of denaturant. A second order polynomial function has been intro-
duced in the folding arm of the plot. Equation A.27 is able to reproduce chevron plots 
for the Sso AcP protein variants studied in section 2.2.3. 
A.3 Calculation of # values 
# value analysis has been carried out in this study on the partially folded ensemble 
(PFE) and transition state ensemble (TSE) populated during the folding of Sso AcP 
(figure A.1). # values for PFE, #IH2O, and for TSE, #‡H2O, are defined as (Matouschek 
and Fersht 1991; Matouschek et al. 1992): 
where ""GI-UH2O, ""G‡-UH2O and ""GF-UH2O are the change in conformational stability 
in the absence of denaturant for PFE, TSE and native state, respectively. 
Calculation of ""GF-UH2O has been carried out as reported in A.1.1. In particular 
where the prime refers to the mutant. To calculate "GF-U and "G’F-U the average m 
value over the mutants was used in equation A.8 as the m value that one can obtain 
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by the best fit of a single mutant to the Santoro & Bolen model arises from the few 
points in the transition zone of the plot and is therefore highly sensitive to the 
experimental error (Matouschek and Fersht 1991). Thus, 
To calculate ""GI-UH2O, with reference to the figure, one has to notice that 
Similar calculations allow us to find ""GF-IH2O: 
""G‡-IH2O and ""G‡-FH2O can now be calculated from kinetic experiments. In fact, us-
ing Arrhenius equation we can calculate folding rates as follows: 
where kI→FH2O and k’I→FH2O are the folding rate constants in the absence of denaturant 
for the wild type and mutant, ! is a frequency factor, kB and h are Boltzmann and 
Planck constants, respectively. From equation A.33 we obtain 
Unfolding rate constants can be calculated as follows: 
where kF→UH2O and k’F→UH2O are the unfolding rate constants in the absence of denatur-
ant for wild type and mutant, respectively. From equation A.35 we obtain 
Combining equations from A.28 to A.36 we experimentally find # values: 
Equations A.37 and A.38 have been used in chapter 2 to calculate # values of a set of 
Sso AcP variants (see section 2.4.8). 
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A.4 Development of enzymatic activity during folding 
Folding of Sso AcP has been followed in chapter 2 by means of enzymatic activity. 
Sso AcP is able to hydrolyse benzoyl-phosphate (BP) producing phosphate and ben-
zoate ions (Stefani et al. 1997; Corazza et al. 2006). Unlike the hydrolysis products, 
the reactant has a significant extinction coefficient at 283 nm (Ramponi et al. 1966). 
Thus, enzymatic activity is proportional to the opposite of the first order derivative of 
the absorbance at 283 nm A283(t). 
The behaviour shown by the Sso AcP variants investigated when unfolded pro-
tein is diluted into refolding buffer can be explained by supposing that no differences 
exist between the two intermediates analysed in section A.2.1. Thus, a single inter-
mediate converts into the native state. In these conditions concentrations of partially 
folded state [I](t) and native state [F](t) are given by the following equation: 
 
 
 
where kI→F is the folding rate constant and Ctot is the protein concentration (see sec-
tion A.2.1). Both states are characterised by a catalytic constant kCAT. The enzymatic 
activity will be a liner combination of the activities of the partially folded state I and 
fully folded state F: 
 
 
 
 
where kCATI and kCATF are catalytic constants for partially folded and fully folded 
states, respectively. Equation A.39 allows us to calculate the expected behaviour for 
A283 as a function of time, A283(t). Indeed, from equation A.39 we obtain 
 
Equation A.41 can be solved to obtain A283(t): 
 
Equation A.42 reproduces experimental traces obtained in section 2.2.1. Moreover, 
substituting equation A.39 in equation A.40 we obtain the enzymatic activity as a 
function of time: 
  
Equation A.43 has been used in section 2.2.1 to analyse data and obtain quantitative 
measurements of the catalytic constants of partially folded and fully folded states of 
the Sso AcP variants analysed in the text. 
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Appendix B  
Models for Sso AcP aggregation 
B.1 Introduction 
In this appendix the possible models for the Sso AcP aggregation mechanism based 
on previously obtained experiments (section 3.1.2) are discussed on the basis of the 
experiments presented in this thesis 3.2. The fourth $-strand is depicted in dark gray. 
The N-terminal unstructured segment is depicted as a filament. 
B.2 Description of models 
B.2.1 Interaction between N-termini 
 
In this model the early aggregates are stabilised by intermolecular interactions be-
tween N-terminal tails of two molecules. The globular part of Sso AcP participates 
only to the second phase of the process. 
This model does not reproduce the experimental results as 
1. The peptide alone should aggregate in the aggregation promoting conditions 
((Plakoutsi et al. 2006) and section 3.2.3). 
2. $-strand 4 should not appear important as it is actually detected by site di-
rected mutagenesis and limited proteolysis (Plakoutsi et al. 2006). 
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B.2.2 Interaction between N-terminus and $-strand 4 
 
In this model the N-terminal tail acts as a bridge between the fourth $-strand and 
another region of the molecule (the fifth $-strand is shown for instance in the figure). 
This induces formation of early aggregates. 
This model does not reproduce the experimental results as: 
1. At least one more region should play a key role in the aggregation in addi-
tion to N-terminus and $-strand 4 (Plakoutsi et al. 2006).
2. "N11 Sso AcP should aggregate in the presence of peptides (section 3.2.3).  
3. "N11 Sso AcP should co-aggregate in the presence of wild type protein (sec-
tion 3.2.3). 
B.2.3 Interaction between N-terminus and $-strand 4; interaction between globular parts 
 
This is a variant of the previous model. In this case (see the figure) bridging of the N-
terminal tail does not give rise to a filamentous aggregate in which Sso AcP molecules in-
teract with two partners. By contrast, a larger assembly forms that can expand in three 
dimensions as N-terminal segment interacts with other regions of other Sso AcP mole-
cules as well (in the figure a two dimension aggregate is shown for simplicity reasons). 
This model does not reproduce the experimental results as: 
1. At least one more region should play a key role in the aggregation in addi-
tion to N-terminus and $-strand 4 (Plakoutsi et al. 2006). 
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2. "N11 Sso AcP should aggregate in the presence of peptides (section 3.2.3).
3. "N11 Sso AcP should co-aggregate in the presence of wild type protein (sec-
tion 3.2.3). 
B.2.4 Separate interactions between N-termini and globular parts 
Both N-terminus and fourth $-strand play a major role in the process. Aggregation of 
Sso AcP is mediated by interactions between the fourth $-strand and the globular 
part of another molecule and by intermolecular interactions of the N-terminal tails. 
This model does not reproduce the experimental results as:
1. "N11 Sso AcP should give rise to oligomers in the aggregation promoting 
conditions (section 3.2.3).
2. The peptide alone should aggregate in the aggregation promoting conditions 
((Plakoutsi et al. 2006) and section 3.2.3). 
3. Wild type Sso AcP should hijack "N11 Sso AcP into early aggregates (section 
3.2.3). 
4. At least one more region should play a key role in the aggregation in addi-
tion to N-terminus and $-strand 4 (Plakoutsi et al. 2006). 
B.2.5 Intra-molecular interaction between N-terminus and $-strand 4 
 
In the presence of 2,2,2-Trifluoroethanol (TFE) the N-terminal peptide gives rise to 
an intra-molecular interaction with $-strand 4. Thus, an aggregation nucleus forms 
that polymerises generating the early aggregates. 
This model does not reproduce the experimental results as:
1. The mutant with the tail at C-terminus should not aggregate because the un-
structured tail cannot reach $-strand 4 in the mutant (section 3.2.1). 
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2. Since the interaction is an intra-molecular one, presence of peptides should
speed up aggregation of wild type Sso AcP and induce aggregation of "N11 
Sso AcP (section 3.2.3). 
3. At least one more aggregation promoting region should be found (Plakoutsi 
et al. 2006). 
B.2.6 Non-specific intra-molecular interaction between N-terminal segment and 
globular part of the Sso AcP molecule 
 
In the presence of TFE the N-terminal peptide gives rise to a non-specific intra-
molecular interaction with different regions of the globular part of Sso AcP as the 
molecule somehow opens due to the destabilisation in the TFE solvent (see the fig-
ure). This leads to the formation of an aggregation prone state that is able to initiate 
the amyloid-like aggregation process. 
This model does not reproduce the experimental results as: 
1. Since the interaction is an intra-molecular one, presence of peptides should 
speed up aggregation of wild type Sso AcP and induce aggregation of "N11 
Sso AcP (section 3.2.3).
2. Since the interaction is non-specific, no aggregation promoting regions 
should be found (Plakoutsi et al. 2006). 
B.2.7 N-terminus and $-strand 4 interact with other regions 
 
In this model both N-terminal tail and fourth $-strand play a major role in the proc-
ess. However, they do not interact with each other. They interact specifically with dif-
ferent regions of the molecule. 
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This model does not reproduce the experimental results as:
1. "N11 Sso AcP should give rise to dimers in the aggregation promoting con-
ditions (section 3.2.3). 
2. At least two more aggregation promoting regions should be found with 
mutagenesis and limited proteolysis (Plakoutsi et al. 2006). 
B.2.8 Interactions N-terminus-N-terminus and $-strand 4-$-strand 4 
 
This model is built on the idea that early aggregates are stabilised by tail-to tail interac-
tions and strand-to-strand interactions. In the figure above the strands stack to each 
other giving rise to an antiparallel sheet but one can imagine a parallel sheet as well. 
This model does not reproduce the experimental results as:
1. "N11 Sso AcP should give rise to dimers in the aggregation promoting con-
ditions (section 3.2.3). 
2. The peptide alone should aggregate in the aggregation promoting conditions 
((Plakoutsi et al. 2006) and section 3.2.3). 
B.2.9 N-terminus acts as a bridge between two $-strands 4 
 
This is another possible model built using only the N-terminus and the fourth $-
strand only. In this case an interaction between the strands is mediated by the termi-
nus. A pyramid-like aggregate forms. 
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This model does not reproduce the experimental results as:
1. "N11 Sso AcP should dimerise in conditions that promote aggregation of 
wild type protein (section 3.2.3). 
B.2.10 Destabilisation induced by N-terminus 
 
In this model N-terminal tail and fourth $-strand play different roles in the process. 
Since a stabilisation was shown in "N11 Sso AcP (Plakoutsi et al. 2006), it is possible 
that in the presence of TFE the tail destabilises the globular part of Sso AcP. This fa-
cilitates fluctuations within the native-like state populated in TFE. Thus, the fourth 
$-strand leads to the formation of native-like assemblies. 
This model does not reproduce the experimental results as: 
1. The I72Vmutation on "N11 Sso AcP should induce aggregation on the same 
time scale as the wild type protein (section 3.2.2). 
2. Peptides should not affect the wild type aggregation (section 3.2.3). 
 
B.2.11 N-terminus induces formation of an aggregation prone monomer through 
specific interactions 
 
In the presence of TFE the native monomer and an aggregation prone monomer in 
which the fourth $-strand is in an amyloidogenic conformation are in equilibrium. 
The tail plays a major role in the transition state of this equilibrium by interacting 
specifically with the fourth $-strand. This interaction is a fundamental step in the 
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formation of the aggregation prone monomer. Starting from such a state the fourth 
$-strand leads to the formation of native-like assemblies. 
This model does not reproduce the experimental results as:
1. Peptides should promote aggregation of "N11 Sso AcP (section 3.2.3). 
2. Peptides should increase the aggregation rate of wild type Sso AcP (section 
3.2.3). 
3. C-tail Sso AcP should not aggregate (section 3.2.1). 
B.2.12 N-terminus induces formation of an aggregation prone monomer through 
non-specific interactions 
 
In the presence of TFE the native monomer and an aggregation prone monomer in 
which the fourth $-strand is in an amyloidogenic conformation are in equilibrium. 
The tail plays a major role in the transition state of this equilibrium by interacting 
with the globular unit in a non-specific way. Starting from this aggregation prone 
monomer, the fourth $-strand leads to the formation of native-like assemblies. 
This model does not reproduce the experimental results as:
1. Peptides should promote aggregation of "N11 Sso AcP (section 3.2.3). 
2. Peptides should increase the aggregation rate of wild type Sso AcP (section 
3.2.3). 
B.2.13 A domain swapping based model 
This model is based on domain swapping. In the presence of TFE $-strand 4 of a 
molecule replaces $-strand 4 of the following molecule. This leads to the formation of 
early aggregates. 
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This model does not reproduce the experimental results as: 
1. "N11 Sso AcP should aggregate and co-aggregate with wild type protein 
(section 3.2.3). 
2. I72V-"N11 Sso AcP should aggregation (section 3.2.2). 
3. Peptides should have no effect on the aggregation of both wild type Sso AcP 
and "N11 Sso AcP (section 3.2.3). 
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